Yaya tsawon lokacin da waɗannan alamun suka kasance?
Kuma musamman ma a cikin mutanen shekarunku, ya kamata a bi da dukan ciwon kirji kamar haka.
Kuma da zazzabi
Kuma ya kamata a gwada yawan cholesterol da ke cikin jininka.
Kuma kana da zazzabi yanzu?
Kuma yanzu kana da wannan ciwon a kirji?
Kuma ba ka da wahalar numfashi?
Kuma za ka iya gaya mini wasu alamun da kake da su a lokacin?
Kuma yawan zafin jikinka
Kuma ina da tari.
Kuma ina da ɗan sanyi da tari.
Kuma a yau, na ji ciwon kirji sosai.
Kuma shin lokaci ne da ya dace ka yi ciwon hay
Kuma yana sa a ji zafi a kirji.
Kuma ina jin kamar ina da zazzabi.
Kuma ina so ku gaya mini inda ciwon kirji yake.
Kuma suna da wata zazzabi.
da kuma tarihin ciwon sukari.
Kuma ina so in gaya muku cewa na ji kamar an murƙushe ƙirjina.
Kuma ina so in gaya muku cewa mutane suna yin tari a kaina a kowane lokaci.
Kuma kana jin zafi a kirji.
Kuma ka ce wannan matsin ne a cikin kirjinka.
Kowa a cikin iyalin yana da ciwon zuciya, ciwon zuciya, bugun zuciya, hawan cholesterol, hawan jini
Da akwai wasu alamun ko matsaloli da ka lura da su tare da ciwon tsoka?
Akwai wasu a cikin iyalinku da suke da irin wannan ciwo kamar yadda kuke da shi?
Kana da wasu alamu?
Kana numfashi?
Har yanzu kana jin ciwon kirji?
Domin wannan shine lokacin mura.
Amma bai kamata mu ware ciwon kirji daga ciwon zuciya ba.
Amma akwai wata matsala da ta fi tsanani, wato ciwon kirji.
Amma ina da matsala na numfashi.
Amma na san cewa mutane da yawa suna yin tari a kaina.
Amma muna bukatar mu ɗauki kowace irin ciwon kirji da muhimmanci.
Amma kana numfashi sosai yanzu?
Na manta da wannan ciwon a cikin kirji.
Shin yana kama da wani yana damfarar kirjinka?
Shin har yanzu kana numfashi?
Suna kuka ne cewa suna rashin lafiya da irin wannan alamun?
Shin kana da wata matsala ta kullum kamar hawan jini ko wani abu?
Kana da wasu matsaloli na rashin lafiya na dogon lokaci kamar ciwon sukari?
Kana da matsalar numfashi tare da ciwon kirji?
Kana da hawan jini?
Kana da wata matsala da numfashi tare da shi?
Ka san alamun da ya nuna?
Kana ganin hoton?
Ka sha ruwa mai yawa a yau
Duk da haka, ina yin gwajin ciwon sukari.
Ko da yake yana da irin halayena.
Yaya zafin zafin jikinka?
Yaya hawan jini?
Idan zazzabi ya ci gaba da ƙaruwa
Idan zazzabinka ya kai digiri 102 ko fiye
Idan ka ga cewa kana da wata cuta ko kuma wata cuta da take bukatar ƙarin kulawa
Na yi zazzabi a jiya.
Na kuma yi zazzaɓi.
Ina da zazzabi jiya.
Ina da ciwon kirji mai tsanani a nan.
Ina da ɗan wahalar numfashi.
Zan aiko muku da hoto.
Ina jin zafi a kirji a yau.
Ina da ciwon kai da zazzabi a yau.
Ina ganin cewa mura ce.
Ina ganin cewa, mura ce mai saurin kamuwa da cutar.
Shin yana kama da wani mutum mai nauyi yana zaune a kan kirjinka?
Ya fara da ciwon kai da kuma zazzabi.
Hakan na sa ni ciwo a tsakiya na kirji.
Wannan yana kama da ciwon kirji.
Yana cikin ƙirjina.
Wannan yana tsakiyar kirjina.
Wannan yana tsakiyar kirji.
Ina da ciwon kirji.
Ina matukar damuwa da ciwon kirji.
Ina so ku yi bayani dalla-dalla game da ciwon kirji.
kamar hawan jini ko ciwon sukari
kamar a tsakiyar kirji
Yanzu za ka iya shan takpirina mai ɗanɗano don zafin jiki
Mary, ka san tsawon lokacin da kake da alamun cutar?
Yanzu ka ce kana da ciwon kirji.
Wani lokaci ina jin zafi a kirji.
To, kana da wasu alamu ban da ciwo?
Ko kuwa kana jin kamar wani yana zaune a ƙirjinka?
Yana kama da ciwon kai da kuma ciwon tsoka da zazzabi da kuma tari.
daidai a tsakiyar kirji
Ka nuna mini hoton inda kake jin zafi.
Tun da ka samu zazzabi
To, kana ganin wasu daga cikin waɗannan alamun suna da nasaba da yin ciki?
Shin yaranku suna nuna wasu daga cikin irin waɗannan alamun?
Ka gaya mini game da ciwon kirji
Zafi yana ƙaruwa da dare
zazzabi da na sha a cikin kwanaki biyu da suka wuce
Jinin da ya wuce ya fara tashi.
Ni ne Dokta Porter a cibiyar kula da gaggawa.
Za ka iya gaya mini game da ciwon kirji?
Ina jin zafi a gaban jikina, a nan a kirji na.
Ina jin zafi sosai a kirji.
Ina jin zafi a kirji
Wane irin ciwo kake ji a kirji?
Yaushe ne ciwon kirji ya fara?
Ina kake jin ciwon kirji?
Ina kake jin wannan ciwon kirji?
Za ka ji kamar ƙirjinka yana da ƙarfi.
Ina so in gaya muku cewa ina da ciwon sukari da dai sauransu.
Ka ce kana da ciwon kirji.
Ƙarfafa ƙaruwar cutar coronavirus (COVID-19) a Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Ƙasar Ingila, daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Cigaban yaduwar cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin EU / EEA da United Kingdom, wanda ke tabbatar da cewa cutar ta COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe, tana faruwa a matakai daban-daban dangane da ƙasa.
Dangane da kwarewar da aka samu daga Italiya, ƙasashe, asibitoci da rukunin kulawa mai mahimmanci ya kamata su haɓaka shirye-shiryen su don saurin ƙaruwar marasa lafiyar COVID-19 waɗanda ke buƙatar kulawa ta lafiya, musamman kulawa mai zurfi.
An sanar da wani rukuni na cututtukan ciwon huhu da ba a san su ba a ranar 31 ga Disamba, 2019, a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafi, China ta sanar da sabon coronavirus, wanda yanzu ake kira da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
Tun daga wannan lokacin, cutar da SARS-CoV-2 ke haifarwa an sanya mata sunan cutar Coronavirus (COVID-19).
Shaida har zuwa yau ita ce kashi 80% na mutanen da ke da COVID-19 suna da ƙananan cututtuka, wato, cututtukan numfashi tare da ko ba tare da cutar ba, kuma mafi yawansu suna warkewa.
A cikin kashi 14 cikin ɗari, COVID-19 yana ci gaba da zama mafi munin cuta da ke buƙatar asibiti yayin da sauran kashi 6 cikin ɗari ke fuskantar mummunan cuta da ke buƙatar kulawa mai mahimmanci.
Mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4 cikin dari.
A cikin wannan binciken, mun kimanta yanayin yaduwar COVID-19 a kowace ƙasa a cikin EU / EEA da United Kingdom (UK) kuma mun gwada shi da lardin Hubei, China.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da UK da Italiya a lokacin 31 ga Janairu - 15 ga Maris, 2020.
Al'amuran COVID-19 a ƙasashen EU/EEA da UK
Bayan China, COVID-19 ya ci gaba da yaduwa ta hanyar yanki kuma a halin yanzu, COVID-19 ya wuce sauran ƙasashe na duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon EU da aka tabbatar da COVID-19 bisa ga ma'anar yanayin WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon mutane uku da aka tabbatar da su a ranar 24 ga Janairu, 2020 a cikin mutanen da ke dawowa daga Wuhan, lardin Hubei, China.
Ya zuwa 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashe 30 na EU/EEA da United Kingdom (UK), tare da 17,750 da mutuwar 1,441 daga Italiya kaɗai, tare da rahoton 39,768 da mutuwar 1,727 tsakanin 31 ga Disamba, 2019 da wannan kwanan wata.
Samun adadin adadin COVID-19 da kuma yaduwar cutar
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta ƙididdigar COVID-19 da aka ruwaito daga kowace ƙasa a duniya a kowace rana da karfe 8:00 na safe, daga tushe na hukuma kawai kamar ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da WHO.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin EU / EEA da UK da kuma kwatanta su da cutar a Italiya.
A matsayin wakilin yaduwar shari'o'in COVID-19 masu aiki, mun ƙididdige taƙaitaccen yaduwar kwanaki 14 na COVID-19 a cikin kowane EU/EEA da UK, yayin la'akari da yanayin yanayin COVID-19 a cikin lokacin Janairu 1 - Maris 15, 2020.
Mun kuma nuna adadin adadin masu kamuwa da cutar a kowace kasa da aka ruwaito a ranar 15 ga Maris, 2020 da karfe 8:00 na safe, idan aka kwatanta da Italiya, a lokacin Janairu 31 - Maris 15, 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da UK
Yanayin kwanan nan na kwanaki 14 na COVID-19 a cikin ƙasashen EU/EEA da UK yawanci yana bin lardin Hubei (China) (Hoto 1).
A cikin EU/EEA da kuma duk Burtaniya, jimlar yaduwar COVID-19 ta fara ƙaruwa a kusa da 21 ga Fabrairu kuma ta ƙaru sosai a kusa da 28 ga Fabrairu, 2020 (Supplementary Material).
Wannan ya kasance ne saboda ƙaruwar ƙaruwar adadin waɗanda aka ba da rahoton daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun ga irin wannan ƙaruwar ƙaruwar COVID-19 (Supplementary Material).
Hoto na 2 ya nuna adadin adadin COVID-19 a cikin EU/EEA da UK idan aka kwatanta da Italiya a cikin Janairu 31 - Maris 15, 2020.
Wannan ya nuna cewa a ranar 15 ga Maris da karfe 8:00 na safe, sauran ƙasashen EU/EEA 15 da Burtaniya sun riga sun ba da rahoton jimlar adadin masu cutar da za a iya kwatanta su da na Italiya makonni 3 da suka gabata ko kuma ƙasa da haka.
Sakamakonmu ya nuna cewa adadin waɗanda aka ba da rahoton COVID-19 suna ƙaruwa cikin sauri a EU/EEA da UK.
Yanayin da aka lura da shi a cikin yaduwar COVID-19 yana ba da shawarar cewa annobar tana ƙaruwa a cikin ƙasashe duka.
Wannan duk da cewa akwai matakai daban-daban a cikin ƙasashe, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa, da ma'anar ma'anar shari'ar da za a iya bambanta a cikin ƙasashe, da kuma ka'idoji daban-daban don zaɓar marasa lafiya waɗanda dole ne a bincika don tabbatar da COVID-19, gami da kamawa da gwaji.
A farkon Maris 2020, likitoci a yankunan da ke fama da cutar a Italiya sun ba da rahoton yanayin da kashi 10% na marasa lafiya na COVID-19 ke buƙatar kulawa mai zurfi kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da rukunin kulawa mai zurfi a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Ana samun bayanai game da asibiti da / ko sashen kulawa mai tsanani na COVID-19 a halin yanzu a matakin EU / EEA don kashi 6% da 1% na shari'o'in, bi da bi (ba a nuna ƙididdiga ba).
Duk da haka, ya kamata a tattara su a hankali don ƙara yawan bayanan sa ido na yanzu, wanda ke mai da hankali kan adadin waɗanda aka ba da rahoton da kuma adadin mutuwar.
Wani bincike da aka yi a shekara ta 2010-11 ya nuna cewa akwai bambanci sosai a wajen samun gado na kulawa mai tsanani da na matsakaici a Turai, daga 29.2 a Jamus zuwa 4.2 a Portugal a kowace dubu ɗari.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu da yawa ko ƙasa da na Italiya (kwana 12.5 na kulawar tsananin kulawa da kulawar matsakaici a kowace mutane 100,000 a cikin 2010-11).
Rashin haɗari na asibiti na COVID-19 na ƙarfin gado na kulawa mai zurfi &gt; 90% na haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗ
Tun da yake har yanzu akwai ƙaruwar lamura a cikin ƙasashen EU/EEA da wasu yankuna na Burtaniya kuma asibitoci da na'urorin kulawa mai zurfi suna ba da sabis ga jama'ar yanki da aka ƙayyade, ya kamata a samar da bayanai game da lamura da gadajen kulawa mai zurfi a matakin Nomenclature of Territorial Units for Statistics 2 (NUTS-2) da farko.
Kwarewa daga Italiya da kuma halin da ake ciki a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ƙaruwa cikin sauri a EU/EEA da UK.
Saboda haka, ƙasashe, asibitoci da rukunin kulawa mai mahimmanci ya kamata su shirya kansu don yanayin ci gaba da yaduwar SARS-CoV-2 a cikin al'umma da kuma karuwar adadin marasa lafiya na COVID-19 da ke buƙatar kulawa ta lafiya, musamman kulawa mai zurfi kamar yadda yake faruwa a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka nuna a cikin sabon ƙididdigar haɗarin ECDC, tare da sauyawar da aka yi na ƙuntatawa zuwa ragewa, ana buƙatar hanzari, hanzari da kuma cikakkiyar hanyar rage yaduwar SARS-CoV-2, saboda idan ba a aiwatar da lokaci ba, ƙaruwa mai sauri da ake tsammani a cikin adadin shari'o'in na iya ba da isasshen lokaci ga masu yanke shawara da asibitoci don fahimta, yarda da daidaita martani.
Binciken Hadarin Hadari ya kuma lissafa matakan kiwon lafiya na jama'a don magance tasirin cutar.
Kasashe ba su da damar da za su kara karfafa kokarin da suke yi na hana yaduwar SARS-CoV-2 da kuma rage matsin lamba a kan kulawar lafiya.
Idan hakan ya gaza, akwai yiwuwar tsarin kiwon lafiya na sauran ƙasashen EU/EEA zai fuskanci ƙaruwar marasa lafiya da ke buƙatar kulawa mai zurfi a cikin kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19) da ke haifar da cutar SARS-CoV-2 ta kashe mutane sama da 3,000, kuma ta kamu da mutane sama da 80,000 a China da sauran wurare a duniya, sakamakon hakan ya haifar da bala'i ga mutane.
Kamar kwayar cutar SARS-CoV da ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya yaduwa daga batutuwan kuma yana haifar da alamun kama da juna ta hanyar aiki iri ɗaya.
Ko da yake COVID-19 yana da ƙananan tsanani da mutuwa fiye da SARS, amma yana da yaduwa sosai kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
A cikin amsa ga yawan littattafai masu tasowa a kan cututtuka masu tasowa, wannan labarin yana ƙoƙari ya ba da lokaci da kuma cikakken nazari game da batun bincike mai tasowa.
Za mu tattauna abubuwa masu muhimmanci game da cutar, ilimin cututtuka, ilimin cututtuka, ganewar asali, magani, tsinkaya da kuma rigakafin cutar.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan cewa wannan bita zai taimaka wajen fahimtar cutar da kuma kawar da ita.
Taron bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa tsammani ba ga duk mutanen China waɗanda aka nemi su zauna a gida a duk lokacin hutu da makonni da yawa bayan haka saboda barkewar cutar Novel Virus.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar SARS a 2003; saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sanya sunan SARS-CoV-2 kuma ta sanya sunan cutar da ke da alaƙa da cutar CoV Disease-19 (COVID-19).
Cutar ta fara ne a Wuhan, China kuma ta bazu cikin sauri zuwa duk ƙasar da kusan wasu ƙasashe 50 na duniya.
Har zuwa 2 ga Maris, 2020, an sami ƙarin lamura 80,000 da aka tabbatar da COVID-19 tare da fiye da marasa lafiya 40,000 da aka sallama daga asibiti kuma fiye da marasa lafiya 3,000 sun mutu saboda cutar.
WHO ta yi gargadin cewa COVID-19 shine abokin gaba na 1 na jama'a kuma mai yiwuwa ya fi ta'addanci ƙarfi.
A cikin ƙasa da watanni biyu bayan rahoton farko a ranar 7 ga Janairu, 2020, an buga fiye da 200 articles akan COVID-19, ciki har da virology, epidemiology, forensics, diagnosis, da magani, wanda ya ƙaddamar da jerin ƙwayoyin cuta ta hanyar keɓewa daga marasa lafiya da yawa, a cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/).
Wannan bita yana ƙoƙari ya ba da labari game da ci gaban bincike a kan sabon kuma mai saurin bunkasa batun.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da kuma wasu cututtuka da ke haifar da CoV, kamar su cututtukan numfashi na Gabas ta Tsakiya (MERS, wanda ya barke a shekarar 2012).
Za mu tattauna abin da muka koya game da rigakafi da kuma tsinkaya na cutar, da kuma wasu tambayoyi masu muhimmanci.
CoVs an yi imani da su a matsayin masu cutarwa ga mutane ba tare da cutar ba, da farko suna haifar da kusan 15% na mura na kowa 4.
Koyaya, a wannan karni mun fuskanci sau biyu na cutar ta mutum, wato, SARS-CoV da MERS-CoV, waɗanda suka fara barkewa a China a 2003 da Saudi Arabiya a 2012 a bi da bi kuma nan da nan suka bazu zuwa wasu ƙasashe da yawa tare da mummunan rashin lafiya da mutuwa.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta CoV a cikin tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, an fara sanar da kwararar cutar ciwon huhu daga Wuhan zuwa Hukumar Lafiya ta Kasa ta kasar Sin a ranar 31 ga Disamba, 2019.
An sake jerin CoVs bayan kwana bakwai.
An ba da rahoton farkon cutar daga Wuhan a ranar 15 ga Janairu, 2020.
A wannan lokacin, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe.
A ranar 20 ga Janairu, an sami rahoton kamuwa da cuta a cikin masu ba da kiwon lafiya, wanda ya nuna cewa yiwuwar kamuwa da mutum daga mutum.
A ranar 23 ga Janairu, an rufe birnin Wuhan tare da rufe dukkan hanyoyin zirga -zirgar jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti kan cutar ya ba da rahoton cewa kawai 21 daga cikin marasa lafiya 41 da ke da lamuran da aka tabbatar suna da hulɗa kai tsaye da kasuwar abincin teku ta Wuhan, wanda ake ganin shine farkon kamuwa da cuta daga wani tushen dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana annobar a matsayin bala'in kiwon lafiya na duniya.
A lokacin wannan rahoton, cutar ta riga ta bazu a duk faɗin China da kusan wasu ƙasashe 50 na duniya (Figure (Figure 2).2).
Tun da yanayin yana ƙaruwa da sauri, har yanzu ba a ƙayyade ƙarshen yaduwar cutar da kuma tsananin cutar ba.
Nazarin da aka yi a wurare da yawa na marasa lafiya 8,866, ciki har da 4,021 da aka tabbatar da marasa lafiya na COVID-19 a ranar 11 ga Fabrairu, 2020 ya ba da mafi kyawun hoto na annoba kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, amma galibi tsakanin shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne a ƙarƙashin shekaru 20, kuma mutane 14 ne kawai ke da shekaru 10 ko ƙasa da haka.
Maza sun fi kamuwa da SARS-CoV-2 fiye da mata (0.27/100,000) da maza (0.31/100,000).
COVID-19 ya yadu a cikin garken da ke kewaye da Hubei.
COVID-19 ya ɗauki matsakaicin kwanaki 5 (2-9) daga farawa zuwa ganewa.
Matsakaicin lokacin incubation ya kasance kwanaki 4. 8 (3.0 - 7.2).
Matsakaicin lokaci daga farkon zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13).
Lambar haifuwa ta asali (R0) ta kasance 3.77 (95% CI: 3. 51 - 4. 05) kuma daidaitaccen R0 ya kasance 2. 23 - 4. 82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, wanda ya yi daidai da yawan zirga-zirgar ababen hawa a China kafin bikin bazara.
Yawan mutuwar marasa lafiya da aka tabbatar da su ya kai 1.44% (95% CI: 1.10-1.86%) kuma adadi na mutuwar marasa lafiya ya kai 3.06% (95% CI: 2.02-4.59%).
Manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥ 60), da kuma ciwon huhu mai tsanani.
CoVs wani ƙaramin iyali ne na ƙwayoyin cuta masu girma da kuma masu ɓoyewa waɗanda suke da ƙwayar RNA guda ɗaya.
Ana iya rarraba su zuwa tsara huɗu, wato, Alpha, Beta, Gamma da Delta, waɗanda aka san cewa Alpha da Beta-CoVs suna cutar da mutane.
Glycoprotein na shinge (S) yana haɗuwa da mai karɓar ƙwayarta na angiotensin - mai canza enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4), a cikin SARS-CoV da MERS-CoV, bi da bi, sannan kuma ya haɗu da membrane.
Kwayar RNA ta kwayar cutar ta fito cikin kwayoyin halitta; bayan kwayar cutar ta fito, kwayar halitta ta samar da kwayar RNA mai nau'in genomic tare da glycoproteins da nucleocapsid proteins, wanda daga baya ya hada da membrane na plasma don sakin kwayar cutar.
An sanar da jerin kwayoyin farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV wanda ya sami daidaiton kwayoyin halitta sama da kashi 99.98% a cikin samfuran jerin 10 da aka tattara daga kasuwar abincin teku ta Hunan, Wuhan, asalin asalin cutar.
SARS-CoV-2 ya fi kama da SARS-CoV a cikin kwayoyin halitta fiye da MERS-CoV.
Ta hanyar watsawa ta hanyar duba siginar lantarki, an gano SARS-CoV-2 a cikin sassan da ba su da kyau na kwayar halittar mutum.
An gano ACE2 na mutum, tare da SARS-CoV-2, a matsayin mai karɓa ga SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana haɗuwa da ACE2 na ɗan adam tare da rashin ƙarfi fiye da SARS-CoV wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta mai tsanani a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya ƙirƙirar sabon ƙaramin furotin wanda aka tsara ta orf3b da kuma furotin da aka ɓoye wanda aka tsara ta orf8.
Orf3b na SARS-CoV-2 na iya taka rawa a cikin cutar kwayar cuta da kuma hana bayyanar IFNβ; kodayake orf8 ba shi da sanannen yanki ko yanayin aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun ba da rahoton tsarin cryo-EM na ACE2 na cikakken tsayi na mutum a ƙuduri 2.9 Å a cikin haɗuwa da mai ɗaukar amino acid B0AT1.
Sun gano cewa cakuda, wanda ke da kyauta da kuma rufewa, an tsara shi azaman dimer kuma ACE2-B0AT1 cakuda na iya haɗa sunadarai biyu na S wanda ke ba da shaidar ganowa da kamuwa da cutar CoV.
B0AT1, zai iya zama makasudin magani don gwajin magani don hana kamuwa da cutar SARS-CoV-2.
Abincin farko da na tsakiya
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga bat kuma an watsa su ga mutane ta hanyar civet cat da raƙumi, bi da bi.
Ta hanyar kwatanta jinsi na SARS-CoV-2 da sauran CoVs, an yi la'akari da bat a matsayin asalin mai gina jiki na SARS-CoV-2 saboda sabon kwayar cutar tana da kama da kashi 96% na SARS-like CoVs guda biyu da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san wane matsakaiciyar mai gina jiki ta taimaka wajen cutar da kwayar cutar ta ƙetare shingen jinsin zuwa ɗan adam ba kuma hanyar watsawa har yanzu tana bayyana.
Ji, et al., sun ba da shawarar cewa macizai sun zama masu ɗaukar kwayar cutar daga bat zuwa ɗan adam wanda ya haɗa da sake haɗuwa da S protein.
A cikin wani bincike, masu bincike a Guangzhou, China sun nuna cewa pangolin - mai tsayi mai tsayi, mai cin dabbobi masu shayarwa da ake amfani da shi a cikin maganin gargajiya na kasar Sin - na iya zama matsakaiciyar matsakaiciyar SARS-CoV-2 bisa ga kamannin kwayoyin halitta 99% da aka samu a cikin CoVs a pangolin.
Duk da haka, bambancin 1% a cikin dukkanin kwayoyin halittar biyu har yanzu babban bambanci ne; saboda haka, ana jiran sakamako mai mahimmanci don tabbatar da tabbaci (Figure (Figure 33).
Abubuwan jiki na SARS-CoV-2 ba a san su ba tukuna.
SARS-CoV da MERS-CoV na iya rayuwa na tsawon sa'o'i 48 a cikin yanayi mai bushe na wucin gadi da kuma kwanaki 5 a yanayin zafi da ke ƙasa da 20 °C da kuma 40-50% na zafi.
SARS-CoV-2 na iya samun irin wannan halayen.
An bayar da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da UV a 56 °C na tsawon mintuna 30; ether, 75% ethanol, chlorine disinfectant, parasitic acid, chloroform da sauran mai narkewa na iya kashe kwayar cutar sosai, amma ba chlorhexidine ba.
Dukan al'ummar dan Adam ba su da kariya ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da cutar.
Babu wani bincike mai zurfi da aka ruwaito game da amsawar rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya yin nuni ne kawai ga binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Figure (Figure 4).4).
A yadda aka saba, bayan kamuwa da cuta ta shiga cikin mai gina jiki, tsarin rigakafin endogenous na mai gina jiki ne zai fara gane ta daga masu karɓar ganewar asali (PRR) ciki har da masu karɓar C-type lectin-like, masu karɓar Toll-like (TLR), NOD-like (NLR), da RIG-I-like (RLR).
Ta hanyoyi daban -daban, kwayar cutar tana haifar da bayyanar abubuwan ƙwayoyin cuta, balagawar ƙwayoyin dendritic da kuma hadawar nau'in I na interferons (IFNs) wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta macrophage phagocytosis na kwayar cutar.
Koyaya, N protein na SARS-CoV na iya taimakawa kwayar cutar ta guje wa amsawar rigakafi.
Ba da daɗewa ba, tsarin rigakafi mai daidaitacce ya shiga cikin yaƙi da ƙwayoyin cuta.
Kwayoyin T, ciki har da CD4+ da CD8+ T sun taka muhimmiyar rawa wajen karewa.
CD4+ T cells suna motsa B cells su samar da ƙwayoyin cuta na musamman da kuma CD8+ T cells suna kashe kwayoyin cuta kai tsaye.
T ƙwayoyin taimako suna samar da ƙwayoyin ƙwayoyin cuta masu hana kumburi don taimakawa ƙwayoyin karewa.
Koyaya, CoVs na iya hana T-cell aiki ta hanyar kashe T-cell.
Tsayayyar triphosphate, gami da ƙarin abubuwa da rigakafi kamar C3a da C5a, ma suna da mahimmanci don yaƙar kamuwa da kwayar cuta.
Alal misali, rigakafin da aka ware daga mai warkewa ya kashe MERS-CoV.
A wani ɓangare kuma, yawan amsawar jikin mutum yana haifar da yawan ƙwayoyin cuta da ke cikin jiki wanda zai iya sa a yi ciwo mai tsanani ga huhu da sauran gabobin jiki, har ma da rashin ƙarfi da mutuwa a cikin yanayi mafi muni.
Cutar SARS-CoV-2 mai alamar farawa a cikin garke na iya shafar tsofaffi da mata masu juna biyu.
Yana da kyau a lura cewa mutanen da suka kamu da ƙwayoyin cuta da yawa ko kuma waɗanda suke da tsarin rigakafi iri ɗaya suna iya kamuwa da cutar fiye da sauran.
Dangane da nazarin shari'o'i 425 na farko a Wuhan, an kiyasta matsakaicin lokacin incubation na SARS-CoV-2 kwanaki 1-14, mafi yawa kwanaki 3-7.
Duk da haka, nazarin shari 'yan 1,099 ya nuna cewa tsawon lokacin incubation ya kasance kwanaki 3 a matsakaici kuma ya kasance daga kwanaki 0 zuwa 24.
Kamar yadda aka ambata a sama, binciken kwanan nan bisa alƙaluma na 8,866 ya nuna cewa lokacin incubation ya kasance kwanaki 4.8 (3.0-7.2).
Daidaita lokacin keɓewa mai tasiri bisa ga mafi ƙarancin lokacin incubation kuma don haka hana mutane kamuwa da cutar amma marasa alamun cutar daga watsawa ga wasu mutane yana da mahimmanci ga hukumomin kiwon lafiya.
A matsayin al'ada, mutane da suka sadu da cutar ko kuma suka kamu da ita suna buƙatar keɓewa na kwanaki 14.
Shin ya kamata a ƙara tsawon lokacin keɓewa zuwa kwanaki 24?
Zazzabi shine babban bayyanar COVID-19 wanda ba shi da alamun bayyanar ko kuma yana iya haɗawa da wasu alamun kamar tari mai bushe, rashin numfashi, ciwon tsoka, dizziness, ciwon kai, ciwon makogwaro, hanci, ciwon kirji, ciki, amai da kuma amai.
Wasu marasa lafiya sun sami wahalar numfashi da/ ko hypoxemia bayan mako guda bayan fara cutar.
A cikin mawuyacin yanayi, marasa lafiya sun sami ƙaruwa cikin sauri na ciwon ciwon numfashi mai tsanani, haɗarin haɗari, ƙarancin ƙwayar cuta, da kuma ƙwayoyin cuta.
Ya kamata a gwada marasa lafiya da zazzabi da / ko cututtukan numfashi da kuma marasa ciwon zazzabi mai tsanani, har ma ba tare da rashin daidaituwa na zane -zane na huhu ba, don gano cutar a kan lokaci.
Nazarin alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98 na alamun cutar zazzabi, kashi 76 na tari, kashi 55% na numfashi mai wuya, da kashi 3% na zawo; kashi 8% na marasa lafiya suna buƙatar taimakon iska.
An ba da irin wannan sakamakon a cikin wasu nazarin da aka yi kwanan nan na garken da aka samu ta hanyar watsawa daga garken iyali da kuma mutum marar alamun.
A kwatankwacin haka, binciken alƙaluma na 2012 ya nuna cewa masu fama da cutar MERS-CoV suna da zazzabi (98%), tari mai bushe (47%) da kuma wahalar numfashi (55%).
Koyaya, fiye da marasa lafiya na COVID-19, kashi 80% na marasa lafiya suna buƙatar taimakon iska kuma wannan ya dace da cutar MERS fiye da COVID-19.
An kuma lura da zawo (26%) da kuma ciwon makogwaro (21%) a cikin marasa lafiya da cutar MERS.
A cikin marasa lafiya na SARS, zazzabi (99-100%), busasshiyar tari (29%-75%), wahalar numfashi (40%-42%), zawo (20-25%) da ciwon makogwaro (13-25%) sune alamun bayyanar kuma kusan 14%-20% na marasa lafiya suna buƙatar taimakon iska.
Rashin mutuwar COVID-19 ya kasance 2% har zuwa 14 ga Fabrairu, lokacin da lamuran da aka tabbatar a duniya suka kai 66,576.
A kwatankwacin haka, mutuwar SARS ta kasance kashi 10 cikin 100 na 8,096 da aka tabbatar da su a watan Nuwamba na 2002.
Ga MERS, yawan mutuwar mutane ya kai kashi 37 cikin dari na 2,494 da aka tabbatar da su, bisa ga binciken alƙaluma na Yuni 2012.
A cikin binciken da ya gabata, an ba da rahoton cewa R0 na SARS-CoV-2 ya fi 6.47 tare da 95% confidence interval (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4 kawai.
An gabatar da kwatancen SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, mutuwa da R0 a cikin tebur na 1.1.
Bayanan da ke sama sun nuna cewa SARS-CoV-2 yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma ba shi da haɗari fiye da na biyun.
Saboda haka, sarrafa cutar SARS-CoV-2 ya fi MERS-CoV da SARS-CoV kalubale.
Kungiya tana farawa ne daga iyali ɗaya ko rukuni ɗaya ko kuma daga wata mota kamar jirgin ruwa.
Marasa lafiya galibi suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da ke fama da cutar ko kuma hulɗa da mutane ko marasa lafiya a cikin makonni biyu da suka gabata tun farkon cutar.
Koyaya, an sanar da cewa mutane na iya watsa kwayar cutar ba tare da bayyanar ba fiye da makonni biyu kuma masu warkewa da aka sallame daga asibiti na iya sake watsa kwayar cutar, yana gargadin ƙara lokacin keɓewa.
A farkon lokaci, marasa lafiya suna da ƙananan ƙananan ƙwayoyin jini (musamman ƙwayoyin lymphocytes).
Misali, an gano lymphopenia da ƙaruwar matakan aminotransferase na aspartate da rigakafin cutar a cikin marasa lafiya 1,099 na COVID-19 tare da ƙididdigar ƙwayoyin jini, ciki har da ƙididdigar ƙwayoyin lymph 1×109/L.
A wasu marasa lafiya, an samu ƙaruwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
A cikin marasa lafiya masu tsanani, matakan D - dimer, wanda shine samfurin raguwar fibrin da ke cikin jini, ya ƙaru kuma ƙididdigar ƙwayoyin lymphocytes sun ragu.
Yawancin marasa lafiya na COVID-19 suna da rashin daidaito a cikin radiography na kirji kuma ana nuna su ta hanyar hotunan tabo na biyu ko kuma rashin haske na gilashin ƙasa a cikin huhu.
Yawancin lokaci marasa lafiya suna samun ciwon huhu mai tsanani, mummunar lalacewar huhu, da kuma ciwon numfashi mai tsanani (ARDS).
Lokacin da ARDS ya faru, ana lalata musayar gas sosai saboda rashin kulawa, tarin ruwa da ci gaba da fibrosis.
Yanayin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Saboda haka, sakamakon da ya fi muni na radiyo na ƙirji yakan zo daidai da yanayin da ya fi muni na cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya gano cewa, a cikin huhu na wani mai cutar da ya mutu, an sami kumburi na ƙwayoyin cuta, da hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan SARS.
Gano SARS-CoV-2 RNA ta hanyar maida-transcriptase polymerase chain reaction (RT-PCR) an yi amfani da shi azaman babban ma'auni don gano COVID-19.
Koyaya, saboda yawan ƙarancin kuskuren da zai iya hanzarta cutar, an fara amfani da shi don tantance bayyanar cututtukan asibiti a China a ranar 13 ga Fabrairu, 2020 (wanda ba ya dogara da RT-PCR kawai).
Haka ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwajin gwaji da binciken radiological ya zama dole kuma dole ne don yin ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, Feng Zheng Group ya ba da rahoton yarjejeniya ta amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano ɓangarorin SARS-CoV-2 RNA na wucin gadi a kan 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 a kowace microliter a shigarwa) ba tare da buƙatar kayan aiki mai zurfi ba, ta amfani da dipstick.
Idan an tabbatar da shi a cikin samfuran asibiti, ana fatan cewa sabuwar fasahar za ta iya haɓaka ƙwarewa da sauƙi.
Saboda rashin gogewa tare da sabon CoVs, likitoci na iya samar da kulawa mai mahimmanci ga marasa lafiya na COVID-19 tare da gwada wasu CoVs kamar SARS-CoV da MERS-CoV da magunguna daban-daban da aka yi amfani da su ko aka ba da shawarar su don magance sauran cututtukan ƙwayar cuta (tebur (tebur 2).2).
Waɗannan hanyoyin sun haɗa da maganin da ake yi yanzu da kuma wanda za a iya yi da maganin rigakafi, maganin hana rigakafi, maganin steroids, maganin plasma daga marasa lafiya da suka warke, maganin shinkafa, da taimakon ƙwaƙwalwa.
An kuma ba da shawarar yin amfani da jini daga marasa lafiya da suka warke.
Kamfanonin magunguna suna ta neman hanyoyin samar da rigakafi da kuma rigakafi.
SARS-CoV-2 yana fara kai hari ga huhu da kuma wasu gabobin da ke bayyana ACE2, kamar tsarin gastrointestinal da koda, a cikin ƙananan iyaka.
Duk da haka, rashin numfashi da rashin ƙarfi suna ci gaba da zama babbar barazana ga marasa lafiya kuma manyan abubuwan mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci don kawar da alamun cutar da ceton rai kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai yawa, iska mai iska mai iska, da iska mai iska mai iska, dangane da tsananin cutar.
Marasa lafiya da ke da alamun numfashi mai tsanani suna buƙatar taimako ta hanyar ingantaccen hanyar ƙwayar cuta ta zuciya da huhu, wanda ake amfani da shi wajen maganin cututtukan zuciya ko kuma rashin numfashi.
Bugu da ƙari, kiyaye ma'aunin lantarki, rigakafin cututtukan na biyu da magani da kuma mummunan rauni, da kuma kare ayyukan mahimman gabobin jiki, dukansu suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa annobar cytokine tana faruwa ne sakamakon yawan amsawar garkuwar jikin mutum a cikin marasa lafiya da SARS da MERS.
Cytokine Storm wani nau'in martani ne na tsarin samarwa wanda ke nuna sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan ƙwayoyin cytokines suna motsa ƙwayoyin cuta su saki ƙwayoyin cuta masu yawa waɗanda suke da babban dalilin ARDS da rashin ƙarfi na gabobin jiki da yawa.
Ana bukatar hana rigakafi wajen magance matsalar cytocin, musamman a marasa lafiya masu tsanani.
An yi amfani da maganin corticosteroid da tosilizumab, maganin rigakafin IL6-anti monoclonal, don maganin Cytotocin Storm.
Sauran maganin hana rigakafi na Cytokinine Storm sun hada da sauye-sauye a cikin amsawar rigakafin T cell; hana IFN-γ, IL-1, da TNF; hana JAK; blinatumumab; hana siginar Cytokinine 4; da kuma hana HDAC.
Ana amfani da steroids a matsayin maganin hana rigakafi a cikin maganin SARS don rage tsananin lalacewar mai bayarwa.
Koyaya, babban allurai na steroids bai kasance da amfani ba a cikin mummunan lalacewar huhu a cikin SARS da marasa lafiya na COVID-19.
Maimakon haka, suna iya haifar da mummunar sakamako mai tsanani, musamman ma rashin ƙarfi.
Duk da haka, ana ba da shawarar yin amfani da gajeren lokaci na maganin corticosteroid a ƙananan zuwa matsakaici a cikin marasa lafiya masu cutar COVID-19.
A lokacin rubuce -rubuce, babu wani maganin rigakafin cutar da aka tabbatar.
Koyaya, Remdesivir, analog na nucleotide a cikin jijiya, an sami tasiri a cikin wani mara lafiya na Amurka na COVID-19.
Remdesivir shine sabon maganin rigakafi wanda Gilead ta fara samarwa don magance cututtukan da Ebola da Malburg suka haifar.
Daga baya, Remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta masu cutar RNA, ciki har da MERS da SARS.
Dangane da waɗannan, Gilead ta samar da mahaɗin ga China don yin gwaji biyu akan mutanen da ke kamuwa da SARS-CoV-2 kuma ana tsammanin sakamakon.
Bugu da ƙari, baritsitinib, interferon-α, iopinavir/ ritonavir, da ribavirin an ba da shawarar su a matsayin magani mai yiwuwa ga marasa lafiya da ke da cututtukan numfashi mai tsanani.
Cutar ta hade da iopinavir/ ritonavir na iya haifar da zawo, naushi, amai, lalacewar hanta da sauran halayen rashin jin daɗi.
Ya kamata a kula da hulɗar waɗannan jiyya tare da sauran magunguna da ake amfani da su a cikin marasa lafiya.
Plasma da kuma samar da garkuwar jiki daga marasa lafiya da suka warke
Akwai dogon tarihi na tattara jini daga marasa lafiya da suka warke daga wani cuta mai saurin kamuwa don magance wasu marasa lafiya da ke fama da cutar ɗaya ko kuma don hana mutane masu lafiya kamuwa da cutar.
A gaskiya ma, marasa lafiya da suka warke suna da ƙwayoyin cuta masu yawa a cikin jini.
Kwayoyin rigakafi da ƙwayoyin B lymphocytes ke samarwa don yaƙi da ƙwayoyin cuta da sauran abubuwa na waje sune immunoglobulin (Ig) kuma suna gano ƙwayoyin da ba su da alaƙa da ƙwayoyin cuta kuma suna kashe su kai tsaye.
Bisa ga wannan, an tattara jini daga jinin wani rukuni na marasa lafiya waɗanda suka warke daga COVID-19 kuma an saka su cikin marasa lafiya 10 masu tsanani.
Alamar sun inganta cikin awanni 24 tare da rage kumburi da nauyin kwayar cuta da kuma ingantaccen oxygen a cikin jini.
Amma, kafin a samu takamaiman magani, ana bukatar tabbaci da kuma bayani don a ba da shawarar yin amfani da wannan hanyar a kan sikelin da ya fi girma.
Bugu da ƙari, duk da tasirin maganin, wasu haɗarin da ke tattare da plasma ya kamata a yi la'akari da hankali.
Alal misali, ƙwayoyin cuta suna iya sa rigakafin ya yi tsattsauran ra'ayi kuma su sa a samu ciwon cytokine, wanda zai iya kashe mutum.
Yawan rigakafi a cikin jini yawanci yana da ƙananan, kuma ana buƙatar plasma don magance marasa lafiya masu tsanani.
Yana da wahala a haɓaka da samar da takamaiman rigakafi cikin sauri don yaƙar cutar ta duniya.
Saboda haka, yana da mahimmanci kuma mai amfani don ware ƙwayoyin B daga marasa lafiya da suka warke da kuma gano lambar kwayar halitta da ke tsara ingantattun rigakafi ko bincika ingantattun rigakafi ga sunadarai masu mahimmanci na kwayar cutar.
Saboda haka, za mu iya ƙara yawan samar da rigakafi.
An yi amfani da TCM a cikin Sin don magance cututtuka da yawa na dubban shekaru.
Koyaya, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban -daban a cikin tsari daban -daban dangane da ƙayyadaddun cutar akan ka'idodin TCM.
Yawancin abubuwan da ke da tasiri ba a san su ba ko kuma ba su da amfani saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwan ko kuma mafi kyawun haɗuwa da su.
A halin yanzu, TCM ya zama ɗayan manyan hanyoyin magani na madadin ga marasa lafiya masu saurin bayyanar cututtuka ko waɗanda suka warke daga mawuyacin yanayi saboda rashin ingantaccen magani na musamman don COVID-19.
Misali, Shu Feng Ji Doo da Lian Hua Qing Wen sun sami tasiri wajen magance COVID-19.
Yawancin lardunan China, ciki har da Gansu (63.7%), Ninksiya (50%), da Hunan (50%), sun sami mafi yawan dawowar cutar COVID-19 a cikin kashi 87% na marasa lafiya da ke amfani da TCM, yayin da lardin Hubei, inda kusan kashi 30% na marasa lafiya na COVID-19 ke amfani da TCM, ya sami mafi ƙarancin dawowar (13%).
Amma, wannan kwatancen yana da ɗan taushi domin wasu abubuwan da za su iya shafar yanayin, kamar yawan marasa lafiya da kuma tsananin cutar, dole ne a yi la'akari da su.
A ranar 18 ga Fabrairu, 2020, Baili Zheng da abokan aiki sun buga wani bincike don kwatanta maganin Maganin Yammacin Turai (WM) kawai da kuma haɗin WM da TCM.
Sun gano cewa lokacin da ake buƙatar jiki ya daidaita, bayyanar cututtuka, da kuma asibiti a cikin WM + TCM sun kasance ƙasa da WM kawai.
Mafi mahimmanci, yanayin rashin lafiyar cutar (mai tsanani) a cikin WM + TCM ya kasance ƙasa da ƙimar (7.4% vs. 46.2%) fiye da na WM kawai, kuma yawan mutuwa ya kasance ƙasa a cikin WM + TCM kawai (8.8% vs. 39%).
Duk da haka, ana bukatar ƙarin gwaji mai kyau a manyan cibiyoyi don tabbatar da inganci da amincin TCM.
Zai kuma kasance mai ban sha'awa don gano tsarin aiki kuma idan ya yiwu ya bayyana abubuwan da ke da tasiri na maganin TCM ko haɗuwa da su.
Masu cutar da ake zargi ko kuma waɗanda aka tabbatar da su da COVID-19 suna jin tsoron cutar mai saurin yaduwa da kuma mutuwa, kuma waɗanda ke keɓewa suna jin haushi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, rashin ƙoshin lafiya da tari, da kuma illa na magani kamar rashin bacci da aka haifar da corticosteroids, na iya haifar da rashin jin daɗi da baƙin ciki.
A farkon farkon barkewar cutar SARS, an ba da rahoton cututtukan tunani da yawa, gami da ci gaba da damuwa, rashin nutsuwa, tashin hankali, tashin hankali, bayyanar cututtukan hankali, tashin hankali, har ma da kashe kansa.
Neman haɗuwa da keɓewa na dole a matsayin ɓangare na martani na kiwon lafiya na COVID-19 na iya sa mutane su kasance cikin damuwa da damuwa game da tasirin cutar, keɓewa, da kuma lalatar da danginsu da abokan su.
Saboda haka, ya kamata a samar da kulawar lafiyar hankali ga marasa lafiya, waɗanda ake zargi da COVID-19, da waɗanda suka haɗu da su, da kuma jama'a.
Tallafin halayyar dan adam ya kamata ya hada da kafa kungiyoyin kula da lafiyar kwakwalwa na fannoni daban daban, sadarwa mai kyau tare da ci gaba da ingantaccen sabuntawa game da barkewar SARS-CoV-2 da tsare-tsaren magani, da kuma amfani da na'urorin lantarki da aikace-aikace na sana'a don kauce wa kusanci da juna.
Ingantattun alluran rigakafi suna da mahimmanci don katse hanyar watsawa daga ƙwayoyin cuta na dabba da mutane masu kamuwa da cuta zuwa masu ƙwayoyin cuta masu mahimmanci kuma galibi suna dacewa da maganin antiviral a cikin sarrafa annoba saboda ƙaruwar ƙwayoyin cuta.
An yi ƙoƙari don haɓaka allurar rigakafin S-protein don samar da rigakafin rigakafi da / ko rigakafi na dogon lokaci da ƙarfi ga SARS-CoV.
An kimanta allurar rigakafin mai rai a cikin samfurin SARS na dabba.
Koyaya, tasirin waɗannan allurar rigakafin a cikin tsofaffi da kuma ƙirar ƙirar ƙira mai haɗari da amincinsu ga kamuwa da cutar cutar zuna mai cutar har yanzu ana ƙayyadewa kafin fara kowane binciken asibiti.
Wataƙila wannan ya faru ne domin SARS ya ƙare a hankali shekaru 17 da suka gabata kuma babu wani sabon shari 'a da aka ruwaito tun daga lokacin.
Akasin haka, kasancewar hanyoyin cutar a yankunan da ake da annobar, wasu lokuta da kuma garken MERS suna ci gaba da tasowa a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna.
An tsara dabarun allurar rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, plasma na DNA, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta, da kuma ƙananan ƙwayoyin cuta masu haɗuwa da wasu kuma an kimanta su a cikin ƙwayoyin cuta.
Samar da ingantaccen rigakafi mai inganci a kan SARS-CoV-2 ga mutanen da ba su da rigakafi, muhimmiyar mahimmanci ce ga shawo kan annobar da ke gudana.
Koyaya, buƙatar dogon lokaci (aƙalla watanni 18) a cikin haɓaka allurar rigakafi da ƙarancin ƙwarewa suna da ƙalubale saboda bambance -bambancen CoVs.
A matsayin sabon cuta, COVID-19 kwanan nan ya fara bayyana duk hanyoyin bincikensa a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya samun sauƙi ba tare da bayyanar cututtuka ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da ƙaruwar rashin lafiya da mutuwa a cikin marasa lafiya tare da mummunan lamura.
Saboda haka, yana da muhimmanci ga hukumomin kiwon lafiya su tsara tsarin ganewar asali don fifita ayyukansu, musamman ma a yankunan da ke da iyakantaccen albarkatu.
Dangane da binciken asibiti da aka sanar har yanzu, waɗannan abubuwan na iya shafar ko kuma suna da alaƙa da ganewar asali na marasa lafiya na COVID-19 (tebur (tebur 33):
Shekara: Shekara ita ce mafi mahimmancin abin da ke haifar da cutar SARS, wanda hakan ma ya shafi COVID-19.
Nazarin na 8,866 na COVID-19 ya faru ne da farko a cikin shekaru 30-65, 47.7% na marasa lafiya sun kasance sama da shekaru 50, kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai zurfi sun fi dacewa da ƙarancin damuwa da rikitarwa kuma waɗanda ba su da buƙatar su sun fi tsufa (a matsakaicin shekaru 51 vs. 66), wanda ke nuna cewa shekaru sune babban abin da ke haifar da sakamakon COVID-19 na marasa lafiya.
Jima'i: Maza sun fi mata kamuwa da cutar SARS-CoV-2 (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a sama.
Cutar cututtuka da rikitarwa: Marasa lafiya na COVID-19 da ke buƙatar kulawa mai tsanani suna da damar kamuwa da mummunan lalacewar zuciya da rashin ƙarfi.
Cutar zuciya ma ita ce sanadin mutuwa a cikin marasa lafiya na SARS.
An ba da rahoton cewa SARS-CoV-2 na iya haɗuwa da ACE2-positive cholangiocytes wanda zai iya haifar da cutar hanta a cikin marasa lafiya na COVID-19.
Yana da kyau a lura cewa shekaru da kuma rashin lafiya na iya shafar juna.
Binciken Lab na Musamman: Matsakaicin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko lalacewar kyallen takarda kuma an ba da shawarar a matsayin mai yuwuwar hasashen cutar, amsawa ga magani da warkewa a ƙarshe.
An kuma ba da shawarar cewa matakin CRP yana da alaƙa da tsananin COVID-19 da kuma ganewar asali.
Bugu da ƙari, ƙara yawan lactate hydrogenesis (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da kuma creatinine kinase (CK) na iya taimakawa wajen hango sakamakon.
Waɗannan enzymes suna bayyana a wurare da yawa, musamman a zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, su ne alamun cututtukan zuciya ko na hanta.
Babban bayyanar cututtuka: Radiography na kirji tare da sauran matsaloli da kuma ci gaban alamun cututtuka na lokaci-lokaci ya kamata a yi la'akari da su don hango sakamakon COVID-19 da rikitarwa.
Amfani da steroids: Kamar yadda aka ambata a sama, steroids sune maganin rigakafi wanda ake amfani dashi azaman maganin haɗin kai a cikin cututtukan cututtukan cututtuka don rage tsananin lalacewar mai ba da magani.
Tun da aka yi amfani da maganin corticosteroid mai yawa a cikin marasa lafiya masu cutar SARS, yawancin waɗanda suka tsira sun sha wahala daga rashin ƙarfi na jijiyoyin jiki tare da nakasa na tsawon rai da kuma ƙarancin ingancin rayuwa.
Saboda haka, idan ya zama dole, ya kamata a yi amfani da steroid a ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsanancin tunani: Kamar yadda aka ambata a sama, marasa lafiya da yawa sun sha wahala daga matsanancin damuwa yayin barkewar COVID-19, kamar yadda suka jimre da tsawan lokacin keɓewa da matsanancin rashin tabbas da kuma ganin mutuwar dangi na kusa da abokan su.
Yana da muhimmanci a ba da shawara ta ruhaniya da kuma taimako na dogon lokaci don taimaka wa waɗannan mutane su fita daga matsi kuma su koma rayuwa ta al'ada.
Binciken alƙaluma da aka yi ya nuna cewa COVID-19 yana da bambancin cututtuka da SARS.
Bugu da ƙari, yin kwafi a cikin ƙananan numfashi, SARS-CoV-2 na iya yin kwafi a cikin ƙananan numfashi kuma ba ya haifar da ƙananan ko babu alamun bayyanar cututtuka a farkon matakin kamuwa da cuta kamar sauran CoVs da ke haifar da sanyi.
Saboda haka, masu kamuwa da cutar na iya samar da kwayar cutar mai yawa a cikin ayyukan yau da kullun a farkon matakin ko lokacin incubation, tare da haifar da ƙalubale mai yawa a cikin sarrafa cutar.
Koyaya, ana tunanin cewa SARS-CoV ya faru ne lokacin da marasa lafiya suka yi rashin lafiya sosai, yayin da yawancin watsawa ba su faru ba a lokacin farkon.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma tana da wuyar sarrafawa.
A halin yanzu, ana ci gaba da manyan ƙoƙari a cikin China, gami da kulle-kulle da kewaye da kusan keɓewar kusan jama'a a Wuhan da biranen da ke kewaye da su, da fatan kawo cikas ga yaduwar SARS-CoV-2.
Duk da yake waɗannan matakan suna lalata tattalin arziƙi da sauran ɓangarorin ƙasar, ƙarancin sabbin masu haƙuri yana nuna alamar koma baya ga annobar.
Mafi yawan masu fata shine cewa cutar za ta ƙare a ƙarshen Maris kuma za ta ɗauki watanni 3-4.
Amma, wasu masana ba su da bege.
Paul Hunter, et al., sun yi hasashen cewa COVID-19 wanda ya fi SARS kamuwa da cuta ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., sun kafa samfurin da zai iya hango sakamakon annobar kuma sun nuna cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Kungiyar ta Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin tsakiya da kuma cikin hanci na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama maimaita cutar kamar cutar mura.
Koyaya, akwai alamun alkibla daga China dangane da raguwar sabbin lamura, wanda ke nuna cewa dabarun yanzu na iya aiki.
An fara hasashen cewa Ebola za ta kai miliyan daya, tare da mutuwar mutane miliyan biyu.
Amma, ta hanyar tsauraran tsare -tsare da kuma keɓewa, an sami nasarar shawo kan cutar.
Yana yiwuwa kamar SARS-CoV, SARS-CoV-2 zai raunana cikin kamuwa da cuta kuma a ƙarshe ya ƙare ko ya zama ƙarancin kwayar cuta mai haɗuwa da ɗan adam.
Kwatanta cutar COVID-19 da SARS da MERS an nuna su a ƙasa (Figure 55)
SARS-CoV-2 yana da yaduwa sosai ta hanyar tari ko sneezing da kuma ta hanyar kai tsaye tare da kayan da ke da cutar.
An kuma gano kwayar cutar a cikin fitsari, wanda hakan ya haifar da sabon yiwuwar yaduwar ta baki ta hanyar fitsari.
Wani binciken da aka yi kwanan nan na mutane 138 ya nuna cewa kashi 41 cikin 100 na masu cutar, ciki har da marasa lafiya 17 da suka riga sun kamu da wasu cututtuka da kuma ma'aikatan kiwon lafiya 40, wataƙila sun kamu ne da cututtukan asibiti.
Saboda haka, ya kamata a yi taka tsantsan don kare mutane, musamman masu ba da kiwon lafiya, ma'aikatan zamantakewa, membobin iyali, abokan aiki, da waɗanda ke tare da marasa lafiya, ko kuma waɗanda ke da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska; amfani da duka masks na tiyata da N95 respiratory masks (jerin # 1860s) yana taimakawa wajen sarrafa yaduwar kwayar cutar.
Abubuwan rufe fuska na tiyata suna hana saukad da ruwa daga mai yuwuwar kamuwa da cutar daga shiga iska ko mannewa da saman abubuwa, daga inda zasu iya zuwa wasu.
Koyaya, tare da kawai 5% na bambance -bambancen da ke iya wucewa gaba ɗaya, kawai N95 (jerin # 1860s) masks na iya hana bambance -bambancen da ke da ƙananan 10 zuwa 80 nm daga shiga cikin numfashi; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma duka suna da kusan 85 nm.
Tun da ƙwayoyin cuta na iya wucewa har zuwa masks biyar na tiyata da aka ɗora a kan ɗaya, masu ba da kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sa N95 (jerin # 1860s) masks, ba masks na tiyata ba.
Tare da abin rufe fuska, masu ba da kiwon lafiya ya kamata su sa rigunan keɓewa waɗanda suka dace don rage haɗuwa da ƙwayoyin cuta.
Ƙwayoyin cuta na iya cutar mutum ta idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2, duk da cewa yana sanye da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga cikin jikinsa ta hanyar idanunsa.
Saboda haka, masu ba da kiwon lafiya ya kamata su sa takunkumin fuska ko tabarau masu haske yayin aiki tare da marasa lafiya.
Ana ba da shawara sosai ga jama'a a yankunan da ke fama da cutar ko kuma waɗanda za su iya kamuwa da cutar su wanke hannayensu da sabulu mai guba fiye da yadda ya kamata, su yi ƙoƙarin kasancewa a cikin gida don keɓe kansu, kuma su iyakance hulɗa da mutanen da ke da cutar.
An yi la'akari da cewa mutane su kasance nesa da mai haƙuri na tsawon ƙafa uku.
Waɗannan ayyukan suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo ne a matsayin sabon kwayar cutar ga dan adam, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, saboda kamanceceniya da SARS-CoV, zai iya sanya China ta yi taka tsantsan bisa zurfin ƙwaƙwalwar ƙwaƙwalwar cutar SARS a 2003.
Koyaya, a ranar 19 ga Janairu, 2020, Daraktan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan ƙasa ta hanyar cewa kwayar cutar ba ta da ƙarancin kamuwa da mutum da ɗan ƙaramin haihuwa kuma babu matsala wajen hanawa da iyakance cutar.
Wannan saƙon ya sa jama'a su ji tsoro, musamman ma a lokacin da dukan ƙasar ke shirin bikin bazara kuma lokacin da ake bukatar a rage cutar a Wuhan ya yi kusa.
Hukumomin kula da cututtuka a China na iya koyan darussa daga wannan kuma su inganta a nan gaba.
Alal misali, waɗannan hukumomi (1) ya kamata su yi taka tsantsan yayin yin sanarwar jama'a domin kowane kalma yana da mahimmanci ga 'yan ƙasa kuma yana iya canza ra'ayinsu da yanke shawara; (2) ya kamata su kasance masu saukin kai da kuma amsawa ga bayanai masu ban mamaki daga asibitoci maimakon jira don sanarwar hukuma daga likitoci ko jami'ai; (3) ya kamata su kasance masu ƙuntatawa don iyakance yiwuwar annoba a farkon matakin maimakon ƙoƙarin ƙarfafa jama'a; da (4) ya kamata su ci gaba da yin amfani da manufa da kuma tasiri don haɓaka wayar da kan jama'a game da annobar kuma a kai a kai suna bincika da kuma inganta tsarin mayar da martani na al'umma.
Cutar COVID-19 da kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya yaɗu a duk ƙasar Sin da kuma kusan ƙasashe 50 na duniya a lokacin rubuta wannan.
Tun da yake kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, barkewar COVID-19 ta haifar da sake dawowar SARS.
Koyaya, akwai wasu mahimman bambance-bambance tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci don iyakance cutar da kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa da maza fiye da mata, kuma tsananin rashin lafiya da mutuwa a cikin tsofaffi sun fi na matasa.
Matsayin mutuwar SARS ya fi na COVID-19 (10.91% vs. 1.44%).
Marasa lafiya na COVID-19 suna watsa kwayar cutar koda kuwa basu da alamun cutar, yayin da marasa lafiya na SARS galibi suna yin hakan lokacin da suka kamu da cutar, wanda ke haifar da wahalar iyakancewar yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana a wani ɓangare dalilin da yasa SARS-CoV-2 ke yaduwa da sauri da kuma yaduwa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a cikin wasu marasa lafiya na COVID-19.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake kamuwa da kwayar cutar.
Waɗannan binciken sun ƙara haɗarin yaduwar kwayar cutar sosai.
Duk da irin wannan ci gaba mai saurin gaske a cikin binciken COVID-19, akwai wasu batutuwa masu mahimmanci da ke jiran warwarewa, kamar su:
Daga ina SARS-CoV-2 ya fito?
Kodayake an sami daidaiton kwayoyin halittar kashi 96% tsakanin SARS-CoV-2 da SARS-like CoVs biyu, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga bat.
Abinda ke da muhimmanci, bari mu ce wane irin dabba ne ya shiga tsakanin watsa kwayar cutar daga bat zuwa mutum?
Idan ba mu san amsoshin tambayoyi na farko da na biyu ba, ba za mu iya hana watsawa ba kuma za mu iya sake yin tashin hankali.
Ko da yake kwayar halittar kwayoyin halitta da gwajin kwayoyin sun nuna cewa SARS-CoV-2 yana haɗuwa da ACE2, ta yaya ainihin cutar ke shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje na cututtuka?
Shin kwayar cutar tana ɗaure da ƙwayoyin ACE2-express a wasu gabobin jiki?
Idan ba tare da amsoshin waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da magani mai inganci ba.
Har yaushe za a ci gaba da wannan annoba?
Ta yaya kwayar cutar take samun ci gaba a cikin kwayoyin halittar mutum?
Shin zai zama annoba ta duniya, a hankali kamar SARS, ko kuma zai ci gaba da faruwa a kai a kai kamar mura?
Yana da muhimmanci, amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu.
Duk da haka, ko da menene farashin, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu ga al'ada.
Tushen kwayar cutar korona ta mutum daga dabbobi
Kwayar cuta da kwayoyin halittarsu (CoVs) sun samo asali ne a cikin shekaru dubbai, saboda canji da daidaitawa.
Kafin 2003, an san mutum biyu da ke haifar da cutar mai saurin kama da mura.
Cutar cutar ta SARS da ta MERS sun juya yanayin gaba daya, suna nuna irin mummunar cutar da HCoV ke haifarwa.
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake kawo CoVs cikin haske kuma ya ba mu mamaki da ƙarancin kamuwa da cuta amma raguwar cutarwa fiye da ɗan'uwansa SARS-CoV.
Cutar HCoV cuta ce ta dabbobi kuma fahimtar asalin dabbobi na HCoVs zai taimaka mana.
Yawancin HCoVs sun samo asali ne daga bat, wanda ba su da cutar.
Akwai kuma bayani game da matsakaitan kwayoyin cuta na wasu HCoVs.
Sanin abinci mai gina jiki yana da tasiri kai tsaye a rigakafin cututtukan ɗan adam.
Binciken hulɗar CoV - mai gina jiki a cikin dabbobi na iya ba da mahimman bayanai game da cutar CoV a cikin mutane.
A cikin wannan bita, muna gabatar da bayyani na bayanan yanzu game da HCoVs bakwai, tare da mai da hankali kan tarihin ganowa da kuma asalin dabbobi da watsawa ta cikin jinsi.
Abin mahimmanci, muna kwatanta da kuma bambance-bambancen HCoVs daban-daban daga ra'ayi na ci gaban kwayar cutar da kuma sake fasalin kwayar halitta.
Ana tattauna wannan a cikin wannan yanayin na cutar CoV Disease 2019 (COVID-19).
Bugu da ƙari, an kuma nuna bukatar sauya abinci mai gina jiki da kyau da kuma tasirin ci gaban cutar a kan tsananin cutar.
Kwayar cuta ta Corona (CoVs) na cikin dangin Coronaviridae wanda ya ƙunshi rukuni na ƙuƙwalwa, mai kyau, guda ɗaya-stranded RNA ƙwayoyin cuta.
An ba da sunayen CoVs saboda tsarin corona-like a ƙarƙashin microscope, wanda shine mafi girma a cikin kwayoyin RNA, yana da 26 zuwa 32 kilobases.
A tsarin, CoVs suna da ƙwayoyin halittar da ba su da sashi waɗanda suke da tsari iri ɗaya.
Kusan kashi biyu cikin uku na kwayoyin halitta suna dauke da manyan sigogi guda biyu (ORF1a da ORF1b) waɗanda suke juyawa zuwa pp1a da pp1ab.
Ana ƙara sarrafa polyprotein don samar da sunadaran 16 da ba na tsari ba, wanda ake kira nsp1 ~ 16.
Sauran ɓangaren kwayoyin suna da ORFs don sunadaran tsari, ciki har da spike (S), envelope (E), membrane (M), da nucleoproteins (N).
Hakanan, wasu sunadarai masu taimako na musamman na CoVs suna yin kwafin su ta hanyar bambance - bambancen jinsi.
Dangane da bambancin jerin sunayen sunadarai, ana rarraba CoVs zuwa tsararraki huɗu (alpha-CoV, beta-CoV, gamma-CoV da Delta-CoV), wanda yawancin HCoVs suke cikin ƙarni na beta-CoV kuma an rarraba shi zuwa tsararraki huɗu (A, B, C da D).
Shaida ta al'ada ta nuna cewa bat da algae sune tushen kwayar halitta na alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune manyan kwayoyin gama-CoVs da Delta-CoVs.
Shekaru dubbai, CoVs sun ci gaba da ƙetare shingen jinsuna kuma sun fito a matsayin wasu muhimman cututtukan ɗan adam.
Zuwa yau, an san kwayar cutar mutum guda bakwai (HCoVs).
Daga cikinsu akwai HCoV-229E da HCoV-NL63 alpha-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar coronavirus mai saurin numfashi (SARS-CoV), cutar coronavirus na numfashi na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da ƙananan alamun kamar sanyi da / ko zawo.
Akasin haka, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 da aka gano, suna da cututtuka masu yawa, suna haifar da mummunar kamuwa da cuta ta ƙananan hanyoyin numfashi a cikin marasa lafiya da yawa, tare da yiwuwar cutar cututtukan numfashi mai tsanani (ARDS) da kuma bayyanar cututtukan zuciya.
An gano nau'in HCoV-229E na farko, B814, daga hanci na marasa lafiya masu sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, ƙarin bayani ya tattara ta hanyar nazarin HCoV-229E da HCoV-OC43, waɗanda duka biyu ke haifar da alamun iyakance kansu.
A zahiri, har zuwa lokacin barkewar SARS, an yarda da ra'ayin cewa kamuwa da kwayar HCoVs ba shi da lahani.
Barkewar SARS a 2003 tana daya daga cikin mafi munin barkewar cutar a tarihin zamani, tare da kamuwa da mutane sama da 8000, tare da mutuwar marasa lafiya kusan 10%.
Shekaru goma bayan haka, barkewar cutar MERS ta haifar da annobar da ta ci gaba a yankin Larabawa tare da yaduwar cutar a wasu wurare a duniya.
2019 novel HCoV (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, shine mai haifar da cutar cutar coronavirus ta 2019 (COVID-19), wanda ya yi sanadiyar mutuwar mutane 3,120 da kuma kamuwa da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi kararrawar gargadi kuma duniya ta shirya don barkewar cutar SARS-CoV-2.
Dukkanin HCoVs bakwai sun samo asali ne daga bat, mice ko dabbobi.
Shaida da yawa suna tallafawa ci gaba na HCoVs daga bat, tare da ƙwayoyin cuta masu dacewa da marasa cutar, amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta gabatar da manyan kalubale na likita, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Gano asalin kwayar cutar HCoVs yana ba da tsari don fahimtar tarihin halitta, motsawa, da abubuwan da ke haifar da rikice-rikice.
Zai iya jagorantar ko kuma samar da damar gano kwayar cutar SARS-CoV-2, matsakaici da kuma haɓaka kwayar cutar, tare da mahimmancin tasiri a cikin hana yaduwar nan gaba.
A cikin wannan bita, mun gabatar da bayyani game da asalin HCoVs, watsawa tsakanin jinsi, da kuma cutar.
Musamman, muna haskakawa da kuma tattauna batun gama gari cewa kwayar cutar HCoVs ba ta da cutar a cikin kwayar halitta ta halitta, amma ta zama mai cutar bayan yaduwar cikin kwayar halitta.
Za mu kuma bincika yanayin ci gaba na HCoVs, wanda yawanci yana haifar da ƙaruwa a cikin kamuwa da cuta tare da raguwar cutar.
An kuma tattauna sakamakon barkewar cutar SARS-CoV-2 da ke gudana a cikin wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin a fara ware nau'in HCoV-229E daga hanci na marasa lafiya da ke kamuwa da mura, an gano CoVs daban-daban daga dabbobi da yawa da suka kamu da cutar, ciki har da turkey, bera, saniya, alade, cat, da kare.
An gano HCoVs bakwai a cikin shekarun da suka gabata.
Takaitaccen taƙaitaccen tarihin gano HCoV (tebur 1) zai zama mai faɗakarwa da koyarwa.
An fara ware kwayar cutar HCoV-229E a cikin shekara ta 1966 daga kwayar cutar ta sama ta hanyar numfashi, wanda daga baya ya dace da girma a cikin layin sel na WI-38 na huhu.
10 ~ 20% na marasa lafiya da ke kamuwa da HCoV-229E sun sami alamun sanyi tare da zazzabi da tari, haushi, rashin jin daɗi, da ciwon makogwaro.
Daga baya a 1967, an ware HCoV-OC43 ta hanyar hanyar tsari a cikin kwakwalwar linzamin kwamfuta da kuma ta hanyar haɓaka gaɓa.
HCoV-OC43 yana da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Dukansu HCoV-229E da HCoV-OC43 suna da yaduwar duniya kuma suna iya yaduwa a cikin hunturu a lokacin sanyi tare da yanayin zafi.
Yawancin lokaci, lokaci na ci gaba na waɗannan ƙwayoyin cuta guda biyu ba ya wuce mako guda, bayan haka kusan makonni 2 na rashin lafiya.
A cewar wani binciken da aka yi na masu sa kai na ɗan adam, mutane masu lafiya da ke dauke da cutar HCoV-229E sun sami saurin kamuwa da mura.
Wasu marasa lafiya da ke da rashin kariya suna da cututtukan ƙananan ƙananan numfashi.
SARS, wanda kuma aka sani da "atypical pneumonia", shine farkon cutar da aka rubuta a tarihin ɗan adam, kuma mai haifar da shi, HCoV na uku da aka gano, SARS-CoV.
Ana iya gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta kai 8,096 tare da mutuwar 774, yayin da ta bazu zuwa kasashe da nahiyoyi da dama.
Baya ga masu yaduwa, an kiyasta cewa kusan za a iya samun karuwar biyu na sakandare saboda kowane shari'a, tare da tsawon lokaci na ci gaba na kwanaki 4 zuwa 7 da kuma bayyanar da mafi girman tasirin kwayar cutar a ranar 10 na cutar.
Marasa lafiya da ke dauke da SARS-CoV suna nuna alamun farko kamar ciwon tsoka, ciwon kai, zazzabi, rashin lafiya da sanyi, wanda ke biye da wahalar numfashi, tari da wahalar numfashi a matsayin alamun gaba.
Lymphopenia, rashin aikin hanta da kuma ƙaruwa a ƙwayar halitta sune abubuwan da ke faruwa a cikin lab na SARS.
An kuma ga lalacewar ƙwayar iska, yaduwar ƙwayoyin epithelial, da kuma ƙaruwa a cikin macrophages a cikin marasa lafiya da SARS.
Kusan kashi 20-30% na marasa lafiya suna bukatar kulawa mai tsanani da kuma iska mai iska.
Baya ga ƙananan hanyoyin numfashi, yawanci tare da hadari na cytokine, yawancin gabobin ciki ciki har da gastrointestinal tract, hanta da kuma kodan na iya kamuwa da cutar a cikin waɗannan mawuyacin yanayi, wanda zai iya zama mai haɗari musamman ga marasa lafiya marasa ƙarfi.
An fara gano kwayar cutar ne daga dangin mai cutar ta hanyar nazarin huhu wanda ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen binciken HCoV.
An ware HCoV-NL63 daga jariri mai wata 7 a ƙarshen 2004 a Netherlands.
An fara gano shi a cikin yara ƙanana, tsofaffi, da kuma marasa lafiya da ke da cututtukan numfashi.
Cutar da HCoV-NL63 ke haifar da ita ta haɗa da sanyi, conjunctivitis, zazzabi, da kuma ciwon daji.
Wani bincike na biyu kuma ya bayyana cewa an gano wannan kwayar cutar ne daga hanci na wani yaro mai wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a Netherlands, amma a gaskiya ya yadu a duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7% na cututtukan numfashi na yau da kullun kuma yana ƙaruwa a farkon bazara, bazara, da hunturu.
HCoV-NL63 yana da alaƙa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
A wannan shekarar, an gano HCoV-HKU1 daga wani tsoho mai shekaru 71 da aka kwantar da shi a asibiti a Hong Kong tare da ciwon huhu da kuma cutar sankarar bargo.
Baya ga cutar pneumonia da bronchiolitis da aka samu daga al'umma, an kuma bayar da rahoton cewa HCoV-HKU1 yana da alaƙa da mummunan annobar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk duniya, yana haifar da cututtukan numfashi masu saurin kamuwa da cuta.
HCoVs da aka samo daga dukkan al'ummomin guda huɗu sun daidaita sosai a cikin mutane kuma suna da ƙarancin yiwuwar canzawa don haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A yadda aka saba, waɗannan HCoVs ma suna da ƙarancin guba ko cutarwa idan sun sami damar watsawa da kyau da kuma ci gaba da kasancewa a cikin mutane.
An fara gano kwayar cutar MERS-CoV a cikin huhu a cikin 2012 a Saudi Arabia na wani mai shekaru 60 wanda ya ci gaba da ciwon huhu da kuma rashin aikin koda.
Yayin da yawancin lab da aka tabbatar da su sun samo asali ne daga Gabas ta Tsakiya, an ba da rahoton shigo da shari'o'in a ƙasashen Turai da Tunisia, tare da wasu lokuta na biyu a tsakanin dangi.
Cutar ta biyu ta faru ne a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da kamuwa da cutar mutum 186.
Bayyanar asibiti na MERS, wanda ke nuna ci gaba mai tsanani na ciwon huhu, ya yi daidai da SARS.
Ba kamar SARS ba, yawancin marasa lafiya da ke da MERS suna ci gaba da rashin aikin koda, wanda har yanzu an lura da shi a cikin MERS kawai a cikin cututtukan da ke haifar da HCoV.
Fiye da kashi 30 cikin dari na marasa lafiya suna nuna alamun gastrointestinal kamar zawo da kuma amai.
Ya zuwa ranar 14 ga Fabrairu, 2020, an ba da rahoton fiye da lambobi 2,500 da aka tabbatar da su tare da yawan mutuwar 34.4%, wanda ya sanya MERS-CoV ɗayan ƙwayoyin cuta mafi haɗari da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano garken masu fama da cutar sankarar bargo da ke da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana annobar cutar SARS-CoV-2 a matsayin gaggawa ta lafiyar jama'a da ke da damuwa ta duniya, kuma ta sanya sunan cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an tabbatar da 90,053 a duniya, tare da rashin lafiyar cutar ta 3.4%.
Abin lura, yawan mutuwar masu cutar a Hubei China ya kai kashi 4.2 cikin dari, yayin da na waje ya kai kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da kamuwa da cuta mai tsanani na numfashi kamar SARS-CoV da MERS-CoV, wanda ke nuna zazzabi, tari da kuma wahalar numfashi.
Wasu marasa lafiya ma suna da zawo.
Ciwon huhu yana ɗaya daga cikin mafi munin alamun kuma yana iya ƙaruwa cikin sauri zuwa matsanancin wahalar numfashi.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban kwatancen jerin nucleotide na 82%, sun faɗi a cikin rassa daban-daban na zuriyar zuriya.
SARS-CoV-2 a bayyane yake ba shi da cutarwa, amma yana da yaduwa fiye da SARS-CoV da MERS-CoV.
An samu rahotanni na marasa lafiya marasa alamun cutar SARS-CoV-2 kuma yana iya taimakawa wajen saurin yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs guda shida, kuma aka duba bambancin, an gano kamance da bambance-bambance masu ban sha'awa.
Na farko, lokaci na kamuwa da cuta da kuma tsarin HCoV suna da kama sosai.
A wannan batun, SARS-CoV-2 yana bin al'adar sauran HCoVs shida.
Na biyu, tsananin bayyanar cututtukan COVID-19 yayi kama da SARS-CoV da kuma HCoVs da aka samo daga al'umma huɗu (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye waɗanda galibi ana lura da su yayin kamuwa da HCoVs da aka samo daga al'umma, gami da rashin takamaiman, mai sauƙi ko babu alamun.
A gefe guda, ana iya ganin ƙaramin ƙaramin ƙaramin COVID-19 mai tsanani, kamar yadda yake a cikin SARS-CoV, kodayake rabo yana da ɗan ƙasa.
Na uku, ana kuma ganin nau'ikan nau'ikan HCoVs da SARS-CoVs da aka samo daga al'umma a cikin watsa SARS-CoV-2.
A gefe guda, cutar SARS-CoV-2 tana da ƙarfi kamar yadda HCoVs ke da ƙarfi daga al'umma.
A gefe guda, har yanzu ana tantance ko cutar SARS-CoV-2 ta ragu bayan ci gaba a cikin mutane kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfuran stool.
Ko SARS-CoV-2 yana da tasiri a cikin wasu yanayi kamar SARS-CoV, har yanzu binciken gaba zai bayyana.
Hakanan yana da matukar ban sha'awa don ganin ko SARS-CoV-2 na iya yin yanayi kamar yadda ake yi da HCoVs da aka samo daga al'umma.
Duk da haka, fasalin SARS-CoV-2, gami da kamuwa da cuta, cutarwa, da kuma ci gaba da yaduwa bayan ya shiga cikin mutane, zai yi tasiri ga ƙarshen barkewar COVID-19.
HCoVs da aka samo daga dukkan al'ummomin hudu masu haifar da laushi sun daidaita da kyau a cikin mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da kyau ga waɗannan HCoVs huɗu.
A wasu kalmomi, duka HCoVs na iya zama masu tsira daga annoba.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma wadanda ke haifar da cututtuka masu tsanani a cikin mutane.
Don hakan ya faru, tarin ƙwayoyin cuta masu daidaitawa waɗanda ke hana ƙwayoyin cuta na ƙwayoyin cuta dole ne su haifar da kwafin HCoVs a cikin mutane zuwa iyakar isa.
A wannan ma'anar, tsawon lokacin da barkewar SARS-CoV-2 ke ci gaba da cutar da mutane da yawa, da alama zai iya daidaitawa sosai ga mutane.
Idan ya daidaita da kyau, zai yi wuya a hana shi ya yaduwa ga mutane ta hanyar keɓewa ko wasu matakan sarrafa kamuwa da cuta.
Shekaru da yawa, CoVs da aka samo daga al'ummomi huɗu suna yaduwa cikin yawan mutane, suna haifar da mura a cikin marasa lafiya marasa ƙarfi.
Waɗannan ƙwayoyin cuta ba sa bukatar kwayar halitta.
Akasin haka, cututtukan SARS-CoV da MERS-CoV ba su daidaita sosai a cikin mutane ba kuma ba za a iya ci gaba da watsa su a cikin mutane ba.
Suna bukatar su ci gaba da zama a cikin kwayar halittarsu kuma su sami zarafin yaduwa zuwa ga mutane masu karɓa ta hanyar daya ko fiye da matsakaici da kuma masu girma.
Halayen SARS-CoV-2 sun yi kama da na SARS-CoV/MERS-CoV da kuma HCoVs da aka samo daga al'ummomi huɗu.
Yana da saurin yaduwa kamar HCoVs da aka samo daga al'umma, aƙalla a halin yanzu.
Koyaya, yana da cutarwa fiye da HCoVs da aka samo daga al'umma kuma ba shi da cutarwa fiye da SARS-CoV ko MERS-CoV.
Ya rage a gani ko za a iya daidaita shi sosai a cikin mutane kuma a kai shi ga mutane ba tare da wani ƙwayar cuta ko kuma matsakaiciyar abinci mai gina jiki ba.
Kafin mu tattauna asalin dabbobi na HCoVs, zai taimaka mana sosai mu tattauna ma'anar da kuma halaye na ci gaban HCoVs, na halitta, na kwayar halitta, na tsaka -tsaki, da na haɓaka.
Dabba mai ci gaba ne mai ci gaba da HCoV idan tana da kakannin da suka yi kusa da juna tare da raba kamanceceniya mai yawa a matakin jerin nucleotide.
Kwayar cutar ta saba da wannan mai cin abinci kuma ba ta da cutar.
Hakazalika, ƙwayoyin cuta suna ba da tsari ga HCoVs a kai a kai kuma na dogon lokaci.
A cikin duka yanayin, ƙwayoyin cuta suna kamuwa da cuta ta halitta kuma sune ƙwayoyin cuta na HCoV ko kuma kwayar cutar ta asali.
Akasin haka, idan HCoV ya shiga wani sabon matsakaici mai gina jiki kafin ko kusa da shi a cikin mutane, ba zai dace da sabon mai gina jiki ba kuma yana haifar da cututtuka.
Wannan matsakaiciyar sinadarin na iya zama tushen kwayar cutar ɗan adam kuma yana iya zama mai haɓaka mai haɓaka ta hanyar barin kwayar cutar ta ɗan lokaci ta sake yin kwafi sannan kuma ta watsa shi ga ɗan adam don haɓaka matakan kamuwa da cuta.
HCoV zai iya shiga cikin kamuwa da cuta idan bai iya ci gaba da yaduwa a cikin matsakaicin mai ba da abinci ba.
A gefe guda, HCoVs na iya daidaitawa zuwa matsakaiciyar abinci mai gina jiki kuma su ci gaba da zama na gida na dogon lokaci.
A wannan yanayin, matsakaicin abinci mai gina jiki ya zama mai gina jiki na halitta.
Bayanai na cututtuka sun nuna cewa alamar SARS shine tarihin hulɗa da dabbobi masu wasa.
Binciken da aka yi na gaba ya nuna cewa akwai yaduwar anti-SARS-CoV IgG a cikin dillalan dabbobi fiye da na jama'a.
An gano masks na palm civet (Paguma larvata) da karnuka masu raɗaɗi a cikin kasuwannin dabbobi masu rai a matsayin masu watsa ƙwayoyin cuta irin na SARS-CoV waɗanda suke da kama da SARS-CoV.
Wannan ya nuna cewa ba a sake samun wani SARS ba bayan an kashe duk wani da aka yi a kasuwa.
Koyaya, an bayar da rahoton cewa yawancin masks na dabba mai rai, daji ko gonaki waɗanda ba su haɗu da kasuwannin dabbobi masu rai ba sun kasance masu ƙarancin SARS-CoV, wanda ke nuna cewa masks na dabba mai ɓoye na iya zama mai mahimmanci a matsayin mai haɓaka mai haɓaka kawai kuma ba a matsayin kwayar halitta ta SARS-CoV ba.
Abin lura, tunda kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da rigakafin SARS-CoV, ba za a iya ƙin yiwuwar cewa yawancin nau'ikan ƙananan dabbobi masu shayarwa na iya zama masu haɓaka matsakaiciyar SARS-CoV ba.
Dukkanin waɗannan suna da alama su ne masu ciyar da SARS-CoV.
Binciken na gaba na SARS-CoV na abinci mai gina jiki ya bayyana wani nau'in bat bat bat mai suna SARS-Rh-BatCoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda aka samo a cikin batutuwan Horseshoe na kasar Sin.
Waɗannan batirin sun sami kwayar cutar SARS-CoV da kuma jerin kwayoyin SARSr-Rh-BatCoV HKU3.
Waɗannan da sauran CoVs na bat suna da kamanceceniya na 88-92% na jerin nucleotide tare da SARS-CoV.
Waɗannan nazarin sun kafa sabon ra'ayi cewa bat ne mai gina cututtukan mutum da ke fitowa.
An kuma gano SARS da yawa kamar CoVs (SL-CoVs) a cikin batsa amma babu wanda aka ware a matsayin kwayar cutar mai rai ban da WIV1.
An gano cewa kwayar halittar mutum mai canza angiotensin 2 (ACE2) ita ce mai karɓar SARS-CoV.
An nuna WIV1 da aka cire daga bat-faeces samfurori don amfani da bat, civet da kuma ACE2 na mutum a matsayin mai karɓa don shigar da kwayar halitta.
Abin sha'awa, ƙwayar SARS da ke warkewa ta iya kashe WIV1.
Ya zuwa yanzu, WIV1 shine mafi kusa ga SARS-CoV a cikin batutuwa, yana raba kusan kashi 95% na daidaiton nucleotide.
Duk da kamanceceniya tsakanin wadannan ƙwayoyin cuta biyu, ana yawan tunanin cewa WIV1 ba shine mafi kusa da kwayar cutar SARS-CoV ba kuma cewa bat ba shine mafi kusa da kwayar cutar SARS-CoV ba.
Binciken al'ada ya rarraba MERS-CoV zuwa rukuni guda kamar Bat CoV-HKU4 da Bat CoV-HKU5.
Bat-bat suna amfani da mai karɓar abinci iri ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar CoV-HKU4 da MERS-CoV.
Tsarin RNA polymerase na MERS-CoV yana da kusanci da kwatankwacin bat beta-CoV da aka gano a Turai da Afirka.
Ya zuwa yanzu, ba a gano wani MERS-CoV mai rai a cikin barayi ba.
MERS-CoV da CoV-HKU25, wanda ya fi kusa da shi, suna da kamanceceniya na nucleotide kashi 87% kawai.
Saboda haka, bat ba zai iya zama mafi kusa da kwayar cutar MERS-CoV ba.
A wani bangaren kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman da ke da ƙugiya kamar raƙuman da ke da asalin Gabas ta Tsakiya a ƙasashen Afirka da dama suna da ƙwayar cuta ga ƙwayoyin cuta na MERS-CoV.
An gano MERS-CoV mai rai, wanda yayi kama da kwayar cutar da aka gano a cikin mutane, daga hancin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Hakanan yana da mahimmanci cewa raƙuman da aka kamu da su tare da MERS-CoV sun sami sauƙin bayyanar cutar amma sun sami babban fitar da kwayar cutar.
Abin lura shi ne, raƙuman da suka kamu da cutar ba sa fitar da ƙwayoyin cuta ta hanyar numfashi kawai amma kuma ta hanyar bakin-ƙwaƙwalwa, wanda kuma shi ne babban hanyar fitar da ƙwayoyin cuta daga bat.
Koyaya, tambayoyi suna nan tun da yawancin tabbatar da shari'o'in MERS ba su da tarihin hulɗa da raƙuma kafin bayyanar bayyanar, mai yiwuwa saboda hanyar watsawa daga mutum zuwa mutum ko wata hanyar watsawa da ba a sani ba wacce ta haɗa da nau'in dabbobi da ke ɗaukar MERS-CoV.
CoV RaTG13 da aka ware daga batutuwan da ke da alaƙa da jinsin Rhinolophus, SARS-CoV-2 yana da kamanceceniya da nucleotide na kashi 96.2 cikin dari.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya isa ya ƙayyade alaƙar dangi.
Wato, ba za a iya samun batirin da ke kusa da SARS-CoV-2 ba, sai dai idan an sami CoVs masu kama da batirin a nan gaba.
Wataƙila, matsakaitan magungunan dabbobi na SARS-CoV-2 dole ne su kasance daga cikin nau'ikan da aka sayar da kashe a cikin kasuwar cin abincin teku na Hunan wanda ke da alaƙa da yawancin farkon COVID-19 wanda ke nuna yiwuwar watsawar mutum daga dabbobi.
Yawancin binciken da aka yi kwanan nan bisa layin metagenomic sun ba da shawarar cewa wani rukuni na ƙananan ƙananan dabbobi masu shayarwa da ake kira pangolins (human javanika) na iya ɗaukar nauyin beta-CoVs na asali da ke da alaƙa da SARS-CoV-2.
Waɗannan sababbin pangolin CoV sun yi kama da jerin nucleotide kashi 85-92% tare da SARS-CoV-2.
Duk da haka, suna da dangantaka mai kyau da RaTG13 tare da kusan kusan 90% kama da juna a matakin jerin nucleotide.
Suna cikin ƙwayoyin cuta guda biyu na SARS-CoV-2-kamar ƙwayoyin cuta a cikin asalin asalin asalin wanda ɗayan ya raba mafi yawan yankin haɗuwa da mai karɓa (RBD) tare da SARS-CoV-2 tare da kamanceceniya na 97.4% amino acid.
Akasin haka, RBDs na SARS-CoV-2 da RaTG13 suna da bambanci sosai duk da yawan kamanceceniya a cikin kwayar halitta.
Wani binciken da aka yi a baya na pangolin da ke da ciwo ya kuma ba da rahoton gano wasu nau'ikan DNA na kwayar cutar a cikin samfurori na huhu, wanda ke da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban -daban na haɗawa da kuma gyaran hannu don samar da jerin kwayoyin halitta na kwayoyin cuta tare da cikakken tsawon kwayar cutar 86.3%.
Ba za mu iya yin watsi da yiwuwar cewa pangolin yana ɗaya daga cikin matsakaitan ƙwayoyin cuta na SARS-CoV-2.
Koyaya, babu wata hujja a halin yanzu don tallafawa asalin pangolin kai tsaye na SARS-CoV-2 saboda bambancin tsari tsakanin SARS-CoV-2 da pangolin SARS-CoV-2-da ke da alaƙa da beta-CoVs.
Hakanan, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da na SARS-CoV-2 da pangolin SARS-CoV-2- da ke da alaƙa da beta-CoVs.
Har yanzu ana bukatar kafa hanyar ci gaba na SARS-CoV-2 a cikin bat, pangolin da sauran dabbobi masu shayarwa.
Inda aka sami mafi yawan kamanceceniya a cikin RBDs tsakanin SARS-CoV-2 da pangolin, beta-CoVs masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi yawan kamanceceniya a cikin genomic.
Yana da matukar zato cewa babban kamance tsakanin pangolin SARS-CoV-2 da beta-CoVs da SARS-CoV-2 RBDs saboda zaɓin da aka daidaita shi ne saboda juyin halitta.
Wani zaɓi na zaɓi yana da alaƙa da sake haɗuwa tsakanin pangolin SARS-CoV-2 da ke da alaƙa da beta-CoV da RaTG13 a cikin nau'in daji na uku.
A matsayin mai motsa ci gaba, sake haɗawa yana da yawa a cikin beta-CoVs.
Har yanzu ba a san asalin asalin dabba na SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa, an kuma yi nazarin asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar genealogical ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali daga CoVs na bat, yayin da aka gano asalin HCoV-OC43 da HCoV-HKU1 a cikin mice.
An ba da rahoton cewa an gano wani CoV mai suna ARCoV.2 (Appalachen Ridge CoV) wanda aka gano a cikin batirin launi uku na Arewacin Amurka yana da alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E ya kasance yana da alaƙa da kwayar cutar CoV mai suna Hipposideros/GhanaKwam/19/2008, wanda aka samo a Ghana, kodayake kamallids ma sun kasance masu kula da matsakaici.
Don ƙarin haske, an taƙaita bayanin yanzu akan asalin dabba na HCoVs da aka sani a cikin Hoto 1 da Table 2.
Nazarin jinsi ya ba da tabbaci game da abubuwan watsawa na HCoVs a cikin tarihi.
Lokacin da HCoV-OC43 ya wuce jinsuna don ya cutar da mutane daga dabbobi a cikin gida a kusa da 1890, an ga annoba ta kamuwa da cutar numfashi.
Tarihin watsawa tsakanin jinsi na HCoV-229E ba shi da tabbas.
An gano alpha-CoVs na bat da ke kusa da HCoV-229E.
A cikinsu akwai wani Alpha-CoV.
Akwai tabbaci da yawa da ke nuna cewa cutar tana iya kaiwa daga bat zuwa ga mutane.
Da farko, mutane ne suka sadu da damisa a cikin yanayin da alpacas suke morewa.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, batutuwan da ke da alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin batutuwan alpha-CoV, yayin da Alpaca alpha-CoV ya haifar da barkewar cutar numfashi a cikin dabbobin da suka kamu da cutar.
A ƙarshe, ba a gano alpaca alpha-CoV a cikin namun daji ba.
Saboda haka, ba za a iya ƙin yiwuwar cewa alpacas suna samun HCoV-229E-da ke da alaƙa da alpha-CoVs daga mutane ba.
A gaskiya ma, ƙwayoyin cuta na rabies, Ebola, Nipah, da kuma Hendra sun zama tushen cututtukan da ke haddasa cututtukan mutane.
Ba abin mamaki ba ne cewa batutuwan na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, inda bat alpha-CoVs su ne gene pool na HCoV-229E, alpacas da raƙuman raƙuman ruwa na iya zama matsakaiciyar mai watsa ƙwayoyin cuta wanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga bat da raƙuman raƙuman ruwa zuwa mutane.
An san ci gaba da MERS-CoV daga batsa a farkon gano shi kuma an ƙarfafa shi ta hanyar binciken da aka yi.
A bayyane yake cewa batutuwan suna ba da wadataccen nau'in ƙwayoyin cuta don musayar jinsuna da watsawa tsakanin jinsuna.
Tsawon rayuwa, ƙauyuka masu yawa, kusanci da hulɗa da kuma iyawar tashi suna da kyau don batutuwan su zama masu watsa ƙwayoyin cuta.
A gefe guda, MERS-CoV ya shiga cikin raƙuman raƙuman raƙuman shekaru da yawa.
Ya dace da waɗannan raƙuman da suka canza daga matsakaiciyar abinci zuwa mai daidaitawa da kuma na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙimar canji a cikin waɗannan dabbobi.
Yana da haɗarin watsawa cikin ɗan adam kuma mutane sun kasance masu ɗaukar ƙarshen MERS-CoV saboda ba za a iya ci gaba da watsa shi ba.
A bambanci da rawar da raƙuma ke takawa wajen watsa MERS-CoV, rawar pangolin, idan akwai, a cikin watsa SARS-CoV-2 ta bambanta.
Musamman, pangolin beta-CoVs suna da matukar cutarwa a pangolin.
Suna iya zama masu ɗaukar hoto na ƙarshe na beta-CoVs masu alaƙa da SARS-CoV-2, kamar yadda Sevet yake a cikin yanayin SARS-CoV.
Akwai yiwuwar watsa SARS-CoV-2 daga dabbobi zuwa ga mutane da yawa da za a yarda da su ko kuma a karyata su a cikin nazarin gaba.
Na farko, batutuwan na iya zama masu kwayar cutar SARS-CoV-2 mai kama da SARS-CoV-2.
Mutane za su iya raba mazaunin muhalli da batutuwan ta hanyar kashe su ko kuma hakar kwal.
Na biyu, pangolin na iya zama ɗayan abubuwan haɓaka na matsakaici waɗanda ke haifar da sabon shiga na cutar SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar kashewa da cin naman da aka yi wasa da shi.
Yana yiwuwa cewa dabbobi masu shayarwa da dama, ciki har da dabbobin gida, na iya kamuwa da SARS-CoV-2.
Ana bukatar bincike na rigakafi a cikin dabbobi masu gida da na daji.
Na uku, kamar yadda aka ambata a sama, SARS-CoV-2 na iya sake haɗuwa da daidaitawa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Ana ci gaba da binciken asalin SARS-CoV-2.
Baya ga nau'ikan abinci na dabbobi, manyan abubuwa uku game da kwayar cutar ma suna da mahimmanci wajen sauƙaƙe ƙetare ƙuntatawa na nau'in CoV.
Na farko, yawan canjin da suke yi a kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ana iya ɗaukar ƙimar canjin CoV a matsayin matsakaici zuwa babba, tare da matsakaicin sauyawar sau ~ 10-4 a kowace shekara a kowane wuri 2, dangane da matakin daidaitawar CoV a cikin sabon abincin.
CoVs suna da hujja-karatun exoribonucleases, wanda lalacewa na iya haifar da matsanancin canji da lalacewa ko kuma raguwar rayuwa.
Abin sha'awa, an yi tunanin cewa remdesivir, kwatankwacin nucleotide, yana hana kwafin CoV ta wannan exoribonuclease da RNA-based RNA polymerase.
Remdesivir yana ɗaya daga cikin magungunan SARS-CoV-2 masu ban sha'awa da aka bincika a cikin gwaji.
Duk da haka, yawan canjin CoVs ya ninka na masu gina jiki sau miliyan.
Bugu da ƙari, yawan canjin canjin yana da yawa idan CoVs ba su daidaita da kyau ga mai gina jiki ba.
Idan aka kwatanta da SARS-CoV tare da ƙimar canji mai yawa, ƙimar canji na SARS-CoV-2 a bayyane yake, yana nuna babban matakin daidaitawa a cikin mutane.
Wataƙila, ya riga ya daidaita zuwa wani abinci mai gina jiki kusa da mutane.
Tare da SARS-CoV-2, wannan kuma ya shafi MERS-CoV wanda ya dace sosai a cikin raƙuman raƙuman ruwa.
A ka'ida, ba zai yiwu ba cewa kwayar halitta za ta hana allurar rigakafi da maganin rigakafi da sauri a kan SARS-CoV-2.
Na biyu, babban RNA a cikin CoV yana sanya ƙarin filastik a kan canjin kwayar halitta don canzawa da sake haɗawa, yana ƙara yiwuwar haɓaka haɓaka cikin jinsuna, wanda ke da fa'ida ga fitowar sabbin CoVs idan yanayi ya dace.
Wannan yana da goyon bayan da ke da ma'ana ta musamman ta buɗe tsarin karatu da kuma ayyukan sunadarai da aka yi rajista a ƙarshen 3 na kwayoyin halitta.
Na uku, CoVs suna canza samfura a kai a kai a lokacin kwafin RNA ta hanyar tsari na musamman na " kwafin zaɓi ".
A cikin abincin da ke aiki a matsayin mai haɗawa, canjin ƙwayoyin yana faruwa sau da yawa yayin fassarar RNA na CoV.
RNA mai cikakken tsawon da kuma subgenomic RNAs, wanda yake da kama da juna, zai iya sake haɗuwa don samar da sabon CoVs.
An sami shaidar al'ada na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43 da kuma CoVs na dabbobi kamar su bat SL-CoV da bat CoV-HKU9.
Haɗin kai na kwayar cutar - mai ɗaukar hoto dangane da watsawa
Baya ga abubuwan da aka ambata a sama guda uku, hulɗar ƙwayar cuta da mai karɓar abinci wani muhimmin abu ne da ke shafar watsawa tsakanin jinsi.
Anan, ana ganin sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zaɓi mai kyau yayin abubuwan watsawa tsakanin jinsi.
Dangane da kwatancen bincike na masu rarrabewa tsakanin ɗan adam da ceta SARS-CoVs, SARS-CoV, musamman tare da maye gurbi akan RBD na S furotin, ana ɗaukarsa mai saurin daidaitawa zuwa nau'ikan abinci.
A yadda aka saba, RBD a cikin S protein na CoV yana hulɗa da mai karɓar ƙwayar cuta kuma ana zaɓar shi ta hanyar amsawar rigakafin mai gina jiki.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 a kan S1 wanda ke haɗuwa da ACE2 na mutum da kuma masu karɓar sa don shigar da kwayar cutar.
RBD na SARS-CoV yana iya gano ACE2 masu karɓa na dabbobi daban-daban, gami da bat, sevet, bera da kare kare, wanda ke haifar da yaduwar ƙwayoyin cuta tsakanin jinsi.
A gaskiya ma, an gano ragowar amino acid guda 6 ne kawai a cikin RBD wanda ya bambanta da na mutum da na kwayar cutar kwayar cutar kuma 4 daga cikinsu suna cikin asalin da ke da alaƙa da mai karɓa na ACE2.
RBD na CIVET SARS-CoV yana da K479N da S487T maye gurbi wanda zai iya haɓaka haɗakar hulɗar ƙwayoyin cuta tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomi, waɗannan amino acid biyu na iya zama mahimmanci wajen daidaitawar kwayar cutar a cikin mutane.
Yana da mahimmanci cewa SARS-CoV-2 yana da karɓar karɓar ƙwayar cuta iri ɗaya tare da SARS-CoV.
Bambanci 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S protein yana nuna cewa haɗin haɗin S protein tare da ACE2 na ɗan adam na iya canzawa.
A zahiri, nazarin Cryo-EM ya nuna cewa haɗuwa ta ninka sau 10 zuwa 20 fiye da haɗuwa tsakanin ƙwayoyin ACE2 na ɗan adam da SARS-CoV S.
Hakanan zai zama mai ban sha'awa don ƙayyade ko ana buƙatar wani mai karɓar SARS-CoV-2 don watsawa.
Abin sha'awa, HCoV-NL63 ma yana haɗuwa da ACE2, amma daga wani ɓangare na S.
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya zama alhakin nasarar daidaita CoVs a cikin mutane bayan watsawa ta cikin jinsuna daga abincin su.
Sakamakon watsa kwayar HCoVs tsakanin jinsi yana sarrafawa ta hanyar wasu abubuwan dogaro da abinci da abubuwan hanawa, ban da masu karɓar kwayar halitta.
Bambancin waɗannan sunadarai masu gina jiki tsakanin mutane da masu amfani da kwayar halitta na HCoVs, kamar su bat, raƙuman ruwa, da kuma ƙwayoyin cuta na iya zama cikas ga watsawar tsakanin jinsi.
Canza HCoVs cikin jinsuna yana buƙatar kawar da abubuwan dogaro da abinci da kuma jujjuya abubuwan hana abinci.
A wannan batun, an gano kuma an bayyana ƙayyadaddun kwayoyin a cikin wannan muhimmin yanki na hulɗar kwayar cutar.
Yin amfani da sabuwar fasahar CRISPR, bincike mai zurfi na kwayar cutar SARS-CoV-2 da abubuwan hanawa na iya zama mai amfani.
Yunƙurin sabon HCoVs: Komawa ga asali
Bambancin bat CoVs yana ba da dama ga fitowar sabon HCoVs.
A wannan ma'anar, bat CoVs suna aiki a matsayin kwayar halitta ta HCoVs.
Bugu da ƙari, haɓakar HCoVs tana faruwa ne ta hanyar saurin canzawa da sake haɗuwa ta hanyar kwayar halitta kuma tana da matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, sabon kwayar halitta tana da ikon canja kwayar cutar da take kamawa ko kuma ta ɓace.
A cikin sunadarai masu taimakawa SARS-CoV, ORF8 an gano yana da mahimmanci a cikin daidaituwa a cikin mutane, tun lokacin da aka ware ƙwayoyin cutar bat da ke da alaƙa da SARS-CoV, amma an same su suna yin lambar sunadarai daban-daban na ORF8.
An gano fasalin rushewar 29-nucleotide na SARS-CoVs a cikin jinsunan da aka ware a farkon cutar ta ɗan adam.
Wannan kawar tana karya ORF8 zuwa ORF8a da ORF8b kuma ana ganin shi ne canji mai dacewa wanda ke inganta sauyawar kwayar halitta.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa tare da asalin alpha- da gamma-CoVs, tare da gano adadi mai yawa na ƙananan yankunan sake haɗuwa a cikin RNA-based RNA polymerases.
An kuma gano wuraren sake haɗuwa a cikin sassan nsp9, mafi yawan nsp10, da nsp14.
Hakazalika, an lura cewa cutar MERS-CoV ta sami abubuwan sake haɗuwa tsakanin tsararru daban-daban, wanda ya faru a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake haɗuwa a cikin sauran HCoVs, wanda HCoVs ke sake haɗuwa da sauran CoVs na dabbobi a cikin ƙwayoyin halittar su.
Ya kamata a lura cewa zaɓin wucin gadi zai iya kawo canje -canje da ba a so ba a cikin kwayar cutar, mai yiwuwa ta ƙwayoyin cuta da ba su da matsin lamba, kamar tsarin rigakafin jiki.
Misali na waɗannan tasirin shine asarar tsawon ORF4 a cikin kwayar HCoV-229E saboda kawar da nucleotides biyu.
Yayin da za a iya ganin ORF4 mara lalacewa a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, Alpaca alpha-CoV yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da frameshift.
A ƙarshe amma ba ƙasa ba, ci gaban ci gaba na sabon HCoVs yana faruwa ne ta hanyar matsin lamba na zaɓi a cikin ƙwayoyin cuta.
An gano marasa alamun ko kuma alamu ne kawai lokacin da batutuwan suka kamu da CoVs wanda ke nuna daidaituwa tsakanin CoVs da batutuwan.
Ya bayyana cewa batutuwan sun daidaita da kyau ga CoVs, a zahiri da kuma jiki.
Misali, aibi a kunna amsa mai kumburi a cikin batsa, yana rage cutarwa da cutar CoVs ke haifarwa.
Bugu da ƙari, ana hana aikin kwayar halitta mai kisa a cikin batutuwan saboda ƙarancin matakan magana na ƙwayoyin halitta mai kisa mai haɗari NKG2/CD94 da kuma manyan ƙwayoyin da ke da alaƙa da ƙwayoyin cuta na Class I.
Bugu da ƙari, ƙimar ƙwayoyin cuta masu saurin amsawa (ROS) waɗanda ke haifar da ƙarin aikin metabolism na batutuwan na iya haifar da hana kwafin CoVs da shafar karatun hujja ta exoribonucleases, don haka samar da matsin lamba don samar da nau'ikan ƙwayoyin cuta masu cutarwa yayin shigar da sabon mai gina jiki.
Hakanan za a iya samar da nau'ikan CoV masu cutarwa ta hanyar sake haɗawa, wanda zai iya haifar da sabon furotin ko fasalin furotin don daidaitaccen abinci.
Saboda haka, ba daidaituwa ba ne cewa sabon nau'in HCoVs guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutarwa ko kuma suna haifar da ƙananan alamomi a cikin ƙwayoyin cuta kamar su bat da raƙumi.
Suna yin kwafi sosai ba tare da nuna ƙarfi ba.
Wannan shi ne asirin da ya sa ake ganin masu dauke da cutar marasa alamun cutar da kuma dalilin da ya sa ake samun mummunar kamuwa da cutar a cikin mutane.
Alamun cutar suna da tsanani, galibi saboda amsawar rigakafi da kuma wuce haddi na sitokin storm, wanda yawan amsawar rigakafi ya haifar da mummunar lalacewar huhu.
Akasin haka, a cikin masu dauke da cutar marasa alamun cutar, amsawar rigakafi ta bambanta da kwafin CoV.
Irin wannan dabarar na ware amsawar rigakafi na iya samun sakamako mai amfani a maganin SARS-CoV-2.
Amsar interferon tana da sauri musamman a cikin bat.
Saboda haka, gudanar da Interferon Type I a cikin mutane ya kamata ya zama mai amfani aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2.
Bugu da ƙari, NLRP3 inflammasome kunnawa a cikin bat ne m.
Ta wannan hanyar, hana NLRP3 inflammasome tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
Yaduwar SARS-CoV-2 tana bin irin yanayin da SARS-CoV da MERS-CoV suka haifar.
Yayin da aka lura da daidaiton nucleotide na bat beta-CoV da SARS-CoV 95%, bat-CoV kuma yana da daidaiton nucleotide na 96% da SARS-CoV-2.
Duk da yake an ga sevet da sauran dabbobi a kasuwa suna ba da gida ga ƙwayoyin cuta masu kama da SARS-CoV, ba a gano mafi kusa da matsakaitan ƙwayoyin cuta na SARS-CoV-2 ba.
An gano pangolin beta-CoVs masu kama da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗayan matsakaitan abinci ko kuma pangolin beta-CoVs na iya ba da gudummawa ga ɓangarorin ƙwayoyin cuta a cikin sabon sigar SARS-CoV-2.
Duk da cewa tambayoyi sun kasance, babu wata hujja da ta nuna cewa SARS-CoV-2 an yi shi da gangan ko kuma mutum ne ya yi shi ba zato ba tsammani.
CoVs sun zama sananne saboda barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin CoVs a cikin bat da sauran dabbobi ya kawo canji sosai a fahimtarmu game da kwayar halittar HCoVs a cikin asalin dabba da kuma daidaitaccen watsawa.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga bat da kuma watsawa ga mutane ta hanyar matsakaiciyar abinci.
Ganin cewa kamuwa da SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da sevet a kasuwanni, rufe kasuwannin wet da kashe sevet a can ya kamata ya kawo ƙarshen cutar ta SARS.
Saboda wannan dalili, dole ne a cire pangolin daga kasuwar nama don hana watsawar dabbobi saboda ganowar zuriya da yawa na pangolin beta-CoVs waɗanda ke da kusanci da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 yana yaduwa ga ɗan adam ta hanyar pangolins da sauran dabbobi masu shayarwa da kuma yadda ake bayyana shi a cikin binciken gaba.
A gefe guda, MERS-CoV ya shiga cikin raƙuman raƙuman raƙuman shekaru da yawa.
Waɗannan raƙuman suna da muhimmanci wajen sufuri ga mazauna yankin, kuma su ne tushen abinci na nama, madara, fata, da kuma ulu.
Sun yadu a Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a yi watsi da dukkan raƙuma don sarrafa MERS ba kamar yadda aka yi a kasuwannin dabbobin daji na China don hana yaduwar SARS-CoV da SARS-CoV-2.
Dole ne a bi da cikakkiyar hanyar haɓaka magungunan rigakafi masu tasiri a kan MERS-CoV don raƙuma a haɗe tare da sauran matakan sarrafa kamuwa da cuta don hana sake fashewar MERS.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, za a iya samun sababbin ƙwayoyin cuta da za su iya haifar da ɓarkewa.
An gano cewa wasu nau'o'in kwayar cutar ta zoon ta yi ta yawo a cikin daji.
Musamman, bat CoVs masu iyawa na dabba suna da bambanci sosai.
Wataƙila waɗannan CoVs na dabba za su iya haɓaka da sake haɗawa, wanda zai haifar da sabbin CoVs waɗanda za su iya zama masu saurin yaduwa da / ko haɗari ga mutane a nan gaba.
Ya kamata a yi watsi da al'adun cin namun daji a wasu yankunan kasar Sin don rage hulɗa mara amfani tsakanin mutane da dabbobi.
Tare da gwaji mai wuya na SARS, MERS da COVID-19, ya kamata a yi kyakkyawan shiri da kuma shirin amsawa.
A gaskiya ma, ƙwayoyin cuta da yawa sun wanzu a duniya na dogon lokaci.
Suna zama a cikin kwayar halitta har sai babu yiwuwar yaduwa.
Ko da yake akwai halaye da yawa na bat da ke taimakawa wajen yaduwar ƙwayoyin cuta, za a iya rage yiwuwar haɗuwa da su da sauran namun daji idan an koya wa mutane yadda za su guje wa bat.
Ci gaba da lura da dabbobi masu shayarwa yana da mahimmanci don fahimtar yanayin yanayin CoVs da abubuwan gina jiki na halitta, wanda zai zama da amfani wajen hana yaduwar mutum daga dabbobi da kuma barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci na hana cutar dabbobi ta hanyar kwayar cuta ita ce mutane su guje wa yanayin halitta na ƙwayoyin cuta na dabbobi.
Yawancin ɓangarorin wuyar warwarewar asalin SARS-CoV-2 har yanzu ba a gano su ba.
Na farko, idan batutuwan sun watsa kwayar cutar SARS-CoV-2 zuwa pangolin, zai zama mai ban sha'awa a ga yanayin da batutuwan da pangolin zasu iya raba yanayin muhalli.
Na biyu, idan batutuwan suna da hannu kai tsaye a watsawa zuwa ga mutane, dole ne a tantance yadda mutane suke hulɗa da batutuwan.
Na uku, idan wani dabba na uku yana aiki a matsayin mai cin abinci na ainihi, ya kamata a bayyana yadda yake shafar wasu nau'o'i, har da mutane, bat da pangolin.
A ƙarshe, tun da yawancin dabbobi masu shayarwa, ciki har da dabbobi masu gida, na iya zama masu kamuwa da SARS-CoV-2, ya kamata a yi sa ido da kuma gwajin kamuwa da cuta.
Ko dai bat ne, pangolin ko wani dabba mai shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma wasu cututtukan da suka yi kama da su za a iya gano su a cikin abincin da suke da shi a nan gaba.
Ci gaba da bincike a cikin wannan yanki zai bayyana hanyoyin ci gaba na SARS-CoV-2 a cikin dabbobi tare da mahimman tasiri a cikin rigakafin COVID-19 da sarrafawa a cikin mutane.
Ana bukatar sabunta ka'idojin bincike na "matsalolin da ake zargi" da "matsalolin da aka tabbatar" na COVID-19.
A ranar 6 ga Fabrairu, 2020, tawagarmu ta wallafa ka'idojin shawarwari na gaggawa don ganewa da kuma maganin cutar 2019 novel coronavirus (2019-nCoV), kuma wannan ka'idojin sun samar da kyakkyawan mahallin ga kwarewarmu da kuma yadda za a magance cutar a duniya.
Ko da yake cutar Coronavirus 2019 (COVID-19) sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ake gudanarwa da kuma kwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta dabarun ganewar asali da magani.
A cikin wannan wasikar, mun amsa wani sharhi kan jagorarmu kuma mun samar da sabbin ka'idojin bincike na "matsalolin da ake zargi" da "ƙaddara" bisa ga sabon ka'idojin bincike da magani na COVID-19 (na bakwai) da kwamitin kiwon lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na 2019, an bullo da cutar Novel Coronavirus (2019-nCoV) na 2019, wanda yanzu aka sanya masa suna Coronavirus Disease 2019 (COVID-19) kuma an sanya wa cutar suna SARS-CoV-2.
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don yaƙar kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawarwari na gaggawa kuma an buga su ta yanar gizo a cikin Military Medical Research a ranar 06 ga Fabrairu, 2020.
Tun da aka buga shi, ya jawo hankali sosai.
Duk da haka, lura cewa COVID-19 sabon cuta ne, kuma iliminmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ake gudanarwa da kuma kwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta dabarun ganewar asali da magani.
Alal misali, tsakanin 16 ga Janairu, 2020 da 3 ga Maris, 2020, kwamitin kiwon lafiya na Jamhuriyar Jama'ar Sin ya fitar da juzu'i bakwai na jagororin da aka bayar don ganewar asali da magani na COVID-19 (http://www.nhc.gov.cn/) tare da sauye-sauye na asali a wasu mahallin.
Yanzu, ka lura da ka'idodinmu da Zhou et al. suka yi, sun gabatar da wani tsari mai sauƙi na alama bisa ga ƙwarewarsu ta asibiti.
Aikinsa ya ba da sabon shaida ga jagorancinmu kuma ya ba da mahimman bayanai game da wannan annobar a duniya.
Muna goyon bayan aikinsa mai muhimmanci kuma muna godiya.
Koyaya, aikin su yana buƙatar sabuntawa bisa ga sabbin ka'idojin bincike da magani don COVID-19 (na bakwai na gwaji) da kuma binciken kwanan nan.
A cewar na bakwai (Maris 3, 2020), ana buƙatar haɗawa da kowane ɗayan abubuwan tarihin annobar tare da abubuwa biyu na bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Tarihin annoba: (1) Tarihin tafiya ko zama a Wuhan da ke kewaye, ko kuma wasu al'ummomi inda aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin hulɗa da cututtukan SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya da ke fama da zazzabi ko alamun numfashi daga Wuhan da ke kewaye, ko kuma wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa da rukunin waɗanda aka tabbatar da su (ƙananan wurare kamar gidaje, ofisoshi, makarantu, da sauransu waɗanda ke da cutar zazzabi ≥ 2 da/ko a cikin makonni 2 da suka shafi alamun numfashi).
Bayyanar asibiti: (1) zazzabi da / ko alamun numfashi; (2) tare da fasalin cutar COVID-19; (3) yawan ƙwayoyin jini suna nuna ƙarancin lymphocyte a farkon farkon farawa.
Ganowar da aka tabbatar da shi ya kamata ya dogara ne akan batun da ake zargi da cutar ko kuma wani abu na hujja na ƙwayar cuta wanda ya kasance: (1) gwajin PCR na ainihi don SARS-CoV-2 ya zama tabbatacce; (2) jerin kwayoyin cuta na ƙwayar cuta suna nuna daidaituwa mai yawa da sababbin ƙwayoyin cuta; (3) gwajin ƙwayar cuta yana nuna tabbataccen IgM na SARS-CoV-2 da IgG na IgG; ko kuma canzawar SARS-CoV-2-specific IgG na cutar daga mara kyau zuwa tabbatacce, ko kuma ƙimar riba ta ƙaru da ≥ 4 sau a cikin lafiyar idan aka kwatanta da matakin gaggawa.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don ƙwayoyin nucleic acid a cikin tsarin numfashi ko samfuran jini a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara ganowar kwayar cutar daga samfurin jini a cikin juzu'i na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan kuma an ƙara hujja ta ƙwayar cuta a cikin juzu'i na bakwai.
Waɗannan gyare - gyare sun dogara ne akan ci gaba da aikin masu bincike, waɗanda ke neman mafi kyawun kayan aikin gano nucleic acid don saurin ganewa, da kuma samfuran numfashi, gami da samfuran jini, wanda ya haɓaka wadatar samfuran daban -daban, da kuma tallafawa kawo takamaiman sakamakon tabbataccen rigakafi zuwa ƙa'idodin tabbatarwa.
Bugu da ƙari, akwai tabbaci da yawa da ke tunatar da mu mu mai da hankali da marasa lafiya marasa alamun rashin lafiya.
Saboda haka, ya kamata a sabunta taswirar da Zhou et al. suka yi, domin sun rarraba mutumin da ba shi da alamun asibiti a matsayin "mai ƙarancin haɗari.
Ana bukatar a tabbatar da tsarin a ci gaba da nazarin asibiti da kuma nazari.
A ƙarshe, muna fatan ƙarin tabbaci kai tsaye zai bayyana kuma muna gayyatar masu karatu su ba da ra'ayoyinsu.
Don tantance "matsalolin da ake zargi" da "ƙaddamar da shari'ar", muna ba da shawarar ganowa da bin sabbin jagororin ƙasashen da suke.
Ƙungiyarmu za ta kuma riƙa sabunta ƙa'idodinta a kai a kai don ba da taimako.
Bangladesh ta samu sabbin mutuwar COVID-19, wanda ya kai na yau da kullum.
Jiya, Bangladesh ta tabbatar da ƙarin mutuwar COVID-19 guda biyar a rana ɗaya.
Wannan shi ne adadin mutuwar da aka taba samu a rana guda saboda cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike (IEDCR) ta Bangladesh ta ba da rahoton adadin waɗanda suka kamu da cutar, wanda ya haɗa da masu aiki 114, da kuma mutane 33 da suka warke daga cutar a gida.
An samu mutuwar mutane 17 a yanzu.
A wani taron labarai na kan layi, Daraktan IEDCR, Dokta Mirjadia Sabrina Flora ta bayyana cewa maza hudu da mace daya sun mutu.
A cewar Dokta Mirjadi, marasa lafiya biyu sun haura shekaru 60, biyu sun kai shekaru 51 zuwa 60, kuma ɗaya ya kai shekaru 41 zuwa 50.
Ya kuma bayyana cewa biyu daga cikin wadanda suka mutu daga Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu cewa, wanda ya mutu, Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, kuma ana kula da shi a asibitin Kuwait Maitre.
A wani sanarwar bidiyo ta yanar gizo a ranar Asabar, Ministan Sufuri da Bridges na Bangladesh, Ubaydul Qadar, ya bayyana cewa za a dakatar da sufuri na hanya har zuwa Asabar mai zuwa, fiye da yadda aka tsara.
An fara wannan dakatarwar ta sufuri a ranar 26 ga watan Maris kuma za ta ƙare a ranar Asabar, 4 ga watan Afrilu.
Ba a hana jigilar kayayyakin rayuwa kamar kayayyakin kiwon lafiya, man fetur da abinci ba.
An fara samun cututtukan COVID-19 a Bangladesh a cikin mutane biyu da suka dawo daga Italiya a ranar 8 ga Maris, ɗaya daga cikinsu kuma matarsa.
A ranar 19 ga Maris, dukan su uku sun warke.
Cutar SARS-CoV-2 ta kai miliyan a duniya
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa a ranar Alhamis, jimillar adadin kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan daya.
An haɗa cutar COVID-19 da cutar coronavirus da mutuwar mutane akalla dubu 52.
Ranar da aka wuce wannan lambar, ranar da aka fara samun cutar coronavirus a Malawi da kuma mutuwar farko ta cutar a Zambia.
Koriya ta Arewa ta yi ikirarin cewa ta kasance cikin fewan ƙasashe kaɗan da suka kasance ba tare da kamuwa da cutar coronavirus ba har zuwa ranar Alhamis.
Kungiyar Lafiya ta Duniya (WHO) ta bayar da rahoton 10,51,635 da suka tabbatar da cutar a jiya, ciki har da 79,332 a cikin sa'o'i ashirin da huɗu kafin 10am (0800 UTC) na tsakiyar Turai a ranar 4 ga Afrilu.
An samu fiye da mutane miliyan biyu da dubu arba'in da hudu da suka kamu da cutar a Amurka, kuma ta yi sanadiyar mutuwar mutane 5,900.
CBS News ta nakalto bayanan Jami'ar Johns Hopkins cewa cutar coronavirus ta yi sanadiyar mutuwar mutane sama da 1,000 a Amurka a ranar Laraba.
Kasashe a duniya sun sanar da karin tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, Magajin garin Moscow Sergei Sobyanin ya tsawaita dokar kulle a birnin har zuwa ranar 1 ga watan Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa, har zuwa 30 ga Afrilu, 'yan Rasha za su ci gaba da samun albashi ba tare da zuwa aiki ba.
Majalisar Portugal ta yi zaɓe don tsawaita dokar ta baci na tsawon kwanaki 15; an amince da shawarar da kuri 'ya 215, tare da mambobi goma da suka ƙi halarta da ɗaya da suka ƙi.
Saudiyya ta kafa dokar hana fita ta sa'o'i 24 a birnin Makka da Madina, inda a baya dokar ta kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand na shirin kafa dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike Dhaine ya sanar da cewa an tsawaita dokar hana fita a jihar har zuwa ranar 1 ga Mayu.
A Ostiraliya, kantuna sun rage yawan takardar wanka da za a iya saya a lokaci guda
A ranar Lahadi da Asabar da yamma, manyan shagunan Australiya Woolworths da Coles sun rage adadin takardar bayan gida da za a iya saya a lokaci guda a duk shagunan su a duk faɗin ƙasar zuwa biyu da ɗaya, bi da bi.
ALDI ma ya kafa iyakar fakitin a ranar Litinin.
An buga waɗannan iyakokin a matsayin saƙonni a shafukan biya da kuma shafukan Facebook na jerin.
An bayar da rahoton cewa masu siye suna siyayya tare don yanayin da ya zama dole su keɓe kansu saboda tsoron COVID-19.
A ranar Laraba, Woolworths ya rage iyakar sayen takardar bayan gida zuwa fakiti ɗaya a kowane oda, har ma don isar da gida.
Kafin waɗannan canje -canje, Woolworths da Coles sun sanya takunkumin hana sayen fakiti huɗu a lokaci ɗaya a ranar 4 da 5 ga Maris, bi da bi.
Koles ya bayyana a cikin sanarwar sa ta 8 ga Maris cewa duk da dokar hana kwantena hudu, "yawancin shagunan suna ta ƙarewa cikin sa'a guda na isarwa", kuma ya kira wannan bukatar da ba a taɓa gani ba, yayin da ALDI ya kira shi "ba zato ba tsammani" a cikin wani sakon Facebook a ranar Talata.
Wani mai magana da yawun kamfanin Woolworths ya ce, tallace -tallace sun yi tashin gwauron zabi a makon da ya gabata.
Shagon Costco da ke Canberra ya rage adadin zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarni ga manyan fakitoci ga masu samarwa kuma ya ƙara yawan isar da su. Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ya tara kaya don samar da shirin na musamman na ranar Laraba da wuri.
Russell Zimmerman, shugaban hukumar 'yan kasuwa na Australia, ya ce 'yan kasuwa su yi ƙoƙarin ƙara yawan kayayyakin da suke da su, amma hakan yana da wuya saboda ƙuntatawa da majalisar ta kafa a kan lokacin da za a kai motocin.
A wani yanayi da masu samarwa suke ƙoƙarin biyan bukatar kuma adadin na musamman ya ragu, Russell yana tsammanin farashin samarwa zai ƙaru.
A ranar Talata, ALDI ta sanar da cewa bayan an saki kayan kafin lokaci, wasu shagunan ba za su iya gudanar da na musamman na Laraba ba.
Wani rahoto da aka wallafa a shafin News.com.au, ya nuna cewa, Dr. Gary Mortimer, wani ƙwararren mai sayar da kayayyaki a jami'ar Queensland ta fasahar zamani, ya ce, shaguna suna cika kayayyaki a kowane dare.
Ya ce takardar bayan gida abu ne mai nauyi, saboda haka ba za a iya samun adadi mai yawa ba, kuma idan aka sayar da duk kayan, sai a bar manyan ɗakunan ajiya a baya, wanda ke ƙara saurin rashin.
Russell Zimmerman ya ce, "Koles da Woolworths suna da ra'ayin cewa idan akwai isasshen kaya a kan shiryayye, kuma kayayyakin kamar takardar wanka da na'urar wankewa za a iya sayarwa kuma a yalwace, za a iya rage tashin hankali.
Kamfanin da ke kera takarda mai amfani da ita mai suna Who Gives a Crap ya ce sun gama kayayyakin da suke da su a ranar Laraba.
Kamar yadda News.com.au ta ruwaito, Kimberly - Clark, mai yin kayan wanka na CLEANEX, da Solaris Paper, mai yin kayan shafa, sun ce suna aiki 24/7 don ci gaba da samar da kayayyaki.
Wani rukunin gidaje mai suna Domain.com ya ba da rahoto cewa a Melbourne, inda ake yin gwanjo kaɗan domin masu saye suna yin hutu a ƙarshen ranar Labor Day, wasu masu sayar da kayayyaki suna ba da takardar wanka kyauta ga waɗanda suka fara yin gwanjo.
A ranar Alhamis na wata jarida da ake kira NT News da ke Darwin, an saka shafuffuka takwas da aka yanke don a yi amfani da su a matsayin takardar wanka.
Wani rahoto na ABC Australia na 3 ga Maris ya nuna cewa, a farko, shaguna ba su da niyyar hana su sayayya; a cikin wannan rahoton, sun ce ba su da wani shiri na hana sayayya.
Russell Zimmerman ya kara da cewa akwai bukatar wasu kayayyaki, ciki har da masks, sanitizers, bushewa, handwashes da kuma gari.
Hakazalika, a waje da Ostiraliya, an sanya iyakar fakiti biyu na 12-roll akan sayan takarda mai tsabta na Andres a cikin kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19, cutar da ke haifar da cutar coronavirus SARS-CoV-2.
Ko da yake kalmar nan "annoba" tana nufin yadda cutar take yaɗuwa, ba yadda hatsarinta yake ba, WHO ta tattauna bukatar ƙarfafa gwamnatoci su ɗauki mataki.
Duk ƙasashe na iya canza yanayin wannan annobar ta duniya a yanzu.
Idan ƙasashe suka amsa, za su iya gano cutar, su kula da marasa lafiya, su ware su, su gano su, su haɗa kai, in ji Daraktan WHO Tedros Adhanom Ghebreyesus.
"Muna matukar damuwa da matakin yaduwar cutar da kuma rashin aikin yi.
A cewar tsohon daraktan Cibiyoyin Kula da Cututtuka na Amurka, Dr. Tom Freeden, wannan annoba ta duniya "ba ta da misali".
A cikin wani jawabi da CNN ta wallafa a watan Fabrairu, ya ce, "Babu wani kwayar cutar numfashi da aka gano ta hanyar yaduwar duniya sai dai cutar mura".
Gabrayiasis ya bayyana irin wannan tunanin lokacin da ya ce, "Ba mu taɓa ganin wata annoba ta duniya ba kamar ta coronavirus.
Ya kara da cewa, "Kuma har zuwa yau, ba mu ga wata annoba ta duniya da za a iya sarrafawa ba.
Wannan sabon lakabi na annoba na duniya ya biyo bayan shawarar WHO a watan Janairu na ayyana annobar a matsayin gaggawa ta lafiyar jama'a mai matukar damuwa a duniya.
"Abin da ya fi muni, zai fi muni", in ji Dokta Anthony Fauci, darektan Cibiyar Kula da Cutar Cutar da ke fama da cuta a Amirka.
Kamfanin dillancin labarai na Associated Press ya ruwaito cewa a ranar Alhamis, akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, kuma fiye da mutane 4,600 sun mutu sakamakon cutar.
2019-20 annobar cutar coronavirus annoba ce mai gudana ta cutar coronavirus 2019 (COVID-19), wadda ke haifar da cutar mai saurin numfashi mai saurin kamuwa da cuta coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a a duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu 2020, an ba da rahoton kusan 1.61 miliyan na COVID-19 a cikin ƙasashe da yankuna 210, wanda ya haifar da kusan mutuwar 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta cewa cutar ta kashe mutane 4 cikin 100 a kasar Sin, yayin da a duniya, ta kai daga 13.04 cikin 100 a Aljeriya zuwa 0.08 cikin 100 a New Zealand.
Alamun na kowa sun hada da zazzabi, tari da kumburi.
Ƙalubalen na iya haɗawa da ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci daga lokacin da aka kamu da kwayar cutar zuwa lokacin bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma yana iya zuwa kwanaki biyu zuwa goma sha huɗu.
Babu wani maganin rigakafi ko takamaiman maganin rigakafin cutar.
Maganin farko shi ne maganin cututtuka da na taimako. Matakan rigakafi da aka ba da shawarar sun hada da: wanke hannu, rufe bakinka lokacin da kake tari, nisantar mutane, da kuma sa ido da keɓe kai ga mutanen da ake zargin suna da cutar.
Hukumomi a duniya sun amsa ta hanyar aiwatar da takunkumin tafiye -tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki, da rufe wuraren aiki.
Cutar ta haifar da mummunan rikice-rikicen tattalin arziki na duniya, ta haifar da jinkiri ko soke wasanni, addini, siyasa da al'adu, kuma ta haifar da raguwar kayayyaki saboda mutane suna cikin fargaba.
A ƙasashe 193, makarantu da jami'o'i suna rufewa a ƙasa ko a gida, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Rashin fahimta game da cutar ya bazu a kan layi, kuma akwai al'amuran tsanar baƙi da nuna bambanci ga wasu daga Sin, Gabas da kudu maso gabashin Asiya da sauran mutanen launin fata, da kuma daga yankunan da ke da yawan masu kamuwa da cutar.
Rage tafiye - tafiye da rufe masana'antu sun rage gurɓataccen iska da fitar da carbon.
Hukumomin lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin lamuran cutar sankarar huhu da ba a san dalilin su ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin lamuran sun danganta ne da kasuwar cin abincin teku ta Hunan kuma saboda haka ana ganin cutar ta samo asali ne daga dabbobi.
Cutar da ke haifar da annobar, wanda aka sani da SARS-CoV-2, sabon kamuwa da cuta ne wanda ke da alaƙa da bat coronavirus, pangolin coronaviruses, da SARS-CoV. An gano farkon mutum da aka sani da alamun cutar a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa da ke bayyane tare da ƙungiyar Wallace Meat Market.
Kashi biyu bisa uku na farkon rukunin shari'o'in da aka ruwaito a watan Disamba na 2019 sun kasance suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoton da ba a tabbatar da shi ba na South China Morning Post ya nuna cewa wani mutum mai shekaru 55 a lardin Hubei a ranar 17 ga Nuwamba, 2019, wanda zai iya zama farkon lamarin. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa sabon karuwar ya faru a cikin Italiya, Iran da Koriya ta Kudu tare da raguwar sabbin shari'o'i a China, tare da sabon adadin sabbin shari'o'in da ke waje da China ya zarce na farko a cikin China.
Ana iya samun ƙarancin rahoton cututtuka, musamman a cikin mutanen da ke da ƙananan alamun.
Har zuwa 26 ga Fabrairu, an samu rahotanni na ƙananan lamura a cikin matasa, waɗanda shekarunsu 19 da ƙasa suka kai kashi 2.4% na adadin masu cutar a duniya. Babban mai ba da shawara kan kimiyyar Burtaniya, Patrick Valens, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin a sami rigakafin garkuwar da ke da tasiri.
Lamura na nufin adadin mutanen da aka gwada su da COVID-19, kuma bisa ga ka'idojin hukuma waɗanda aka tabbatar da tabbataccen gwajin.
Ya zuwa ranar 23 ga Maris, babu wata ƙasa da ta gwada sama da kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland suna da manufofin hukuma na ƙin gwada waɗanda ke da ƙananan alamun kawai.
Wani bincike da aka buga a ranar 16 ga Maris ya gano cewa a China, har zuwa ranar 23 ga Janairu, kimanin kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma cewa wadannan cututtukan da ba a gano ba ne tushen kamuwa da cutar a kashi 79% na wadanda aka samu.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin mutanen da suka kamu da cutar a Italiya ya fi adadin da aka ruwaito.
Hasashen farko na ainihin yawan haihuwa (R0) don COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyoyin Kula da Cututtuka da Rigakafin Amurka suka wallafa ya ce zai iya zama 5.7.
Yawancin mutanen da ke kamuwa da COVID-19 suna warkewa.
A cikin waɗanda ba su warke ba, lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 da 41, tare da kwanaki 14 a mafi yawan.
Ya zuwa 10 ga Afrilu 2020, COVID-19 ya yi sanadin mutuwar mutane kusan 97,000.
A China, har zuwa 5 ga Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin mutanen da suka haura shekaru 60, kuma kashi 75% na shari'o'in suna da yanayin kiwon lafiya na baya-bayan nan, gami da cututtukan zuciya da ciwon sukari.
Adadin mutuwar COVID-19 na iya zama da yawa, saboda ba zai iya haɗa da mutanen da suka mutu ba tare da gwaji ba kamar a gida, a cikin gidajen jinya, da sauransu.
Ƙididdigar Italiya ta gano cewa ƙarin mutuwar da aka samu yayin annobar sun ninka na COVID sau 4-5 fiye da na hukuma.
Wani mai magana da yawun Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka (CDC) ya yarda "Mun san cewa an yi hasashen ƙasa da [adadin mutuwar]", wata sanarwa da ke da goyan bayan bayanan da ba a lissafta su ba a cikin Amurka. Irin waɗannan ƙananan hasashe suna faruwa sau da yawa a cikin annoba, kamar yadda ya faru a cikin cutar sankarar naman alade ta 2009 H1N1.
Mutuwa ta farko a wajen kasar Sin ta faru ne a Philippines a ranar 1 ga watan Fabrairu, kuma ta farko a wajen Asiya a Faransa a ranar 14 ga watan Fabrairu.
Ya zuwa 28 ga Fabrairu, fiye da mutane goma sha biyu sun mutu a waje da babban yankin China, a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, an samu rahoton mutuwar a ƙasashe da yankuna sama da arba'in a kowace nahiya, sai dai Antarctica. Ana amfani da ma'auni da yawa don ƙayyade yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki da lokaci, kuma suna da tasiri ta yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon ɓarkewar, da halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya. Adadin mutuwa ya nuna adadin mutuwar da aka raba da adadin waɗanda aka gano a cikin takamaiman lokaci.
Bisa ga bayanan Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan adadi yana canjawa bisa ga yankin.
A China, kimantawar mutuwar-labarin rabo ya ragu daga 17.3% (ga waɗanda suka fara bayyanar cututtuka daga 1-10 ga Janairu 2020) zuwa 0.7% (ga waɗanda suka fara bayyanar cututtuka bayan 1 ga Fabrairu 2020). Sauran matakan sun haɗa da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da suka mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu (wanda aka gano da wanda ba a gano ba) daga cutar.
Waɗannan bayanan ba su da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warkewa.
Masu ilimi da yawa sun yi ƙoƙari su ƙididdige waɗannan lambobin don takamaiman mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin annoba tsakanin 0.1% da 0.39%.
Wannan ƙididdigar sama ta daidaita da sakamakon binciken ƙididdiga na farko na COVID-19 a cikin Jamus da kuma nazarin tasirin gwajin akan ƙididdigar CFR.
WHO ta yi ikirarin cewa za a iya sarrafa cutar.
Lokacin ƙarewa da ƙarshen ɓarkewa ba shi da tabbas kuma yana iya bambanta da wuri.
"Idan aka bar su ba tare da kulawa ba, yawanci cututtukan cututtuka suna daidaitawa kuma suna fara raguwa idan babu abubuwan gina jiki don cutar", in ji Mackie Bonney na Penn State University.
Amma a yanzu, ba shi yiwuwa a yi tunanin lokacin da hakan zai faru.
Zhong Nanshan, babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China, ya yi jayayya cewa "za a iya kawo karshen wannan a watan Yuni" idan dukkan kasashe suka bi shawarar WHO kan matakan hana yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kula da Lafiya da Magunguna ta London ya ce SARS-CoV-2 "mai yiwuwa zai kasance yana yawo na shekara ɗaya ko biyu".
Wani binciken kwalejin na Imperial wanda Neil Ferguson ya jagoranta ya ce, yin nisantar jiki da sauran matakan zai zama dole "har sai an samu rigakafin (watakila watanni 18 ko fiye).
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan coronavirus za ta halaka gaba daya, saboda tana yaduwa cikin sauki" kuma tana iya "canza zuwa wani yanayi na cutar, wanda ke dawowa kowace shekara".
Yanayin dawowar zai dangana ne akan yawan garkuwar jiki da kuma yawan canjin da aka yi.
Alamun COVID-19 na iya zama marasa ma'ana kuma mutanen da ke kamuwa da cutar na iya zama masu rashin lafiya.
Alamun biyu da suka fi kowa su ne zazzabi (88%) da kuma busasshiyar tari (68%).
Wasu alamun rashin lafiya sun haɗa da: gajiya, ƙarancin ƙanshin numfashi (ƙanshin huhu), ƙarancin ƙanshin ƙanshi, kumburi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, ƙarancin jini, zawo, ko kuma ƙanshin ƙwai.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka (CDC) ta lissafa alamun gaggawa kamar su wahalar numfashi, ciwon kirji ko matsi na yau da kullun, rikicewar kwatsam, wahalar farkawa, da launin shuɗi na fuska ko lebe; ana ba da shawarar kulawar likita nan da nan idan waɗannan alamun sun bayyana. Ci gaban cutar na iya haifar da ciwon huhu mai tsanani, cututtukan numfashi mai tsanani, sepsis, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Wasu daga cikin mutanen da suka kamu da cutar na iya zama marasa lafiya, ba tare da alamun asibiti ba, amma sakamakon gwajin ya tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa ya kamata a kula da mutanen da ke da kusanci da mutanen da suka kamu da cutar sosai kuma a gwada su don kawar da kamuwa da cutar.
Kimanin kashi 44 cikin dari na yawan rashin lafiya a ƙasar Sin.
Lokacin da ake samun cutar (tsakanin kamuwa da cutar da bayyanar cututtuka) ya fara daga kwana daya zuwa 14; yawanci kwana biyar. Wani misali na rashin tabbas shine kimantawa na kashi na mutanen da ke da COVID-19 waɗanda suka rasa ƙanshin su, wanda ya fara daga kashi 30 cikin dari kuma daga baya ya ragu zuwa kashi 15.
Har yanzu ana tantance wasu bayanai game da yadda cutar ke yaduwa.
An yi imanin cewa cutar tana yaduwa ne ta hanyar ƙananan raɗaɗɗen da aka samar yayin haɗuwa da coughing, sneezing, ko magana; lokacin da kusanci ya kasance tsakanin 1 zuwa 2 mita (3 zuwa 6 feet).
Bincike ya nuna cewa saurin shan ƙishi zai iya kaiwa daga mita 4.5 (mita 15) zuwa mita 8.2 (mita 27).
Wasu sun ba da shawarar cewa za a iya yada kwayar cutar ta hanyar ƙananan raƙuman da aka samar yayin magana waɗanda ke kasancewa a cikin iska na dogon lokaci. Raƙuman numfashi na iya haifar da numfashi yayin numfashi, gami da magana, kodayake kwayar cutar ba ta da iska.
Za a iya kai raɓa cikin hanci ko baki na waɗanda suke kusa ko kuma a cikin huhu ta hanyar numfashi.
Wasu hanyoyin kiwon lafiya kamar su tube penetration da cardiopulmonary therapy (CPR) na iya haifar da jinkirin fitar numfashi kuma ta haka ne ya haifar da yaduwar iska.
Hakanan zai iya yaduwa idan mutum ya taɓa wani gurɓataccen wuri, ciki har da fata, sannan ya taɓa idanunsa, hanci, ko baki.
Ko da yake akwai damuwa cewa ana iya yada shi ta hanyar stool, ana ganin cewa ba shi da haɗari.
Gwamnatin China ta yi watsi da yiwuwar watsa SARS-CoV-2 ta hanyar magana. Kwayar cutar tana da kamuwa sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya samun yaduwa a cikin matakan cutar kafin bayyanar cututtuka da kuma bayan bayyanar cututtuka.
Mutane sun gwada tabbatacce ga cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa yana yiwuwa a watsa kafin a sami alamun bayyanar cututtuka.
Rahotanni kaɗan ne kawai na lab da aka tabbatar da ƙwayoyin cuta, amma wasu ƙasashe sun gano watsa ƙwayoyin cuta yayin binciken tuntuɓar.
A cewar Cibiyar Kula da Cututtuka ta Turai (ECDC), ko da yake ba a bayyana yadda sauƙin cutar take yaɗuwa ba, mutum ɗaya yakan kamu da mutane biyu ko uku.
Musamman, an gano kwayar cutar a kan filastik (polypropylene) da bakin karfe 304 har tsawon kwanaki uku, a kan kwali har tsawon kwana ɗaya, da kuma a kan jan ƙarfe har tsawon awanni huɗu.
Koyaya, ya bambanta dangane da zafi da zafin jiki. Dabbobi da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu tabbacin cewa kwayar cutar za ta iya wucewa daga dabbobi zuwa ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannayenku bayan haɗuwa da dabbobi, kamar yadda ake yi bayan haɗuwa da wasu wurare da mutumin da ke da cutar ya taɓa.
Cutar cutar sankarar numfashi mai tsanani (SARS-CoV-2) wani sabon kwayar cuta ne da aka fara ganowa a Wuhan daga mutane uku da ke fama da cutar sankarar numfashi da ke hade da wasu cututtukan sankarar numfashi.
Dukkanin halayen kwayar cutar SARS-CoV-2 ana samunsu a cikin coronaviruses masu alaƙa da ke wanzu a cikin yanayi. A waje da jikin mutum, kwayar cutar tana mutuwa ta hanyar sabulu na gida, wanda ke lalata garkuwar kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa kwayar cutar ta samo asali ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta Coronavirus ta kasance daga cikin Betacoronaviruses, wani nau'in subgenus Sarbecoviruses (genus B), tare da nau'ikan nau'ikan bat-derived guda biyu.
Wannan ya yi daidai da kashi 96% na sauran bat coronavirus samfurori (BatCov RaTG13) a matakin dukkanin kwayoyin halitta.
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa bambancin amino acid guda daya ne kawai a wasu sassan jerin kwayoyin halittar tsakanin kwayar cutar daga pangolins da kwayar cutar daga mutane.
A cikin kwatancen da aka yi na gaba ɗaya, an sami matsakaicin kashi 92% na kayan halittar tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da cewa pangolins suna da matsakaicin abinci mai gina jiki ba.
Ana iya gano kamuwa da kwayar cutar ta hanyar bayyanar cututtuka na ɗan lokaci, kodayake an tabbatar da shi daga baya ta hanyar jujjuyawar jujjuyawar polymerase chain reaction (rRT-PCR) ko hotunan CT.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR saukin ganewa, duk da cewa ba shi da bambanci da wasu siffofin hoto da ke kama da sauran cututtukan huhu da kuma hanyoyin cutar.
Har zuwa Maris 2020, Kwalejin Magunguna ta Amurka ta ba da shawarar cewa "Kada a yi amfani da CT a matsayin gwajin farko don bincika ko gano COVID-19.
WHO ta wallafa wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda aka fitar da na farko a ranar 17 ga Janairu.
Wannan gwajin yana amfani da ainihin lokaci na juyawa juyawa polymerase chain reaction (rRT - PCR).
Ana iya yin gwajin ne a kan numfashi ko kuma jini.
Sakamakon yana samuwa a cikin 'yan sa'o'i zuwa kwanaki.
Ana yin gwajin ne a kan hanci, amma ana iya yin amfani da hanci. Yawancin dakunan gwaje - gwaje da kamfanoni suna haɓaka gwajin serological don gano rigakafi.
Har zuwa 6 ga Afrilu 2020, babu ɗayan da ya tabbatar da cewa ya isa a amince da shi don amfani da shi a cikin manyan wurare.
Wani gwajin ƙwayar cuta da Cellex ya samar a Amurka an amince da shi ne kawai don amfani da gaggawa ta hanyar ingantattun dakunan gwaje - gwaje.
Bayanan hoto na alamomi a kan radiographs da computed tomography (CT) na mutanen da ke da alamun sun haɗa da rashin daidaituwa na gilashin ƙasa da kuma ɓacewar ƙwayar huhu.
Kamfanin Radiological na Italiya yana tattara bayanan bayanan hoto na duniya akan layi don tabbatar da lamuran.
Saboda kamanceceniya da sauran kamuwa da cuta kamar su adenoviruses, ba tare da tabbaci ta hanyar PCR ba, hoton yana da iyakantaccen ƙayyadaddun bayanai a cikin gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa kodayake hoton ba shi da takamaiman kamuwa da cuta, yana da sauri kuma yana da saukin kamuwa da cuta, wanda ke ba da shawarar yin la'akari da shi azaman hanyar bincike a cikin yankunan annoba.
An haɓaka hanyoyin sadarwa na kwakwalwa masu ƙirar ƙira don gano fasalin hoto na kwayar cutar tare da duka radiographs da CT.
Don hana yaduwar cutar, dabarun sun hada da kiyaye tsabtar mutum gaba daya, wanke hannu, guje wa taɓa idanu, hanci ko baki da hannaye marasa wankewa, da kuma tari ko sneezing a cikin wani abu da jefa shi kai tsaye cikin kwandon shara.
Ana ba da shawarar cewa mutanen da suka riga sun kamu da cutar su sanya abin rufe fuska a wuraren jama'a.
Ana kuma ba da shawarar kiyaye nisantar jiki don hana yaduwar cutar. Yawancin gwamnatoci sun hana ko ba da shawarar duk abubuwan da ba su da mahimmanci a cikin ƙasashe da yankuna da cutar ta shafa.
Koyaya, kwayar cutar ta kai matakin yaduwar al'umma a yawancin ɓangarorin duniya.
Wannan yana nufin cewa kwayar tana yaduwa a cikin al'ummomi, kuma wasu membobin al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar masu ba da kulawa da ke kula da mutumin da ke kamuwa da cutar su bi ƙa'idodin ƙa'idodi, su yi amfani da matakan tuntuɓar, kuma su kiyaye idanu.
Amfani da bayanan wurin wayar salula ta gwamnati don wannan manufar ya haifar da damuwa game da sirri, wanda Amnesty International da sama da wasu kungiyoyi 100 suka ba da sanarwar kan iyakokin irin wannan sa ido.
An aiwatar ko kuma an ba da shawarar aikace-aikacen hannu daban-daban don amfani da son rai, kuma har zuwa 7 ga Afrilu, 2020, sama da gungun masana dozin suna aiki kan mafita mai dacewa da sirri, kamar amfani da Bluetooth don yin rajistar kusanci da mai amfani da wasu wayoyin salula.
Masu amfani suna karɓar saƙo idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce na COVID-19. Rashin fahimta yana yaduwa game da hanyoyin hana kamuwa da cuta; misali, shafa hanci da goge baki da wanka.
Babu maganin COVID-19 da ake da shi, duk da haka kungiyoyi da dama suna aiki don samar da maganin.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa akai -akai na akalla sakan ashirin, musamman bayan sun je bayan gida ko kuma idan hannayensu sun kasance masu datti; kafin cin abinci; da kuma bayan sun fesa hanci, sun yi tari ko kuma sun yi tari.
Wannan saboda a wajen jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke karya kumfa mai kariya.
Bugu da ƙari, CDC ta ba da shawarar yin amfani da kayan aikin tsabtace hannu na tushen giya wanda ke da aƙalla kashi 60% na giya, lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane su guji taɓa idanunsu, hanci, ko baki da hannayensu marasa wanke.
Za a iya kashe abubuwa da yawa da yawa, ciki har da 62% 71% ethanol, 50% 100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.2% 7.5% povidone -iodine (a cikin minti daya na hulɗa da maganin kashe ƙwayoyin cuta zuwa saman bakin karfe).
Wasu maganganu, kamar su benzalkonium chloride da crohexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko an tabbatar da cutar COVID a wani wuri kamar ofis ko wurin kulawa da rana, ya kamata a yi amfani da maganin kashe ƙwayoyin cuta a duk wuraren kamar ofisoshi, wuraren wanka, wuraren jama'a, kayan aikin lantarki da aka raba kamar su Allunan, allon taɓawa, maɓallan maɓalli, sarrafawa na nesa, da na'urorin ATM da ke amfani da marasa lafiya.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da ƙugu ko kuma wani abu da zai rufe su sa'ad da suke yin tari ko kuma hancin su, kuma su zubar da duk wani abu da suka samu nan da nan.
Ana ba da shawarar abin rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance adadin saukad da numfashi da za a iya ɗauka yayin magana, sneezing da coughing.
WHO ta ba da umarni kan lokacin da kuma yadda ake amfani da abin rufe fuska.
A cewar Stephen Griffin, wani masanin cutar a Jami'ar Leeds, "saka abin rufe fuska na iya rage yawan mutane su taba fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da tsaftace hannu ba". An kuma bada shawarar cewa masu kula da wanda ke da cutar su yi amfani da abin rufe fuska.
WHO ta ba da shawarar sanya abin rufe fuska ta hanyar mutanen da ke da lafiya kawai idan suna cikin haɗari, kamar waɗanda ke kula da mutumin da ke da COVID-19, kodayake ta kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Yawancin ƙasashe sun fara ƙarfafa amfani da abin rufe fuska ta hanyar mutane.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na ba-magani da aka yi da masana'anta. China ta ba da shawarar musamman amfani da masks na likita mai zubar da jini ta hanyar mutanen da ke da lafiya, musamman lokacin da suke cikin kusanci da wasu mutane (mita 1 (ƙafa 3 ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska yayin amfani da sufuri na jama'a ko kuma kasancewa a wuraren da mutane ke yawan taruwa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi takunkumin fuska na tufafi a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje a wuraren jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga Maris, Vietnam ta nemi kowa ya sanya abin rufe fuska yayin tafiya zuwa wuraren jama'a don kare kansa da sauransu.
Gwamnatin Austriya ta tilasta wa duk mutanen da ke shiga kantin sayar da kayan masarufi su sanya abin rufe fuska.
Isra'ila ta nemi dukkan 'yan kasa su sanya abin rufe fuska a wuraren taruwar jama'a.
Taiwan, wacce ke samar da abin rufe fuska miliyan 10 a kowace rana tun tsakiyar Maris, ta sanya sanya abin rufe fuska a kan jiragen kasa da bas na tsakanin birane daga ranar 1 ga Afrilu.
Panama ta sanya sanya abin rufe fuska a waje, yayin da kuma shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya sayan abin rufe fuska ba.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Yin nesa da jama'a (wanda kuma ake kira da nisantar jiki) ya ƙunshi ayyukan sarrafa kamuwa da cuta, wanda ke nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun haɗa da keɓewa; ƙuntatawa kan tafiye - tafiye; da rufe makarantu, wuraren aiki, filayen wasa, gidajen kallo, ko cibiyoyin kasuwanci.
Mutane na iya aiwatar da hanyoyin nisantar jama'a ta hanyar zama a gida, ta hanyar iyakance tafiya, guje wa wuraren taruwa, amfani da gaisuwa ba tare da tuntuɓar mutum ba, da kuma nisantar da kansu daga wasu.
Gwamnatoci da yawa yanzu suna ba da shawarar ko kuma ba da shawarar nisantar zamantakewa a yankunan da cutar ta shafa.
An rage yawan jama'a da aka ba da shawarar ta hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya daga mutane 250 (idan babu sanannen yaduwar COVID-19 a wani yanki) zuwa mutane 50, sannan daga baya zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane sama da biyu. Manya tsofaffi da mutanen da ke da yanayin rashin lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma tsarin rigakafi masu rauni suna da haɗarin kamuwa da cututtuka masu tsanani da rikitarwa kuma CDC ta shawarce su da su zauna a gida kamar yadda ya yiwu a yankunan da ke da barkewar cutar. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "nesa" da "nesa ta jiki", don bayyana cewa manufar zamantakewa ita ce rage hulɗa ta jiki yayin kiyaye ko dai na kamala ko na nesa.
Amfani da kalmar "nesa da jama'a" ya haifar da ma'ana cewa, mutane su bi cikakkiyar keɓewa maimakon ƙarfafa su su ci gaba da hulɗa da wasu ta hanyar madadin. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani yayin annobar.
Wannan ya haɗa da shawarwari na yin jima'i da mutumin da kake zama tare da shi kawai, wanda ba shi da cutar ko kuma alamun cutar.
An ba da shawarar keɓe kai a gida ga mutanen da aka gano suna da COVID-19 da waɗanda ake zargin suna da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun umarni don keɓancewar kai. Gwamnatoci da yawa sun ba da shawarar ko kuma sun ba da shawarar keɓe kai ga dukan mutanen da ke zaune a yankunan da ke fama da cutar.
An ba da umarnin keɓe kai mafi ƙarfi ga rukunin haɗari.
Mutanen da suka iya kasancewa tare da wanda ke dauke da cutar COVID-19 da kuma waɗanda suka ziyarci ƙasa ko yanki kwanan nan tare da yaduwar yaduwar cutar an shawarce su da su keɓe kansu na tsawon kwanaki 14 daga lokacin da suka kasance cikin haɗari.
Dabaru na sarrafa ɓarkewar cutar su ne hanawa, da kuma ragewa.
Ana gudanar da rigakafi a farkon farkon barkewar cutar kuma yana nufin gano mutanen da ke kamuwa da cutar tare da aiwatar da sauran matakan sarrafa kamuwa da cutar da allurar rigakafi don hana cutar yaduwa ga sauran jama'a.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, ƙoƙari ya koma ga jinkirta: ana ɗaukar matakai don rage yaduwar cutar da rage tasirinta ga tsarin kiwon lafiya da al'umma.
Za a iya yin amfani da maganin hanawa da kuma maganin hanawa a lokaci guda.
Rashin ƙarfi yana buƙatar ƙarin matakan matsananci, don juya annoba ta hanyar rage ainihin yawan haihuwa zuwa 1. Wani ɓangare na gudanar da barkewar cutar mai yaduwa shine ƙoƙarin rage girman annoba, wanda aka sani da rage yanayin annoba.
Wannan yana rage haɗarin lalacewar kiwon lafiya kuma yana ba da ƙarin lokaci don haɓaka alluran rigakafi da magunguna.
Hanyoyin da ba na magani ba da za su iya sarrafa barkewar cutar sun haɗa da matakan rigakafin mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓewa; matakan al'umma da ake so don nisantar da jiki kamar rufe makarantu da soke taron taro; sa hannu cikin al'umma don ƙarfafa yarda da shiga cikin irin waɗannan hanyoyin; da kuma tsaftace farfajiyar kamar tsaftace muhalli. An yi aiki mai tsauri a cikin China don magance cutar lokacin da tsananin cutar ya bayyana, kamar ƙuntatawa da keɓewar birane da tsauraran ƙa'idodi.
Sauran ƙasashe ma sun ɗauki matakai da dama da nufin rage yaduwar cutar.
Koriya ta Kudu ta fara yin bincike mai yawa da keɓewa, kuma ta ba da gargadi kan motsin mutane masu kamuwa da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar waɗanda suka keɓe kansu kuma suka sanya manyan tarar waɗanda suka kasa yin hakan.
Taiwan ta haɓaka samar da abin rufe fuska da kuma hukunta tara kayan kiwon lafiya. Yin kwaikwayon ga Burtaniya da Amurka ya nuna cewa akwai manyan ƙalubale a cikin ragewa (ragewa amma ba dakatar da yaduwar cutar) da hanawa (juyawa ci gaban cutar).
Daidai da hanyoyin magance cutar, za a iya rage bukatar kulawar lafiya ta musamman da kashi biyu cikin uku da kuma rage mace - mace da rabi, amma har ila yau, ana kashe daruruwan mutane kuma ana lalata tsarin kiwon lafiya.
Za a iya ba da fifiko ga hanawa, amma ana buƙatar kiyaye shi har sai cutar ta bazu cikin yawan mutane (ko har sai an sami allurar rigakafi, idan ta fara), in ba haka ba sassauƙa a cikin matakan yana dawo da watsawa cikin sauri.
Saurin tsauraran matakai don hana annobar yana haifar da tsadar zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19 da aka amince da shi, amma ana ci gaba da kokarin ci gaba, gami da gwajin magungunan da ake da su.
Shan magungunan sanyi da ba a rubuta wa likitanci, shan ruwa, da kuma hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin, ana iya bukatar maganin oxygen, ruwan da ke cikin jijiya, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya sa sakamako ya yi muni.
Yawancin mahaɗan da aka riga aka amince da su don magance wasu cututtukan ƙwayar cuta ana bincika su don amfani da su a cikin maganin COVID-19.
WHO ta ce wasu "magungunan gargajiya da na gida" na iya taimakawa wajen rage alamun cutar SARS-CoV-19.
WHO ta bayyana haɓaka iyawa da daidaita kiwon lafiya don bukatun marasa lafiya na COVID-19 a matsayin matakin amsawa na farko.
ECDC da WHO na Ofishin Yankin Turai sun ba da jagororin don canja wurin albarkatu a matakai da yawa ga asibitoci da sabis na kula da lafiyar farko, gami da: mai da hankali kan sabis na dakin gwaje-gwaje kan gwajin COVID-19, soke hanyoyin zaɓe a duk lokacin da ya yiwu, warewa da keɓe marasa lafiya da ke kamuwa da COVID-19, da haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka adadin masu sanyaya iska da gadaje.
Akwai ra'ayoyi da yawa game da inda lamarin ya fara (wanda ake kira marasa lafiya).
An gano farkon sanannen yanayin cutar coronavirus a Wuhan, Hubei, China, a ranar 1 ga Disamba, 2019.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
An fi yawan su ne a kasuwar cin abincin teku ta Hunan, inda ake sayar da rayayyun dabbobi, kuma ana ganin cewa cutar ta fito ne daga daya daga cikin irin wadannan dabbobi; ko kuma, a wasu kalmomi, ta samo asali ne daga dabbobi. An lura da wani nau'in cutar sankarar bargo da ba a san dalilin ba a ranar 26 ga Disamba kuma likita Zhang Jixian ne ya kula da shi a asibitin lardin Hubei, wanda ya sanar da CDC a Wuhan Jiangnan a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wani rukuni na likitoci a asibitin Wuhan na tsakiya sun gargadi abokan aikinsu game da "kwayar cutar korona irin ta SARS".
'Yan sanda sun gargadi likitoci takwas, ciki har da Li Wenliang, kuma wani likita mai suna I Feng ya fuskanci tsautawa daga shugabanninsa, saboda yada jita -jita.
Hukumar Lafiya ta Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An sanar da hukumomin lafiya a Wuhan game da wasu cututtukan cutar sankarar bargo da ba a sani ba, wanda ya haifar da fara bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa wasu lardunan Sin saboda yawan zirga-zirga da Wuhan, cibiyar sufuri da manyan hanyoyin jirgin ƙasa.
A ranar 20 ga Janairu, China ta yi rahoton kusan sabbin mutane 140 a rana, ciki har da biyu a Beijing da mutum ɗaya a Shenzhen.
Bayanai na baya-bayan nan sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar a ranar 20 ga Janairu, 2020. Har zuwa 26 ga Maris, Amurka ta zarce China da Italiya tare da yawan adadin waɗanda aka tabbatar da su a duniya. Har zuwa 9 ga Afrilu, 2020, an ba da rahoton fiye da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Akwai akalla mutum ɗaya a kusan ƙasashe da yankuna 200.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun hana 'yanci tafiya kuma sun kafa matakan iyaka.
Amsoshin ƙasa sun haɗa da matakan hanawa kamar su keɓewa (wanda aka fi sani da umarnin zama a gida, umarnin mafaka a wurinka, ko kulle-kulle) da kuma dokar hana fita. Har zuwa 2 ga Afrilu, kusan mutane miliyan 300 ko kusan kashi 90% na yawan jama'a a Amurka suna cikin wani nau'i na kulle-kulle, sama da mutane miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'i na kulle-kulle, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon tabbataccen shari'ar COVID-19 a Wuhan a ranar 1 ga Disamba, 2019; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya faru ne a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya lura da tarin cututtukan cutar sankarar bargo da ba a san dalilin su ba a ranar 26 ga Disamba, bayan haka asibitin ya sanar da Wuhan Jiangnan CDC a ranar 27 ga Disamba.
Gwajin kwayoyin farko na samfuran mai haƙuri a ranar 27 ga Disamba, 2019 ya nuna bayyanar SARS-like coronavirus.
A ranar 31 ga Disamba, Hukumar Lafiya ta Wuhan ta ba da sanarwar sanarwa.
An sanar da WHO a ranar.
Bayan wannan rahoton, 'yan sanda a Wuhan sun gargadi likitoci da su "yantar da jita -jita" game da barkewar cutar.
Hukumar Lafiya ta Kasa ta kasar Sin da farko ta yi ikirarin cewa babu "tabbacin tabbatacce" na kamuwa da cutar daga mutum zuwa mutum.
A ƙarshen watan Janairu, gwamnatin China ta fara wani mummunan yaƙi don hana yaduwar kwayar cutar, wanda Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping ya kira "yaƙin mutane".
An bayyana shi a matsayin "mafi girman keɓewa a tarihin ɗan adam", an sanar da yankin kewaye don dakatar da motsi a Wuhan a ranar 23 ga Janairu, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birni.
An soke bikin Sabuwar Shekara ta Sin (Janairu 25) a wurare da yawa.
Hukumomin sun kuma sanar da gina asibitin wucin gadi, asibitin Hoshensen, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti, Lichenson Hospital, daga baya don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitoci, kasar Sin ta kuma sauya wasu wurare 14 a Wuhan kamar cibiyoyin taro da filayen wasa zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta kafa ƙarin matakan hana barkewar COVID-19, gami da bayar da sanarwar kiwon lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a ko'ina cikin ƙasar.
Yankunan Hong Kong da Macau sun kafa wasu matakai, musamman game da makarantu da jami'o'i.
An kafa hanyoyin aiki daga nesa a yankuna da yawa na kasar Sin.
An sanya takunkumin hana zirga - zirga a ciki da wajen Hubei.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi na ɗan lokaci a duk faɗin ƙasar Sin.
An kafa takunkumin hana zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa mutane kusan miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wani nau'i na takunkumin fita waje. Bayan barkewar cutar ta kai ga matakin duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana "zuwan" cutar daga wasu ƙasashe.
Misali, Beijing ta sanya wa dukkan matafiya na duniya da ke shiga birnin wa'adin keɓewa na kwanaki 14. A ranar 23 ga watan Maris, an sami mutum daya ne kawai da aka kai gida a cikin kwanaki biyar da suka gabata a cikin babban yankin kasar Sin, a wannan yanayin ta hanyar wani matafiyi da ke dawowa daga Istanbul zuwa Guangzhou.
A ranar 24 ga Maris, 2020, Firayim Ministan China Li Keqiang ya sanar da cewa an dakatar da yaduwar cututtukan da ake yadawa a cikin gida kuma an sarrafa barkewar cutar a China.
An sassauta takunkumin tafiye -tafiye a Hubei ban da Wuhan a ranar, watanni biyu bayan an sanya dokar kulle. Ma'aikatar Harkokin Wajen Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigar masu riƙe da biza ko izinin zama daga ranar 28 ga Maris, tare da ba da takamaiman bayani kan lokacin da wannan manufar za ta ƙare.
Waɗanda suke son shiga ƙasar Sin dole ne su nemi biza a ofishin jakadancin ƙasar Sin ko kuma ofishin jakadancin ƙasar.
Gwamnatin kasar Sin ta karfafa kasuwancin da masana'antu don sake buɗewa a ranar 30 ga Maris kuma ta ba da fakitin haɓaka tattalin arziki ga kasuwancin. Majalisar Jiha ta ayyana ranar makoki ta fara da minti uku na shiru na kasa a ranar 4 ga Afrilu, da karfe 10:00 na safe, daidai lokacin bikin Qingming, duk da cewa gwamnatin tarayya ta nemi iyalai su yi ta'aziyya ta yanar gizo, suna bin ka'idojin nisantar jiki don guje wa sabon barkewar COVID-19.
An tabbatar da yaduwar COVID-19 a Koriya ta Kudu daga China a ranar 20 ga Janairu, 2020.
Hukumar Lafiya ta Kasa ta ba da rahoton karuwar lamura da aka tabbatar a ranar 20 ga Fabrairu, wanda ya danganta da yawan jama'a a cikin wani sabon motsi na addini da ake kira Daigu, wanda aka sani da Ikilisiyar Shinchiji na Yesu.
Shinchiji Bhakti, wanda ya zo daga Wuhan zuwa Daigu, ya yi shakkar asalin cutar.
A ranar 22 ga Fabrairu, 1,261 daga cikin mabiya cocin 9,336, ko kuma kusan kashi 13 cikin ɗari, sun ba da rahoton alamun. Koriya ta Kudu ta ba da sanarwar matakin gargaɗi mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an sami sama da mutane 2,000 da aka tabbatar da su a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan gwajin da aka yi ya tabbatar da cewa sojoji uku sun kamu da cutar.
Shirin da Koriya ta Kudu ta gabatar, wanda aka yi la'akari da shi a matsayin mafi girma kuma mafi kyawun tsari a duniya don bincika yawan jama'a don cutar da ke ware duk waɗanda ke da cutar, da kuma ganowa da keɓe waɗanda suka yi hulɗa da su.
Hanyoyin binciken sun hada da tilastawa kai tsaye na alamun cututtuka ta hanyar sabbin masu shigowa ta hanyar wayar salula, saurin gwaji don cutar tare da sakamakon da zai kasance a rana ta gaba, da kuma kara karfin gwaji don gwada mutane 20,000 a rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasara wajen sarrafa barkewar cutar duk da cewa ba a keɓe dukan biranen ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tuhumi Moon, ko kuma sun yaba da yadda gwamnatin ta amsa, suna zargin rashin kula da annobar.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu cutar a cikin mako huɗu.
A ranar 29 ga Maris, an sanar da cewa za a keɓe duk sabbin masu shigowa daga kasashen waje na tsawon makonni biyu daga ranar 1 ga Afrilu.
A ranar 1 ga Afrilu, kamar yadda rahotanni ke nunawa, Koriya ta Kudu ta samu buƙatun tallafin gwajin cutar daga ƙasashe daban -daban 121.
Iran ta ba da rahoton farkon tabbatar da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Komi, inda, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu a wannan ranar.
Matakan farko da gwamnati ta sanar sun hada da rufe kide kide da sauran al'adu, wasanni, da sallar Juma'a, da kuma jami'o'i, cibiyoyin ilimi mafi girma da makarantu.
Iran ta ware tiriliyan biyar na Riyal don magance cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na keɓe yankunan da cutar ta shafa kuma za a keɓe mutane ne kawai.
An sanar da shirin rage zirga - zirgar tsakanin biranen a watan Maris, duk da cewa ana ci gaba da samun cunkoso tsakanin biranen kafin sabuwar shekara ta Farisa.
A ranar 16 ga Maris, 2020, wuraren ibada na Shia a Kom sun kasance a buɗe ga masu yawon shakatawa. A watan Fabrairu, Iran ta zama cibiyar watsa kwayar cutar bayan China.
A tsakanin ikirarin ɓoye girman cutar a Iran, sama da ƙasashe goma sun sami alaƙar shari'o'insu da Iran har zuwa 28 ga Fabrairu, wanda ke nuna cewa cutar na iya zama mai tsanani fiye da shari'o'in 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An dakatar da majalisar dokokin Iran bayan da 23 daga cikin mambobinta 290 suka kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga Maris, Human Rights Watch ta kuma bukaci hukumomin gidan yarin na Iran da su saki 'yan kare hakkin dan adam da aka tsare saboda zanga-zangar lumana ba tare da wani sharadi ba, da kuma sakin dukkan fursunoni masu cancanta na wucin gadi.
Ya ce, cibiyoyin da aka rufe kamar su cibiyoyin keɓewa suna da babban haɗarin yaduwar kwayar cutar, wanda kuma ya ƙunshi rashin isasshen kulawa ta likita.
A ranar 15 ga Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, wanda shine mafi girma da aka samu a kasar tun lokacin da annobar ta barke.
Aƙalla 'yan siyasa da jami'an gwamnati 12 na yanzu ko na baya sun mutu daga cutar a ranar 17 ga Maris.
Har zuwa 23 ga Maris, ana samun sabbin mutane 50 a kowace awa a Iran kuma ana samun sabon mutuwa a kowane minti goma saboda cutar coronavirus.
A cewar wani jami'in WHO, adadin da ake samu a Iran zai iya ninka na yanzu da sau biyar.
An kuma ba da shawarar cewa takunkumin Amurka akan Iran na iya shafar ikon kuɗin ƙasar don amsa cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu na kasar Sin a Rome suka gwada tabbatacce ga SARS-CoV-2.
Lamarin ya fara ƙaruwa, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da dawowa daga China kuma ta ayyana dokar ta baci.
An gano wani rukunin marasa alaƙa na COVID-19 a Lombardy a ranar 21 ga Fabrairu, farawa da 16 da aka tabbatar. A ranar 22 ga Fabrairu, Majalisar Ministocin ta ba da sanarwar sabon doka-da-ka'ida don hana barkewar cutar, tare da keɓe mutane sama da 50,000 daga garuruwa 11 daban-daban a arewacin Italiya.
"A yankunan da ake fama da cutar, ba za a samar da shiga da fita ba", in ji Firayim Minista Giuseppe Conte.
An riga an ba da umarnin dakatar da ayyukan aiki da shirye -shiryen wasanni a waɗannan yankuna. A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, saboda mutuwar mutane 100 a Italiya.
An shirya cewa za a yi manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, ba tare da masu kallo ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin har tsawon wata guda.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci, sai dai kantin sayar da kaya da kantin magani. A ranar 6 ga Maris, Kwalejin Kula da Magunguna, Anaesthesia, Resuscitation and Intensive Care (SIAARTI) ta wallafa shawarwarin ɗabi'a game da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'in.
A ranar 19 ga Maris, Italiya ta zarce China a cikin yawan mutuwar da ke da alaƙa da coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 daga cutar.
A ranar 22 ga Maris, an sanar da cewa Rasha ta tura jiragen soja tara zuwa Italiya dauke da kayan aikin kiwon lafiya.
Ya zuwa ranar 5 ga Afrilu, Italiya tana da mutane 128,948 da aka tabbatar, 15,887 da suka mutu, da kuma 21,815 da suka warke, tare da mafi yawan masu kamuwa da cutar a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffi na Italiya da rashin iya gwajin waɗanda ke da cutar a lokacin na iya ba da gudummawa ga yawan mutuwar.
Amsar da Burtaniya ta bayar ga cutar ta bayyana a farkon farkon ƙasashe da aka shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta aiwatar da kowane nau'in nisantar zamantakewa ko matakan keɓewa a kan 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin saurin da kuma tsananin amsawa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da shawarar dakatar da duk tafiye-tafiye da ba dole ba da kuma hulɗa da jama'a, yana ba da shawarar mutane su yi aiki daga gida a duk lokacin da zai yiwu kuma su guji wurare kamar mashaya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa za a rufe duk wuraren nishaɗi kamar mashaya da dakin motsa jiki da wuri-wuri, kuma ta yi alƙawarin biyan ma'aikata har zuwa 80% na albashin su har zuwa iyakar £2,500 a wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da matakan tsauraran matakan nisantar zamantakewar jama'a, wanda ya haramta tattara mutane sama da biyu da kuma iyakance tafiye-tafiye da ayyukan waje ga ayyukan da ake ganin dole ne.
Ba kamar yadda aka yi a dā ba, 'yan sanda sun yi amfani da wannan dokar ta wajen tara mutane da kuma tarwatsa su.
An ba da umarnin rufe yawancin kasuwancin, ban da waɗanda aka ɗauka "mahimmanci", waɗanda suka haɗa da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, tashoshin mai da kaya da gidajen haya.
A ranar 20 ga Janairu, an tabbatar da sanannen shari'ar COVID-19 a cikin wani mutum a jihar Pacific Northwest na Washington, wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar White House Coronavirus Task Force a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, kuma ta hana shigowar matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa ta haɓaka kayan gwajin ta.
Duk da haka, Amurka ta fara gwajin a hankali, wanda ya sa ya yi wuya a fahimci ainihin yaduwar cutar a lokacin.
Gwajin ya kasance ta hanyar rashin ingantattun kayan gwajin da gwamnatin tarayya ta yi a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta masana ilimi, kamfanoni da asibitoci) a ƙarshen Fabrairu, da kuma ƙuntatawa na ƙa'idodi (wanda ya buƙaci umarnin likita daga baya) don mutane su cancanci gwaji ɗaya a farkon Maris.
Har zuwa ranar 27 ga Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwaji kasa da 4,000 a Amurka.
Har zuwa 13 ga Maris, The Atlantic ta ba da rahoton cewa an yi gwaji ƙasa da 14,000.
A ranar 22 ga Maris, The Associated Press ta ba da rahoto: "Mutane da yawa da suke da alamun cutar kuma suna da umarnin likita sun jira na sa'o'i ko kwanaki don a gwada su". Bayan an ba da rahoton mutuwar farko a jihar Washington a ranar 29 ga Fabrairu a Amurka, Gwamna Jay Inslee ya ayyana dokar ta baci, wani mataki da wasu jihohi suka bi.
Makarantu a yankin Seattle sun soke azuzuwan a ranar 3 ga Maris kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar suna rufewa. A ranar 6 ga Maris, 2020, wani rukuni na masana ilimin cututtuka a Imperial College London ya shawarci Amurka game da hasashen tasirin sabon coronavirus a kasar.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen Cutar Coronavirus da Amsa, wanda ya ba da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya don mayar da martani ga barkewar cutar.
Kamfanoni sun hana ma'aikata tafiya, sun soke taro, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke wasannin wasanni da zaman. A ranar 11 ga Maris, Trump ya sanar da takunkumin hana tafiye -tafiye na kwanaki 30 ga yawancin Turai, ban da Burtaniya, wanda ya fara aiki a ranar 13 ga Maris.
Washegari, ya faɗaɗa takunkumin zuwa Ƙasar Ingila da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya samar da kudaden tarayya don mayar da martani ga rikicin.
Farawa daga ranar 15 ga Maris, yawancin kamfanoni sun dakatar da aiki ko rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da annobar a duk jihohi 50 da Gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da shari'o'in 10,700 na coronavirus, fiye da jimlar shari'o'in da ke Koriya ta Kudu.
A ranar 25 ga Maris, Gwamnan ya ce nisantar zamantakewar jama'a yana aiki, saboda ƙididdigar ninkawar lamura ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Har zuwa 28 ga Maris, New York City tana da lamura 32,308, kuma mutane 672 sun mutu daga kwayar cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton ƙarin lamuran kamuwa da kwayar cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya. Har zuwa 8 ga Afrilu, Amurka ta tabbatar da lamura 400,335 kuma mutane 12,841 sun mutu.
A ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ka'idojin nisantar zamantakewar jama'a har zuwa 30 ga Afrilu, a cewar rahotanni na kafofin watsa labarai.
A wannan ranar, jirgin asibiti mai suna USNS Comfort, mai gado kusan 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, an samu mutuwar mutane 884 a Amurka sakamakon cutar coronavirus a cikin awanni 24.
An soki fadar White House saboda rage girman barazanar da kuma umarci jami'an kiwon lafiya da masana kimiyya da su daidaita maganganun jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin Mataimakin Shugaban Kasa Mike Pence.
Trump ya nuna son kai wajen magance matsalar da ke da bambanci.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, gami da kayan aikin likitanci masu mahimmanci.
An yi amfani da tsarin tafiye -tafiye na iska don yin bincike da kuma hasashen yaduwar kuma an buga shi a cikin tsakiyar Janairu 2020 a cikin Jaridar Tafiya ta Tafiya.
Bisa ga bayanan 2018 daga Kungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan fasinjoji daga Wuhan.
An kuma sanar da Dubai, Sydney da Melbourne a matsayin wuraren da mutane ke zuwa daga Wuhan.
An nuna Bali a matsayin mafi ƙarancin ƙarfi a cikin shahararrun biranen balaguro 20 dangane da shirye-shirye, yayin da biranen Ostiraliya suka kasance mafi ƙarfi. Ostiraliya ta fitar da shirin gaggawa na gaggawa don cutar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya ce ba a san komai game da COVID-19 ba, kuma Australia za ta ba da fifiko kan kula da kan iyakoki da sadarwa a cikin martani ga annobar.
A ranar 21 ga watan Maris, an ayyana dokar ta-baci ta lafiyar dan Adam a Australia.
Saboda ingantattun hanyoyin keɓewa na sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa suna shirin fitar da 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta hanyar jiragen da aka yi na ƙasar, wanda hukumomin China suka ba da izini.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand su ne na farko da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta fitar da 'yan kasar Sin ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu, ban da 'yan Poland huɗu, ɗan China ɗaya da ɗan ƙasar Indiya ɗaya.
'Yan ƙasar Poland, China, da Indiya sun sauka daga jirgin a ƙasar Poland, inda jirgin ƙasar Brazil ya tashi daga inda ya tsaya ya koma ƙasar Brazil.
An keɓe 'yan Brazil da suka je Wuhan a wani sansanin soja da ke kusa da Brasilia.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko, da 39 daga jirgin na biyu da gwamnatin Amurka ta yi izini) daga Wuhan zuwa CFB Trenton kuma an killace su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama da ke dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australiya sun kwashe mutane 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake gina shi a matsayin wurin keɓewa, inda suka zauna tsawon kwanaki 14.
Jirgin gudun hijira na New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da wasu daga Australia da Pacific) an killace su a wani sansanin sojan ruwa a Whangaporoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, wani jirgin sama da ke dauke da fasinjoji 129 na Kanada ya sauka a Trenton, Ontario, wanda aka kwashe daga Diamond Princess.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, wani jirgin saman kamfanin South African Airways da gwamnatin Afirka ta Kudu ta yi hayar ya dawo da 'yan kasar Afrika ta Kudu 112.
An yi gwajin likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu waɗanda ke nuna alamun cutar coronavirus don rage haɗarin.
'Yan Afirka ta Kudu da suka gwada ba su da lafiya ne kawai aka mayar da su.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu ba su da cutar, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin jin kai, waɗanda duk sun kasance a ƙarƙashin kulawa mai kyau kuma an keɓe su a wurin shakatawa na Ranch na tsawon kwanaki 14.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga Fabrairu, Ma'aikatar Harkokin Wajen Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga China.
Wasu daliban kasar Sin daga jami'o'in Amurka sun hada kai don taimakawa wajen tura agaji zuwa sassan kasar Sin da cutar ta shafa, tare da wani hadin gwiwa a yankin Chicago da ke bayar da rahoton cewa sun tura abin rufe fuska 50,000 na N95 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief, a cikin hadin gwiwa tare da FedEx, ta aika da abin rufe fuska 200,000 tare da wasu kayan kariya na mutum, gami da safofin hannu da riguna, zuwa asibitin Wuhan Union ta hanyar jirgin gaggawa a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don kare "mutane masu hadari a Afirka da Kudancin Asiya" tare da samar da kudade don binciken rigakafi da ƙoƙarin magani.
InterXon ta ruwaito cewa gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, lokacin da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan a Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 a Wuhan, Malaysia ta sanar da bayar da gudummawar safofin hannu na likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita daban -daban, gami da kayan aikin 10,000, kuma Amurka ta ba da gudummawar kayan aikin likita tan 17.8 ga China da kuma alkawarin dala miliyan 100 a cikin ƙarin tallafi ga ƙasashen da abin ya shafa. Bayan da al'amuran suka daidaita a China, ƙasar tana tura taimako zuwa ƙasashe daban -daban waɗanda cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da kwararru zuwa Italiya don taimakawa wajen magance annobar cutar ta coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kayan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya, ya aika wa Panama kayan gwaji 5,000, abin rufe fuska 100,000, da na'urorin motsa jiki 5.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Czech Republic sun nuna damuwarsu game da abin rufe fuska da kayan gwajin da aka yi a China.
Misali, Spain ta dawo da kayan gwajin cutar coronavirus 58,000 da aka yi a China tare da daidaito na kashi 30 cikin dari, yayin da Netherlands ta dawo da abin rufe fuska na kasar Sin 600,000 wadanda suka kasance marasa inganci.
Belgium ta dawo da abin rufe fuska 100,000 da aka ɗauka cewa sun fito ne daga China, amma a zahiri daga Colombia.
A wani bangare kuma, tallafin da ake bayarwa daga China ya samu karbuwa a wasu sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da gaggawa na tallafi ga kasashe masu tasowa.
WHO ta yaba wa kokarin da hukumomin kasar Sin ke yi wajen sarrafa cutar da kuma shawo kanta.
WHO ta yi magana game da bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin China da yin ɓoye-ɓoye wanda ya hana ƙoƙarin hanawa da sarrafawa, da kuma rikicin na yanzu inda gwamnatin tsakiya ta "ba da sabuntawa a kai a kai don kauce wa tsoro kafin hutun sabuwar shekara ta Lunar".
A ranar 23 ga Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da takunkumin hana zirga-zirga a Wuhan, wakilin WHO Gauden Gallia ya yi sharhi cewa yayin da "ba a ba da shawarar WHO ba" wannan "lamari ne mai matukar muhimmanci na jajircewa don hana annobar a inda ta fi yawa" kuma ya kira shi "wanda ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan tabbatar da kamuwa da cutar daga mutum zuwa mutum da kuma karuwar adadin sauran shari'o'i a wajen kasar Sin, WHO ta ayyana wannan annobar a matsayin gaggawa ta lafiyar jama'a ta duniya (PHEIC), wanda shine na shida tun lokacin da aka fara daukar matakan rigakafin cutar a lokacin annobar cutar ta Flynn a shekarar 2009.
Daraktan WHO Tedros Adhanom ya ce PHEIC na haifar da "hadarin yaduwar duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba.
A cikin martani ga aiwatar da takunkumin tafiye -tafiye, Tedros ya ce "babu wani dalili na matakan da ke tsoma baki ba dole ba a cikin tafiye -tafiye da kasuwancin duniya" kuma cewa "WHO ba ta ba da shawarar iyakance kasuwanci da motsi".
A ranar 5 ga Fabrairu, WHO ta yi kira ga al'umma ta duniya da ta ba da gudummawar dala miliyan 675 don shirye-shiryen dabaru a ƙasashe masu ƙarancin kuɗi, tana mai ambaton buƙatar taimaka wa ƙasashe waɗanda "ba su da tsarin da za su iya gano waɗanda ke kamuwa da cutar, koda kuwa ta fito".
Tedros ya sanar a cikin ƙarin maganganu, cewa "mu masu ƙarfi ne kawai kamar yadda muke da rauni" kuma ya bukaci al'ummar duniya da su "saka hannun jari a yau ko kuma su biya ƙarin daga baya". A ranar 11 ga Fabrairu, WHO ta gabatar da wani taron manema labarai a matsayin sunan da cutar ta COVID-19 ta kafa.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya, António Guterres ya amince da ba da "ikon da dukan tsarin Majalisar Dinkin Duniya ke da shi wajen mayar da martani".
Sakamakon haka ya haifar da kunna ƙungiyar gudanar da rikice-rikice ta Majalisar Dinkin Duniya, wanda ya daidaita aikin na Majalisar Dinkin Duniya, wanda, a cewar WHO, zai ba su damar "mayar da hankali kan aikin kiwon lafiya, yayin da sauran hukumomi za su iya amfani da ƙwarewarsu wajen magance tasirin zamantakewar al'umma, tattalin arziki da ci gaba na barkewar cutar".
A ranar 14 ga Fabrairu, an kunna tawagar hadin gwiwar WHO tare da China don taimakawa wajen gudanar da gida da kuma ziyarar yankin don ba da gaskiya ga ƙwararrun ƙasashen duniya da na WHO a China, ta hanyar gudanar da bita da tarurruka tare da manyan cibiyoyin ƙasa da kuma "tabbatar cutar da yaduwar cutar" da kuma kimanta "tasirin ayyukan mayar da martani a matakan lardi da na gunduma, gami da na birane da na karkara". A ranar 25 ga Fabrairu, WHO ta sanar da cewa "ya kamata duniya ta yi ƙoƙari sosai don shirya don yiwuwar cutar coronavirus", ta ce duk da cewa ya yi saurin faɗi, ƙasashe su kasance cikin "matakin shiri".
A cikin martani ga barkewar cutar a Iran, WHO ta aika da tawagar hadin gwiwa don kimanta halin da ake ciki. A ranar 28 ga Fabrairu, hukumomin WHO sun ce za a kimanta barazanar coronavirus a duniya daga "babba" zuwa "mai yawa", wanda shine mafi girman matakin faɗakarwa da kimanta haɗari.
A wata sanarwa, Mike Ryan, Darakta na Hukumar Kula da Lafiya ta WHO, ya yi gargadin cewa, "Wannan gwaji ne na gaskiya ga kowace gwamnati a duniya: lokaci ya yi da za a farka.
Wannan kwayar cuta na iya zuwa kuma kuna buƙatar ku kasance cikin shiri", yana mai ba da shawara cewa matakan amsawa masu dacewa na iya taimakawa duniya ta guji "mafi munin sa".
Ryan ya kara da cewa, bayanan na yanzu ba su shawo kan hukumomin kiwon lafiya su ayyana annobar ba, yana mai cewa irin wannan sanarwar za ta nuna "muna da tabbacin cewa kowane mutum a duniya zai iya fuskantar cutar".
A ranar 11 ga Maris, WHO ta ayyana annobar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO "tana da matukar damuwa game da matakin yaduwar cutar da kuma tsananin cutar, da kuma matakin rashin aiki". WHO ta fuskanci babban zargi game da rashin kula da cutar, ciki har da jinkirin sanar da dokar ta baci ta jama'a da kuma rarraba cutar a matsayin annoba.
Wannan takardar ta hada da takardar neman darakta Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu a kai, har zuwa ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, ƙwararrun masanan haƙƙin ɗan adam na Majalisar Dinkin Duniya sun ba da shawarar girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun hanyoyin ceton rai kuma wannan hakkin na gwamnati ne.
Ƙungiyar ta nanata cewa, rashin albarkatu ko rashin inshorar lafiya ba za a taɓa amfani da su ba a matsayin hujja na nuna bambanci ga takamaiman rukuni.
Masana sun jaddada cewa kowa yana da hakkin kiwon lafiya, ciki har da mutanen da ke da nakasa, ƙalilan, tsofaffi, waɗanda suka rasa gidajensu, waɗanda ke zaune a cikin matsanancin talauci, waɗanda ke zaune a cikin ƙunci, da kuma 'yan gudun hijira da sauran rukunin da ba a bayyana ba da ke bukatar taimakon gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar Tattalin Arziki da Ci Gaban ta kafa wani dandamali don samar da bayanai masu dacewa da kuma cikakkun bayanai, da kuma ra'ayoyi da shawarwari kan martani na manufofi a kasashe a duniya.
Daga manufofi zuwa ƙarfafa tsarin kiwon lafiya da tattalin arziƙin duniya zuwa magance tasirin ƙuntatawa da ƙuntatawa kan tafiye -tafiye, Cibiyar Dijital ta ƙunshi mai bin diddigin manufofin ƙasa, kuma tana da nufin taimakawa ƙasashe su koya daga juna da sauƙaƙe amsawar duniya mai daidaitawa ga ƙalubalen coronavirus.
Gwamnatin China ta fuskanci matsalar cutar da ta barke a lardin Hubei na kasar Sin, wanda ya yi suka da Amurka, Ministan Burtaniya na ofishin majalisar ministocin Michael Gove, da Eduardo Bolsonaro, dan shugaban Brazil Jair Bolsonaro.
An sallami wasu masu gudanarwa na matakin lardi na Jam'iyyar Kwaminis ta Sin (CPC) don magance kokarin killacewa a tsakiyar China, wanda ke nuna rashin jin daɗin halayen siyasa ga barkewar cutar a yankunan.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne don kare Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da yarda da cutar coronavirus da ta fara a Wuhan, suna mai da hankali kan makircin da ke tattare da COVID-19 wanda ya samo asali daga Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta kira coronavirus "kwayar Sin" ko "kwayar Wuhan", tana mai cewa "tsarin sarrafawa na kasar Sin ya juya cutar zuwa annoba ta duniya", wanda wasu masu sukar suka yi la'akari da wariyar launin fata da kuma "rashin nasarar gwamnatinsa na hana cutar".
Jaridar Daily Beast ta sami wani sakon gwamnatin Amurka wanda ke nuna cewa an dakatar da sadarwa tare da bayyananniyar asali a cikin Majalisar Tsaro ta Kasa, wanda aka ambata a matsayin dabarun cewa "duk game da China ne.
An nemi mu yi kokarin isar da wannan sakon ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin. "Kasuwanci kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na tura agaji ga kasashen da suka kamu da cutar wani bangare ne na farfaganda don kara tasirin duniya.
Joseph Borel, shugaban manufofin kasashen waje na Tarayyar Turai ya yi gargadin cewa akwai "wani bangare na siyasa wanda ya hada da gwagwarmaya don tasiri ta hanyar canji da kuma 'siyasa ta 'yanci.'
Borrell ya kuma ce "China tana ta daɗa saƙon cewa, ba kamar Amirka ba, ita ce abokiyar tarayya mai aminci".
China ta kuma bukaci Amurka da ta cire takunkumin da ta kafa kan Syria, Venezuela da Iran, inda ta ce ta tura taimakon ga kasashen biyu na karshe.
An hana tallafin Jack Ma na kayan rufe fuska 100,000 ga Cuba a ranar 3 ga Afrilu ta takunkumin Amurka.
An kuma zargi hukumomin Amirka da canja taimakon da ake yi wa wasu ƙasashe zuwa ƙasarsu.
Kuma akwai takaddama game da abin rufe fuska tsakanin ƙasashe kamar Jamus, Austria da Switzerland; da Czech Republic da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin motsa jiki da aka yi niyyar turawa zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai tare da Italiya da cutar coronavirus ta shafa.
Ma'aikatar Italiya a Tarayyar Turai Maurizio Massari ta ce, "China ce kawai ta mayar da martani a bangaren kasashen biyu.
Babu shakka, wannan ba kyakkyawan alama ba ne na haɗin kan Turai".
A ranar 22 ga Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaba Vladimir Putin na Rasha ya shirya aika likitocin soja, motocin kashe cututtuka na musamman da sauran kayan aikin likita zuwa rundunar sojin Rasha.
Jaridar La Stampa ta Italiya ta yi nuni da wani "babban jami'in siyasa" da ba a ambata sunansa ba cewa kashi 80 cikin 100 na taimakon Rasha "ba shi da amfani ko kuma ba a yi amfani da shi sosai ba".
Wannan majiyar ta zargi Rasha da yin "yanayin siyasa da kuma na diflomasiyya".
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Meo sun musanta rahoton kuma sun nuna godiya.
Rasha ta tura kayan agaji zuwa Amurka ta jirgin kaya.
Dmitry Peskov, mai magana da yawun Kremlin ya ce "ta hanyar ba da taimako ga abokan hulɗa na Amurka, [Putin] ya yi imanin cewa lokacin da masana'antun Amurka na kayan aikin likita da kayan aiki suka haɓaka samarwa, za su iya biyan diyya idan ya cancanta".
Za a gudanar da atisayen soji na NATO "Defender 2020", mafi girma a cikin NATO tun ƙarshen Cold War a Jamus, Poland, da ƙasashen Baltic a ƙananan matakan.
Sakatare Janar na Nuclear Disarmament Kate Hudson ya soki aikin Defender 2020: "A cikin rikicin kiwon lafiya na yanzu, yana barazana ba kawai ga rayukan sojojin Amurka da na wasu ƙasashen Turai ba, har ma da mazauna ƙasashen da ke cikin wannan aikin inda suke aiki".
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya a ranar 14 ga Maris, 2020, don neman taimako, yana mai cewa kasarsa tana fama da fama da barkewar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka akan Iran. Wannan barkewar cutar ta haifar da kiraye-kirayen Amurka don yin amfani da manufofin zamantakewa kamar sauran ƙasashe masu arziki, gami da kula da lafiyar jama'a, kula da yara gaba ɗaya, izinin biyan kuɗi, da kuma babban matakin kuɗi don lafiyar jama'a.
Masu sharhi na siyasa sun yi hasashen cewa hakan na iya shafar damar sake zabar Donald Trump a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "ƙoƙarin keɓewar kai da rashin aiki" na Japan lokacin da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a keɓe shi na tsawon makonni biyu a wuraren da gwamnati ta tsara.
Da farko, al'ummar Koriya ta Kudu sun rabu bisa yadda Shugaba Moon Jae - in ya amsa matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tuhumi Moon, suna ikirarin rashin kula da annobar da gwamnati ta yi, ko kuma sun yaba da martani.
Wasu masu sharhi sun nuna damuwa cewa hakan zai iya taimaka wa gwamnatoci su ƙarfafa ikonsu.
A Hungary, majalisar ta yi zabe ta ba Firayim Minista, Viktor Orbán damar yin mulki har abada, ta dakatar da majalisar da kuma zaben, kuma ta hukunta mutanen da aka samu suna yada labaran karya game da cutar da kuma yadda ake magance matsalar da kuma gwamnatin.
An zargi barkewar cutar ta coronavirus da misalai da yawa na karancin wadata, wanda ya samo asali daga amfani da kayan aiki don yaƙar barkewar cutar a duniya, cinikin tsoro, da katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da na'urorin kiwon lafiya saboda karuwar bukatar mabukaci da kuma katsewar masu samar da kayayyaki.
An kuma ga yanayin cin kasuwa mai cike da tsoro a yankuna da yawa, wanda ya sa aka rasa kayan masarufi kamar abinci, takardar wanka, da ruwan kwalba daga shelves, wanda ya haifar da raguwar wadata.
An gargadi masana'antar fasaha musamman game da jinkirin jigilar kayan lantarki.
Dangane da Darakta Janar na WHO Tedros Adhanom, bukatar kayan kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da ƙaruwar farashin al'ada har sau ashirin kuma tare da jinkirin samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Wannan ya haifar da karancin kayan kariya na mutum a duniya, wanda WHO ta yi gargadin cewa zai sanya ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu siyar da daigu don sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin jaririn a wasu manyan kantuna kuma daga baya gwamnatin Australia ta dakatar da shi. Duk da yawan adadin COVID-19 da kuma babban bukatar kayayyakin abinci a arewacin Italiya da yankin Wuhan, duka yankunan suna fama da karancin abinci.
Matakan da China da Italiya suka ɗauka a kan ajiyar kayayyaki masu muhimmanci da kuma cinikin haram sun yi nasara, wanda ya hana a yi tsananin karancin abinci da ake tsammani a Turai da kuma Arewacin Amirka.
Arewacin Italiya ba ta ga raguwar kayayyakin noma masu mahimmanci ba, amma farashin na iya ƙaruwa, a cewar wakilan masana'antu.
A birnin Wuhan ma, an ga shaguna da abinci a wucin gadi, yayin da jami'an gwamnatin kasar Sin suka saki kayan da ake ci da sukari don tabbatar da yawan jama'a.
A Italiya, irin wannan doka ta tilasta wa masu shuka abinci su ajiye kayan abinci a lokacin da ake bukatar gaggawa.
An ji rauni ga tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, matakan gwamnati na hana yaduwar kwayar cutar, da raguwar tallace-tallace da kashi 20.5% sun yi mummunan rauni ga tattalin arzikin China a farkon watanni biyu na 2020.
Tunda babban yankin China babban tattalin arziki ne da cibiyar masana'antu, an yi la'akari da barkewar kwayar cutar a matsayin babbar barazanar rashin zaman lafiya ga tattalin arzikin duniya.
Agathe Demaris na sashen bincike na Economist Intelligence Unit ya ce har sai an sami cikakken bayani game da sakamakon da zai iya zuwa, kasuwanni za su yi taɓarɓarewa.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa tasirin tattalin arzikin cutar a kan ci gaban duniya na iya wuce barkewar cutar SARS ta 2002-2004.
Wani masani a jami'ar Washington da ke St. Louis ya kimanta cewa, za a iya kashe fiye da dala biliyan 300 a kan sarkar samar da kayayyaki a duniya, kuma hakan zai iya kaiwa shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta yi "hargitsi" bayan faduwar farashin mai saboda karancin bukatar da ake samu daga China.
Kasuwannin hannayen jari na duniya sun faɗi a ranar 24 ga Fabrairu saboda ƙaruwa mai yawa a cikin adadin COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, wasu alamun hannun jari na Amurka, ciki har da NASDAQ-100, S&amp;P 500 Index, Dow Jones Industrial Average, sun ba da rahoton raguwa mafi girma tun 2008, tare da Dow ta faɗi maki 1,191, mafi girma a rana ɗaya bayan rikicin kuɗi na 2007-08.
Duka alamun sun ragu da fiye da kashi 10 cikin 100 a wannan makon.
A ranar 28 ga Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da kimantawar ikon mallakar kasar Sin, amma ya ci gaba da kasancewa da mummunan fata.
Hannun jari sun sake faduwa bisa ga fargabar cutar coronavirus, mafi girma a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa za a iya samun koma bayan tattalin arziki.
Masanin tattalin arziki Mohammed Al-Arian ya yaba wa matakan gaggawa na bankunan tsakiya da jihohi.
Babban bankuna suna amsawa da sauri fiye da matsalar kuɗi ta 2008.
Yawon shakatawa na ɗaya daga cikin fannonin da aka fi shafa, saboda takunkumin tafiye -tafiye, rufe wuraren jama'a, ciki har da wuraren jan hankali, shawarwarin gwamnatoci na dakatar da kowane tafiya a duk faɗin duniya.
Sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Quantum sun soke zirga -zirgar jiragen sama saboda karancin bukatar, yayin da kamfanin jiragen sama na yankin Birtaniya Flybe ya fadi.
Sakamakon wannan ya kasance mafi girma a masana'antar jirgin ruwa.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa.
Lokacin annobar ya kuma yi daidai da lokacin babban lokacin tafiya, Chunyun, wanda ya shafi hutun Sabuwar Shekarar Sin.
An soke manyan tarurruka da suka hada da bikin Sabuwar Shekara na shekara -shekara da gwamnatocin kasa da na yanki suka yi, tare da kamfanoni masu zaman kansu suna rufe shagunan su da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe wasu abubuwan bikin Sabuwar Shekara da wuraren yawon bude ido a Beijing don hana taron jama'a, ciki har da Forbidden City da kuma bukukuwan haikalin gargajiya.
A cikin larduna 24 daga cikin 31 na kasar Sin, da garuruwa da yankuna, hukumomi sun tsawaita hutun sabuwar shekara har zuwa 10 ga Fabrairu, tare da umarnin cewa yawancin wuraren aiki ba za su sake buɗewa ba har zuwa wannan kwanan wata.
Waɗannan yankuna sun wakilci kashi 80 cikin ɗari na GDP na ƙasar da kuma kashi 90 cikin ɗari na fitar da kayayyaki.
Hong Kong ta kara yawan cutar ta kamuwa da cuta kuma ta ayyana dokar ta baci, tare da rufe makarantu har zuwa watan Maris da kuma soke bikin Sabuwar Shekarar ta.
Ziyarar 'yan kasuwa a Turai da Latin Amurka ta ragu da kashi 40 cikin dari.
Masu sayar da kayayyaki a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50-60 cikin dari.
A watan Maris, mutane sun ragu da kashi 33-43 cikin ɗari a hanyar tafiya zuwa cibiyoyin cin kasuwa idan aka kwatanta da watan Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duniya sun ɗauki ƙarin matakai, kamar haɓaka tsabta, shigar da na'urorin duba yanayin zafi na masu sayayya, da soke taro. A cewar wani ƙididdigar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan da cutar ta haifar na iya barin mutane miliyan 14 zuwa 22 a Latin Amurka cikin matsanancin talauci wanda ba su da shi ba tare da cutar ba.
A cikin Janairu da Fabrairu na 2020, a lokacin da annobar ta yi zafi a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin ma'aikatan karkara na karkara kusan miliyan 300 na kasar Sin suna cikin gida a lardunan cikin gida ko kuma suna cikin lardin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar ta coronavirus na iya rage ayyuka miliyan 47 a Amurka kuma ƙididdigar bankin tarayya na St. Louis na iya rage yawan rashin aikin yi zuwa 32%. An yi wa 'yan gudun hijirar miliyan da yawa rashin aiki (wanda ake biya ta hanyar albashi na yau da kullun) sakamakon kulle-kullen da aka yi a Indiya. Binciken da Angus Reed ya gudanar ya gano cewa kashi 44% na iyalai a Kanada sun sami wani nau'in rashin aikin yi.
A lokacin rabin Maris, ma'aikata miliyan 4 na Faransa sun nemi taimakon rashin aikin yi na wucin gadi kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan biyu a Jamus sun tura ma'aikatansu zuwa shirye-shiryen aiki na ɗan gajeren lokaci da gwamnati ke bayarwa wanda ake kira Kurzarbet.
An amince da tsarin biyan diyya na ɗan gajeren lokaci na Jamus a Faransa da Ingila.
Yankin wasan kwaikwayo da al'adun al'adu sun sha wahala sosai daga annobar, wanda ya shafi ayyukan ƙungiyoyi a duniya, da kuma ma'aikata da masu zaman kansu.
Ƙungiyoyin al'adu da al'adu suna ƙoƙari su ci gaba da aikinsu (yawanci: tallafawa jama'a) don samar da damar samun al'adun al'adu ga al'umma, don kiyaye lafiyar ma'aikatansu da jama'a, da kuma tallafa wa masu fasaha a duk inda zai yiwu.
Har zuwa Maris 2020, a duk duniya da kuma a wasu wurare, gidajen tarihi, ɗakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu an rufe su har abada tare da soke ko jinkirta nune-nunen su, tarurruka da nune-nunen.
A sakamakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani sakamako na kwanan nan da ke ƙaruwa na cutar shi ne soke ayyukan addini, manyan tarurrukan wasanni, da sauran taron jama'a, kamar su kide kide da taro da taron fasaha da nunin tufafi.
Har ila yau, masana'antar fim ta fuskanci tsangwama. Vatican ta sanar da cewa an soke bikin mako mai tsarki a Roma, wanda ke faruwa a makon ƙarshe na lokacin makoki na Kirista na Lent.
Yawancin bishoprics sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar taro a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, live streaming ta kan layi ko talabijin, yayin da wasu ke ba da bautar drive-in.
Yayin da Diocese na Roman Katolika na Rome ya rufe majami'unsa da wuraren ibadarsa kuma ya kori masu aikin hajji daga St. Peter's Square, sauran hukumomin addini sun soke ayyuka a majami'u, masallatai, wuraren ibadar Yahudawa, temples da gurduras kuma sun iyakance tarurrukan jama'a.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga baya an rufe wuraren ibadar, yayin da Saudi Arabiya ta hana shiga wuraren ibadar na kasashen waje da na jama'a a wuraren tsarki a Makka da Madina.
Cutar ta haifar da babbar matsala a kalandar wasanni a duniya tun bayan yakin duniya na biyu.
An soke ko kuma dage yawancin manyan wasannin wasanni, ciki har da 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 NBA Season, da kuma 2019-20 NHL Season.
Barkewar cutar ta katse shirin gasar wasannin Olympics na shekarar 2020, wanda aka tsara a farkon watan Yuli; Kwamitin Olympic na International ya sanar a ranar 24 ga Maris cewa za a sake shirya taron "zuwa ranar da za a yi bayan 2020 amma ba bayan bazara na 2021 ba". An rufe gidajen caca da sauran wuraren caca a duniya kuma an jinkirta ko soke wasannin karta na rayuwa.
Wannan ya sa 'yan caca da yawa suka shiga hanyar kan layi, tare da rahoton ƙaruwa mai mahimmanci a cikin ƙimar sabon rajista a yawancin rukunin caca na kan layi. Har ila yau, masana'antar nishaɗi ta sha wahala, tare da wasu ƙungiyoyin kiɗa da suka dakatar ko soke kide kide.
Wasu manyan gidajen wasan kwaikwayo kamar su Broadway ma sun dakatar da duk wani wasan kwaikwayon.
Wasu masu fasaha sun gano hanyoyin ci gaba da raba aiki a kan Intanet a matsayin madadin wasan kwaikwayon gargajiya, kamar yin raye -raye na wasan kwaikwayo ko ƙirƙirar "taron" na yanar gizo don nunawa, rarraba, da kuma tallata ayyukan masu fasaha.
A kan layi, yawancin abubuwan da ke cikin Intanet na coronavirus sun bazu a matsayin abin dariya da damuwa a cikin rashin tabbas.
Tun barkewar COVID-19, an lura da karuwar son zuciya, kyamar baƙi, da wariyar launin fata ga mutanen Sinawa da na Gabashin Asiya, da kuma waɗanda ke da cibiyoyi a Turai, Amurka, da sauran ƙasashe.
An ga tsoro, shakka da kuma adawa a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya da Fasifik.
Bayanai tun daga watan Fabrairu (lokacin da mafi yawan lamura har yanzu suna iyakance ga China), sun rubuta ra'ayoyin wariyar launin fata na mutanen China a cikin ƙungiyoyi daban -daban a duniya waɗanda suka cancanci samun cutar ko kuma samun hukunci mai adalci.
Wasu ƙasashe a Afirka ma sun ga ƙaruwar rashin amincewa da Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci bisa asalin yankin su.
Akwai taimako na kan layi da na waje ga mutanen China da kuma waɗanda ke yankunan da cutar ta shafa.
Bayan ci gaban barkewar cutar a cikin sabbin kasashe masu zafi, mutanen Italiya, na farko a Turai da suka fara fuskantar mummunan barkewar COVID-19, na iya fuskantar shakku da kuma kyamar kasashen waje. 'Yan ƙasa daga ƙasashe ciki har da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun hana Sinawa shiga ƙasashensu a ƙoƙarin hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama ruwan dare a shafin Twitter.
A cikin kasar Sin, da kuma sauran mutanen Asiya a Burtaniya da Amurka, sun ba da rahoton karuwar cin zarafin wariyar launin fata da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda kiran coronavirus da "kwayar cutar Sin", wanda masu sukar suka yi la'akari da wariyar launin fata da kuma adawa da China.
Masu zanga-zanga a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan gudun hijirar Ukraine da na kasashen waje daga Wuhan zuwa Novi Sad.
Dalibai daga arewa maso gabashin Indiya, wanda ke iyaka da China, waɗanda ke karatu a manyan biranen Indiya, an ba da rahoton cewa sun fuskanci zalunci dangane da barkewar cutar coronavirus.
Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata Party na jihar Bengal, ya ce Sinawa sun lalata yanayi kuma "Allah ya rama musu".
Daga baya ofishin jakadancin China a Kolkata ya la'anci wannan tsokaci, yana mai cewa "kuskure ne". A China, cutar ta haifar da kyamar xenophobia da wariyar launin fata ga mazauna kasashen waje da ba Sinawa ba, inda aka bayyana baƙi a matsayin "ƙazamar ƙasashen waje" da kuma "targoma".
Jaridu da yawa da ke da Paywalls sun cire su don wani ɓangare ko duka na ɗaukarsu na cutar coronavirus.
Masu wallafa kimiyya da yawa sun ba da takardun kimiyya game da annobar a buɗe.
Wasu masana kimiyya sun zaɓi su raba sakamakon su da sauri a kan sabobin preprint kamar bioRxiv.
Cutar cuta mai tasowa - cuta mai tasowa ta kamuwa da cuta, sau da yawa sabon abu ne a yanayin ɓarkewarta ko hanyar watsawa.
Duniya da Cututtuka - Binciken Duniya da Cutar
Jerin annoba da kuma annoba mai yawa - jerin mutuwar cututtuka
Cinikin namun daji da cututtuka masu yaduwa - haɗarin kiwon lafiya da ke tattare da cinikin namun daji na ƙasashen waje
Binciken dakin gwaje-gwaje don cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 mai alaƙa sun haɗa da hanyoyin gano bayyanar cutar da kuma gano ƙwayoyin cuta da aka samar a matsayin martani ga kamuwa da cuta.
Ana tabbatar da kasancewar ƙwayoyin cuta a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na cutar SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtukan kwanan nan ko masu aiki.
Ana iya amfani da gano rigakafi (hematopoiesis) don tantancewa da kuma lura da mutane.
Gwajin rigakafi na nuna yawan mutanen da suka kamu da cutar, har da waɗanda alamun su na da sauƙi ko kuma waɗanda ba su da alamun.
Sakamakon wannan gwajin zai iya ba da cikakken bayani game da mutuwar cutar da kuma matakin garkuwar jama 'a.
Saboda iyakancewar bincike, babu wata ƙasa da ke da tabbataccen ƙididdigar yaduwar cutar a cikin mutane har zuwa Maris 2020.
Ya zuwa ranar 23 ga Maris, babu wata ƙasa da ta gwada sama da kashi 3 cikin ɗari na yawan jama'arta kuma akwai bambance-bambance masu yawa a kan yawan gwajin da aka yi a ƙasashe daban-daban.
Wannan bambancin na iya shafar yawan mutuwar da aka ruwaito, wanda a wasu ƙasashe za a iya kimantawa sosai.
Ta amfani da halayen polymerase chain reaction (rRT-PCR) na lokaci na ainihi, ana iya bincika a kan samfuran numfashi da aka samu ta hanyoyi daban -daban, gami da samfurin nasogastric ko na mucous membrane.
Sakamakon yakan kasance cikin 'yan sa'o'i zuwa kwana biyu.
Binciken RT - PCR da aka yi tare da hanci da yatsunsu ya kasance mai inganci a cikin makon farko na cutar.
Bayan haka, kwayar cutar na iya ɓacewa daga cikin makogwaro, yayin da take ci gaba da girma a cikin huhu.
Ga waɗanda suka kamu da cutar da aka bincika a mako na biyu, a madadin haka, ana iya ɗaukar samfurin daga cikin iska ta hanyar catheter na tsotsa ko kuma amfani da kayan da aka fitar daga tari (ƙwaƙwalwa).
An haɓaka ɗayan farkon gwajin PCR ta amfani da halayen polymerase chain reaction (rRT-PCR) na lokaci-lokaci a cikin Janairu 2020 a Charité a Berlin, kuma ya zama tushen rarraba kayan aikin 250,000 ta Hukumar Lafiya ta Duniya (WHO).
Har ila yau, Burtaniya ta haɓaka kayan aikin bincike har zuwa 23 ga Janairu 2020. Kamfanin KoganBiotech na Koriya ta Kudu ya haɓaka wani nau'in bincike, PCR-based SARS-CoV-2 Test Kit (Powercheck Coronavirus) a ranar 28 ga Janairu, 2020.
Yana bincika "E" gene wanda duk beta coronavirus ke raba shi, da kuma RdRp gene wanda aka samo a cikin SARS-CoV-2, musamman. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami yardar amfani da gaggawa na PCR-based SARS-CoV-2 na kayan bincike daga Hukumar Kula da Kayan Kiwon Lafiya ta China. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) suna rarraba sabon coronavirus na 2019-nCoV (2019-nCoV) na ainihi na RT-PCRR diagnostic panel zuwa dakunan gwaje-gwaje na kiwon lafiya ta hanyar albarkatun ƙasa da ƙasa.
Wani daga cikin gwaje - gwaje uku na asali a cikin tsofaffin sigar kayan aikin bincike ya sami sakamako mara kyau saboda ƙwayoyin cuta masu lalacewa, kuma ya haifar da matsala a gwaji a CDC a Atlanta; wannan ya haifar da matsakaicin samfuran da aka sarrafa cikin nasara a cikin watan Fabrairu na 2020 zuwa ƙasa da 100 a rana.
Gwaje-gwajen da ke amfani da abubuwa biyu ba a amince da su ba har zuwa 28 ga Fabrairu, 2020 kuma har zuwa lokacin ba a ba da izinin fara gwajin ga jihohi da na gida ba.
An amince da gwajin ta Hukumar Abinci da Magunguna a ƙarƙashin izinin Amfani da Gaggawa.
Har zuwa 5 ga Maris, 2020, LabCorp ya sanar da cewa ana samun gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
Quest Diagnostics ta samar da gwajin COVID-19 a duk faɗin ƙasar har zuwa 9 ga Maris, 2020.
Babu iyakar adadin da aka sanar; dole ne a tattara da sarrafa samfurori bisa ga bukatun CDC.
A Rasha, an haɓaka kuma an samar da gwajin COVID-19 ta Cibiyar Nazarin Jiha ta Virology da Biotechnology VECTOR.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ta hanyar Hukumar Kula da Kiwon Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, Mayo Clinic ta sami rahoton cewa tana haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Rosh Diagnostics ta sami izinin FDA don yin babban adadin gwajin da za a iya yi a cikin awanni 3.5, sakamakon haka, ana iya yin kusan gwaje-gwaje 4,128 a cikin awanni 24 daga na'ura ɗaya.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa (EUA) ga Abbott Laboratories don yin gwaji a kan tsarin m2000 na Abbott; FDA ta ba da izini iri ɗaya ga Holological, LabCorp, da Thermo Fisher Scientific.
Hakazalika, a ranar 21 ga Maris, 2020, Sheffield ta samu EUA daga FDA don gwajin da ke ɗaukar kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da ba a buƙatar jerin zafin jiki mai canzawa, wannan hanyar na iya ba da sakamako mai kyau a ƙasa da minti biyar da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kusan 18,000 irin waɗannan na'urori a cikin Amurka kuma Abbott yana son haɓaka samarwa don gwajin 50,000 kowace rana. Ana haɓaka kayan aikin gwaji a Taiwan wanda ke amfani da rigakafin monoclonal wanda ke haɗuwa da furotin nucleocapsid (N) na sabon kwayar cutar coronavirus, tare da fatan cewa zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin mura mai sauri.
Wani bita na wallafe-wallafen Maris 2020 ya kammala da cewa "Radiography na kirji a farkon matakin yana da ƙarancin mahimmancin asibiti, yayin da CT [computerized tomography] sakamakon na iya kasancewa kafin bayyanar cututtuka. "
Musamman na CT sun haɗa da ƙirar gilashi mai yawa tare da rarrabawar gefe, asymmetrical da baya.
Yayin da cutar ke ci gaba, tasirin subplural, crazy paving da consolidation suna tasowa.
Nazarin da ya kwatanta PCR da CT a Wuhan, tushen cutar ta yanzu, ya ba da shawarar cewa CT yana da ƙwarewa fiye da PCR, duk da cewa ba shi da ƙwarewa, tare da yawancin halaye na hoto suna kama da na sauran cututtukan huhu da hanyoyin cuta.
Har zuwa Maris 2020, Kwalejin Magungunan Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin gwaji ko gwajin farko don gano COVID-19. Har zuwa Maris 2020, CDC ta ba da shawarar PCR don bincike na farko.
Sashin amsawar rigakafi ga kamuwa da cuta ya ƙunshi samar da rigakafi, gami da IgM da IgG.
Ana iya amfani da su don tantance rigakafin da ke farawa a cikin mutane daga kwanaki 7 ko kusa da farkon bayyanar cututtuka da kuma gano kamuwa da cuta don lura da mutane. Ana iya bincika gwaje - gwaje a cikin dakunan gwaje - gwaje na tsakiya (CLT) ko ta hanyar gwajin Point - of - Care (PoCT).
Tsarin atomatik mai ƙarfin gudana a yawancin dakunan gwaje - gwaje na asibiti zai iya yin waɗannan gwaje - gwaje amma wadatar su zai dogara da ƙimar samar da kowane tsarin.
Ana amfani da samfurin jini guda ɗaya don CLT, ko da yake za a iya amfani da jerin samfurori don duba amsawar rigakafi.
Ana samun samfurin jini guda ɗaya daga cikin takunkumin fata don PoCT.
Ba a buƙatar matakin farko na fitarwa na gwaji wanda ya bambanta da hanyoyin PCR. A ranar 26 ga Maris, 2020, FDA ta sanya rukunin 29 waɗanda ke ba da bayani ga hukumar idan ya cancanta kuma don haka yanzu suna iya rarraba gwajin rigakafin su.
Har zuwa 7 ga Afrilu 2020, kawai gwajin guda ɗaya ne FDA ta amince da shi a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics & Epitope Diagnostics sun sami amincewar Turai don kayan aikin binciken su waɗanda zasu iya gano IgG da IgA antibodies ga kwayar cutar a cikin samfuran jini.
Yana da ikon bincika ɗaruruwan samfura a cikin 'yan sa'o'i kaɗan kuma saboda haka ya fi sauri fiye da gwajin PCR na gargajiya na RNA na kwayar cuta.
Ana iya gano masu rigakafi a cikin kwanaki 14 bayan farawar kamuwa da cutar. A farkon watan Afrilu, UK ta gano cewa babu wani kayan gwajin rigakafin da suka saya da ya isa amfani.
Hong Kong ta tsara shirin da zai ba da marasa lafiya masu zargi su zauna a gida, "Sashen gaggawa zai ba da bututun samfurin ga mai haƙuri", za su yi taushi a ciki kuma su dawo da sakamakon binciken ba da daɗewa ba. NHS ta Burtaniya ta sanar da cewa suna ƙaddamar da shirin don bincika marasa lafiya masu zargi a gida, wanda ke kawar da haɗarin mai haƙuri na cutar da wasu idan ya je asibiti ko kuma cutar da motar asibiti da aka yi amfani da ita.
A Jamus, Ƙungiyar Ƙwararrun Likitocin Kiwon Lafiya ta Ƙasar ta ce a ranar 2 ga Maris, suna da damar yin gwaji kusan 12,000 a kowace rana a cikin yanayin asibiti kuma sun yi gwaji 10,700 a makon da ya gabata.
Idan likita ya ba da umarnin bincike, asibiti na kula da lafiyar zai biya kuɗin.
A cewar shugaban Cibiyar Robert Koch, jimillar damar Jamus ita ce 160,000 a kowane mako.
An ba da gwajin tuki a manyan birane da yawa har zuwa 19 ga Maris.
Har zuwa 26 ga Maris, 2020, ba a san adadin gwajin da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
Binciken farko na dakin gwaje-gwaje ya gano cewa aƙalla an gwada jimillar 483,295 samfura har zuwa mako na 12/2020, gami da mako na 12/2020 kuma 33,491 (6.9%) samfura sun gwada tabbatacce ga SARS-CoV-2. A Isra'ila, masu bincike a asibitin Teknion & Rembrandt sun haɓaka kuma sun gwada hanyar yin gwajin samfura daga marasa lafiya 64 tare ta haɗuwa da samfura kuma idan an sami samfurin haɗin gwiwa, bincika shi gaba ɗaya. A Wuhan, wani asibitin BGI na ɗan lokaci mai nisan mita 2,000 mai suna "Huo-Yan" (Cinese: 火眼, ko "Fire Eye" a Turanci) an ƙaddamar da shi a ranar 5 ga Fabrairu, 2020, wanda zai iya aiwatar da sama da samfurori 10,000 a rana.
Tare da sanya ido kan ginin da Wang Jian, wanda ya kafa BGI, ya yi, kuma ya ɗauki kwanaki 5, samfurin ya nuna cewa idan ba a fara wannan damar ba, yawan masu kamuwa da cutar a Hubei zai karu da kashi 47% kuma farashin da ya shafi magance keɓewa zai ninka.
An bi Wuhan Laboratory da sauri ta Huan-yen Labs a Shenzhen, Tianjin, Beijing da Shanghai, a cikin birane 12 a duk ƙasar Sin.
Har zuwa 4 ga Maris, 2020, jimlar damar kwararar yau da kullun ta kasance 50,000 gwaje-gwaje a kowace rana. Origami Assay ya fitar da tsarin buɗe tushen buɗewa wanda zai iya bincika samfurori na COVID19 har zuwa 1122 ta amfani da gwaje-gwaje 93. Waɗannan daidaitaccen tsarin za a iya gudanar da su a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar mai sarrafa ruwa na robotic ba.
Kafin Maris, rashi da isassun adadin kayan aikin sun zama matsala a manyan bincike a EU, UK da Amurka.
Wannan ya sa wasu marubuta suka gano hanyoyin yin samfur wanda ya hada da dumama samfurori zuwa 98 °C (208 °F) na tsawon minti 5 don sakin kwayar RNA don ƙarin bincike. A ranar 31 ga Maris, an sanar da cewa Hadaddiyar Daular Larabawa yanzu tana gwada yawan jama'arta don coronavirus a kowane mutum fiye da kowace ƙasa, kuma tana kan hanyar haɓaka matakin gwaji don isa ga yawancin jama'a.
Wannan ya faru ne saboda haɗuwa da damar yin gwajin motsa jiki da sayen dakin gwaje - gwaje - gwaje na taro mai yawa daga Group 42 da BGI (bisa ga "Huo - Yan" na gaggawa a China).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje yana iya yin dubban gwajin RT-PCR a kowace rana kuma shine na farko a duniya da ke aiki a wannan babban sikelin a wajen China.
An haɓaka hanyoyin bincike daban -daban waɗanda ke niyya ga ɓangarori daban -daban na tsarin kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta ɗauki hanyar Jamus kuma ta tura ta ga ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatu don haɓaka kayan aikin kansu.
An buga hanyar Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba ta kasance ba har zuwa 28 ga Janairu, wanda ya jinkirta samun samfurori a cikin Amurka. Akwai matsaloli game da amincin kayan aikin gwaji tsakanin China da Amurka a farkon barkewar cutar kuma ba su iya samar da isassun kayan aikin gwaji don biyan buƙatun bincike da shawarwari daga ƙwararrun masanan kiwon lafiya na ƙasashen waje da na Australia.
Akasin haka, masana sun nuna cewa samun damar yin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta haɓaka ƙarfin bincike, musamman a cikin dakunan gwaje - gwaje na masu zaman kansu, tsawon shekaru.
A ranar 16 ga Maris, WHO ta ce, kara shirye-shiryen gwaji shine hanya mafi kyau don rage haɓakar cutar ta COVID-19. Yawan buƙatun gwaji ya haifar da dubban abubuwan da suka rage a cikin dakunan gwaje-gwaje na Amurka masu zaman kansu da kuma samar da magunguna da magungunan sinadarai.
A watan Maris na 2020, China ta ba da rahoton matsalolin daidaito a cikin kayan aikin gwajin ta.
A Amurka, akwai ƙarancin kayan aikin gwaji da CDC ta haɓaka; Gwamnati ta sake cire takunkumin hukuma wanda ke hana gwajin sirri. Spain ta sayi kayan aikin gwaji daga kamfanin Shenzhen Bioge Biotechnology Co., Ltd., na China, amma ta gano cewa ba su da cikakkun sakamako.
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya zama sakamakon rashin tattara samfurori ko rashin amfani da kayan aikin yadda ya kamata.
Ma'aikatar Spain ta ce za ta cire kayan aikin da ke ba da hujja ba daidai ba kuma ta maye gurbinsa da wasu kayan aikin da aka samar da Shenzhen Bioge. Kashi 80% na kayan aikin da Czech Republic ta saya daga China sun ba da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China, waɗanda ba a gano su daidai ba.
Firayim Minista Matovič ya ba da shawarar cewa a jefa su a cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskuren kuskure" kuma ba su yi amfani da su ba. UK, wanda ya sayi kayan gwajin miliyan 3.5 daga China a farkon Afrilu 2020, ya bayyana cewa ba su da amfani.
Bayan binciken, an gano mutanen da suka kamu da cutar SARS-CoV-2 kuma an gano su.
A wurin da aka fara mutuwa daga COVID-19 a Italiya, masu bincike da ke aiki a garin Vò na Italiya sun bincika sau biyu a cikin yawan mutane kusan 3,400 a tsakanin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an killace duk waɗanda aka gano su da cutar.
Ƙuntatawa a wurin da ake zuwa ya kawar da sababbin kamuwa da cuta.
Ta hanyar ganowa ta hanyar kai hari, hana tafiye -tafiye na cikin gida, bincika da keɓewa, amma ba tare da takunkumi masu ƙarfi ba kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki, annobar cutar coronavirus ta 2020 ta yi jinkiri sosai a Singapore fiye da sauran ƙasashe masu tasowa.
An soke ayyuka da yawa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida tun daga ranar 28 ga Maris, amma makarantu sun sake buɗewa a ranar 23 ga Maris bayan hutun.
Wasu ƙasashe da yawa, kamar Iceland da Koriya ta Kudu, suma sun gudanar da annobar ta hanyar ganowa, hana tafiye -tafiye na cikin gida, gwaji da keɓewa, amma tare da ƙuntatawa.
Binciken ya nuna cewa ƙasashe da ke da yawan bincike fiye da adadin mutuwar suna da ƙananan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da ikon yin gwaji kuma waɗanda ke da ƙarancin ƙwarewa a kan COVID-19 su aika da samfuran COVID-19 na farko biyar masu kyau da na farko 10 masu ƙarancin gwaji zuwa ɗaya daga cikin dakunan gwaje-gwaje na 16 na WHO don tabbatarwa.
A cikin dakunan gwaje - gwaje 16 da aka yi amfani da su, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin ginshiƙi da ke ƙasa, kashi na gwaji a gwajin yana da tasiri ga manufofin gwaji na ƙasar.
Kamar dai yadda yake a wasu abubuwa, ƙasar da take bincika waɗanda suke asibiti ne kawai, za ta sami kashi mafi girma na gwaji fiye da ƙasar da take bincika dukan 'yan ƙasa, ko suna da alamun cutar ko a'a.
Wanke hannu (ko wanke hannu), wanda kuma aka sani da tsabtace hannu, shine aikin tsabtace hannayenka don cire ƙura, mai, ƙwayoyin cuta ko wasu abubuwa marasa so.
Wanke hannuwanka da sabulu a kai a kai a "lokacin da ya dace" a rana yana hana yaduwar cututtuka da yawa, kamar zawo da kuma fitsari, waɗanda ke gudana ta hanyar hanci da na ciki.
Mutane ma za su iya kamuwa da cututtukan numfashi kamar su mura ko kuma sanyi, alal misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko baki (watau, mucous membranes).
Akwai muhimman lokuta guda biyar a rana inda wanke hannu da sabulu yake da muhimmanci: kafin da kuma bayan wanka, bayan wankewa da kuma canza jariri, kafin ciyar da jariri, kafin cin abinci, da kuma kafin da kuma bayan cin abinci ko cin nama, kifi, ko kaji.
Idan ruwa da sabulu ba su samuwa, za a iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta bada shawarar wanke hannaye a lokutan da suka biyo baya:
Kafin, lokacin da kuma bayan shirya abinci.
Kafin mu kula da marar lafiya da kuma bayan haka.
Bayan an canja diaper ko bayan yaro ya yi amfani da banɗaki.
Bayan ka fesa hanci, ka yi tari ko kuma ka yi tari.
Bayan ka taɓa dabba, abincin dabba, ko kuma sharar dabba.
Tsabtace hannu na asibiti yana nufin ayyukan tsabtace jiki da suka shafi hanyoyin magani.
Wanke hannu kafin a ba da magani ko kulawar likita na iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu shine a kawar da kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da ke iya haifar da cuta) da kuma sinadarai da ke iya haifar da lalacewa ko cuta.
Wannan yana da muhimmanci musamman ga mutanen da suke sarrafa abinci ko kuma waɗanda suke aiki a fannin kiwon lafiya, amma yana da muhimmanci ga talakawa.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, ciki har da: rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututttukan cututttukan cututtuk da cututtuk da cututtuk da cututtuk da cututtuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttutt
Kuma rage yawan mutuwar jarirai a cikin haihuwa a gida.
Wani bincike na 2013 ya nuna cewa yin amfani da wanke hannu sosai a cikin yara 'yan ƙasa da shekara biyar na iya inganta ƙimarsu kaɗan.
A ƙasashe masu tasowa, sauye - sauye na dabi'a kamar fara wanke hannu da sabulu na iya rage mutuwar jarirai da ke da nasaba da cututtukan numfashi da na farji.
Wannan aiki mai sauƙi zai iya rage yawan mutuwar cututtuka da ke faruwa da su da kusan kashi 50.
Matakan da ke inganta wanke hannu na iya rage cututtukan zawo da kusan kashi daya bisa uku, kuma hakan yayi daidai da samar da ruwa mai tsafta a yankunan masu karamin karfi.
Kashi 48% na raguwar cututtukan zawo na iya danganta ga wanke hannu da sabulu. Wanke hannu da sabulu a matsayin halayyar motsa jiki a gidaje, makarantu da al'ummomi a duk duniya shine hanya mafi inganci da araha don hana zawo da cututtukan numfashi mai zurfi (ARI).
Babban ARI, cutar huhu ita ce sanadin mutuwa mafi girma a cikin yara 'yan kasa da shekara biyar, inda ake kiyasta cewa tana kashe yara miliyan 18 a kowace shekara.
Rashin kumburi da ciwon huhu suna kashe yara kusan miliyan 35 a kowace shekara.
UNICEF ta ce, yin amfani da sabulu wajen wanke hannu kafin cin abinci da kuma bayan amfani da bayan gida zai iya ceton rayuka fiye da na duk wani allurar rigakafi ko magani, wanda zai iya rage yawan mutuwar da ke faruwa daga zawo da kusan rabi da kuma mutuwar cututtukan numfashi na tsanani da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu tare da sauran matakan tsabtace jiki a matsayin ɓangare na shirye -shiryen ruwa, tsabtace tsabta da tsabta (WASH).
Wanke hannu yana hana impetigo wanda ke yaduwa ta hanyar hulɗa ta jiki.
Wani karamin illa na wanke hannu shine cewa wanke hannu sau da yawa na iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken Danish na 2012 ya gano cewa yawan wanke hannu na iya haifar da yanayin fata mai itchy, mai laushi wanda aka sani da eczema na hannu ko kuma dermatitis na hannu, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa kuma ana ganin alama ce ta rikicewar damuwa (OCD).
Akwai muhimman lokuta guda biyar a rana lokacin da wanke hannu da sabulu ke da mahimmanci don rage yaduwar cutar ta hanyar wucewa ta hanyar wucewa: bayan amfani da bayan gida (sharar hanci, zubar da najasa), bayan wanke ƙashin jariri (bayan canzawa), kafin ciyar da jariri, kafin cin abinci da kuma kafin / bayan cin abinci ko cin nama, kifi, ko kaji.
Sauran lokutan da ya kamata a yi amfani da fasaha mai kyau na wanke hannu don hana yaduwar cuta su ne: kafin da kuma bayan maganin ciwo ko rauni; bayan yin tari, tari ko kuma fantsama hanci; bayan taɓa sharar dabbobi ko sarrafa dabbobi; da bayan taɓa shara.
A ƙasashe da yawa, ba a wanke hannaye da sabulu sosai ba.
Wani bincike na wanke hannu a cikin kasashe 54 a shekarar 2015 ya gano cewa, a kan matsakaita, kashi 38.7% na iyalai sun yi amfani da wanke hannu da sabulu. Wani bincike na 2014 ya nuna cewa Saudi Arabia ce ke da kashi 97 cikin dari na yawan wanke hannu; Amurka ce ke da kashi 77 cikin dari na matsakaicin yawan wanke hannu; kuma China ce ke da kashi 23 cikin dari na yawan wanke hannu.
Shirin Kula da Lafiya da ake Bukata da Ma'aikatar Ilimi ta yi a Philippines misali ne na gagarumin aiki don inganta kiwon lafiya da ilimi ga yara.
Wannan shirin na kasa ya hada da tsabtace hakora da fluoride kullum, wanke hannu da sabulu kullum, shan maganin antiseptic sau biyu a shekara.
An yi amfani da shi sosai a Indonesia.
Za a iya inganta cire kwayoyin cuta daga fata ta hanyar hada sabulu ko kayan wankewa a cikin ruwa.
Babban aikin sabulu da na'urar wankewa shine rage shinge a cikin maganin, da kuma kara narkewa.
Ruwa shi kaɗai ba shi da kyau wajen tsabtace fata domin kitse da furotin da suke cikin ƙasa ba sa narkewa cikin ruwa.
Duk da haka, isasshen ruwa yana taimakawa wajen tsabtace.
Saboda amfani da shi sau da yawa, sabulu mai ƙarfi na iya ƙunsar ƙwayoyin cuta da suka rage daga amfani na baya.
Wasu nazarin da suka bincika yadda ƙwayoyin cuta suke motsawa daga sabulu mai ƙazanta sun kammala cewa ba za a iya motsawa ba saboda ƙwayoyin cuta suna wankewa tare da kumfa.
Duk da haka, CDC ta ce "safi da ke da kayan aikin da ke sa ruwan sabulu ya sauko a kan hannu ba tare da taɓa hannu ba ya fi kyau".
An ba da shawarar sosai ga sabulu masu hana ƙwayoyin cuta don jama'a masu kula da lafiyar.
Har zuwa yau, babu tabbaci cewa amfani da maganin kashe ƙwayoyin cuta ko maganin kashe ƙwayoyin cuta yana haifar da kwayoyin cuta masu tsayayya da kwayoyin cuta a yanayi.
Koyaya, sabulun antibacterial suna ƙunshe da wakilai na yau da kullun kamar Triclosan, wanda ke da jerin nau'ikan ƙwayoyin cuta masu tsayayya.
Saboda haka, ko da sabulu masu hana ƙwayoyin cuta ba sa haifar da tsayayyar ƙwayoyin cuta, ba za su iya zama masu tasiri ba kamar yadda ake tallata su.
Baya ga kayan shafawa da kare fata, ingantattun maganganu na iya zama acid (acetic acid, ascorbic acid, lactic acid), antibacterially active benzoic acid, da sauran masu inganta fata (aloe vera, bitamin, methall, tsire - tsire na shuke - shuke) a matsayin masu daidaita pH. Wani bincike mai zurfi na Jami'ar Oregon School of Public Health ya nuna cewa sabulu mai sauƙi yana da tasiri sosai wajen hana cututtuka da kuma kawar da ƙwayoyin cuta daga hannaye, kamar yadda sabulu mai amfani da ƙwayoyin cuta na Trichlorous.
Ruwa mai zafi da muke amfani da shi wajen wanke hannu ba ya isa ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna ƙaruwa sosai a zafin jiki (37 ° C).
Koyaya, ruwan zafi, sabulu yana da tasiri fiye da sanyi, sabulu ruwa don cire ƙura da ƙwayoyin cuta masu ƙwayoyin cuta.
Akasin abin da mutane suke tsammani, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba ya rage yawan kwayoyin halittar da ke hannayenka.
Mai tsabtace hannu ko mai tsabtace hannu shine mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, kayan aikin tsabtace hannu na ruwa mai ba da ruwa (wanda kuma aka sani da alcohol -based hand rubs, disinfectant hand rubs, ko kuma hand sanitizer) sun fara samun karbuwa.
Yawancin waɗannan isopropyls suna dogara ne akan barasa ko ethanol, waɗanda aka tsara tare da glycerin a cikin wani gel, kamar carbomer (polymer na acrylic acid), ko a cikin wani ruwa ko kumfa, kamar moisturizer, don sauƙin amfani da rage tasirin bushewar giya.
Haɗa hydrogen peroxide yana ƙara ƙarfin aikin rigakafi. Hannun hannu masu tsabtace hannu da ke da kashi 60 zuwa 95% na giya suna da ingantattun maganin kashe ƙwayoyin cuta.
Maganin tsabtace giya yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙin magani (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccina, influenza da hepatitis) da kuma masu cutar.
Maganin tsabtace hannu wanda yake da kashi 70% na barasa yana kashe kashi 99.97% na kwayoyin cuta bayan dakika 30 na amfani (ƙarancin log 3.5, daidai da rage na decibel 35) kuma minti 1 bayan amfani yana kashe kashi 99.99% zuwa 99.999% na kwayoyin cuta (ƙarancin log 4).
Maganin hannu na tushen giya ba shi da tasiri ga nau'in cutar Norovirus (ko Norvoc) wanda shine mafi yawan sanadin cututtukan gastroenteritis. Ya kamata a yi amfani da isasshen maganin kashe cuta na hannu ko kuma ruwan shafawa na giya don shafawa ko rufe hannaye duka.
A gaba da baya na hannaye biyu da kuma a tsakiya da kuma a kan yatsunsu duka an shafe kimanin dakika 30, har sai ruwan, kumfa ko gel sun bushe.
Dole ne a wanke yatsunsu sosai ta hanyar shafawa a cikin hannayensu. Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar wanke hannu maimakon rubs na tsabtace hannu, musamman idan hannayensu suna da datti.
Amfani da waɗannan masu amfani yana ƙaruwa ne bisa saukin amfani da saurin kashewa ga ƙwayoyin cuta; duk da haka, kada a yi amfani da su azaman maye gurbin wanke hannu da kyau sai dai idan sabulu da ruwa ba su da wadatar.
Yin amfani da hanta na tushen giya na iya haifar da bushewar fata sai dai idan an haɗa man shafawa da / ko moisturizer na fata a cikin maganin.
Za a iya rage ko kawar da tasirin bushewar giya ta hanyar haɗa glycerin da / ko wasu kayan shafawa a cikin tsari.
A gwaji na asibiti, man shafawa mai amfani da giya ya rage yawan zafin jiki da bushewa idan aka kwatanta da sabulu ko maganin kashe ƙwayoyin cuta.
Abubuwan da ke haifar da rashin lafiyar haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da haɗuwa da juna.
Ƙananan halayen da ke haifar da cututtukan fata na tuntuɓar da ke damun mutum fiye da wanke hannu da sabulu da ruwa ya zama abin jan hankali.
Duk da ingancinsu, masu aikin ruwa ba sa tsabtace kwayoyin ta hannu, amma suna kashe su ne kawai.
Wannan shine dalilin da ya sa kayan tsabtace hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Ingancin kayan aikin hannu marasa giya ya dogara sosai da kayan aiki da kuma tsari, kuma a tarihi sun kasance masu aiki sosai fiye da giya da kuma giya.
Kwanan nan, ba kamar giya ba, wanda aka nuna yana rage tasiri bayan amfani da yawa, mai yiwuwa saboda ci gaba da mummunan halayen fata, an nuna cewa yana da ci gaba da haɓaka aikin antimicrobial bayan amfani da maganganu masu amfani da benzalkonium chloride.
Mutane da yawa a cikin ƙananan al'ummomi ba za su iya sayan sabulu ba kuma suna amfani da toka ko ƙasa maimakon.
Ash ko ƙasa na iya zama mafi tasiri fiye da ruwa shi kaɗai, amma ƙasa da tasiri fiye da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta, zai iya ƙara yaduwar cutar maimakon ragewa.
Kamar sabulu, toka ma wakili ne na kashe ƙwayoyin cuta domin idan ta fuskanci ruwa sai ta samar da wani bayani mai ƙamshi.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu, idan babu sabulu.
Daidaitaccen fasahar wanke hannu da Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar don hana watsa cutar ta ƙunshi waɗannan matakan:
Ka yi wanka da ruwan zafi ko ruwan sanyi.
Ana ba da shawarar ruwa mai gudana saboda ƙauyuka masu ruwa mai sanyi na iya zama mai ƙazanta, kodayake zafin ruwan ba shi da mahimmanci.
Yi amfani da sabulu mai yawa a hannunka, ciki har da bayan hannunka, tsakanin yatsunsu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan suna amfani da sabulu maimakon ruwa kawai.
Ka shafe akalla dakika 20.
Yin ta ya haifar da tsagewa, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma yin ta na dogon lokaci yana fitar da ƙwayoyin cuta da yawa.
Ka wanke sosai a ƙarƙashin ruwan da ke gudana.
Wanke hannu a cikin tafki zai iya sake gurɓata hannaye.
Ka bushe da tawul mai tsabta ko ka bar shi ya bushe a iska.
Wanka da kuma ruwa suna da sauƙin sake gurɓata. Wuraren da aka fi watsi da su sune yatsunsu, wuyan hannu, tsakanin yatsunsu, da kuma ƙarƙashin ƙusa.
Na'urar ƙusa da ƙusa mai ƙyalli na iya ba da gida ga ƙwayoyin cuta.
Ana ba da shawarar sauƙin moisturizing don hana hannaye daga bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa cututtuka.
A ƙasashe masu tasowa inda babu ruwan famfo da/ko sabulu, idan ya zama dole, za a iya yin zaɓuɓɓuka masu tsada daban -daban don sauƙaƙe wanke hannu, misali, a zuba ruwa daga kwanon rufi ko kwanon rufi tare da ramuka masu dacewa da kuma/ko amfani da toka. A cikin yanayin iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), ana samun hanyoyin kiyaye ruwa, kamar "Tippy - taps" da sauran zaɓuɓɓukan da ba su da tsada.
Tippy - tap wani fasaha ne mai sauƙi wanda ke amfani da igiya da aka rataye ta igiya, da kuma mai amfani da ƙafa don zuba ruwa a kan hannayensu da kuma takalmin sabulu.
Yin bushewar hannu yadda ya kamata wani ɓangare ne na aikin tsabtace hannu, amma akwai wasu muhawara game da yadda za a bushe hannu a cikin wuraren wanka na jama'a.
Bincike mai yawa ya nuna cewa takarda mai wanka yana ba da tsabta fiye da na'urar bushewa na lantarki da ake samu a cikin gidajen wanka da yawa.
A shekara ta 2008, an gudanar da bincike da Jami'ar Westminster, London, wanda masana'antar takarda ta takarda ta tallafawa The European Tissue Symposium, wanda ke nufin kwatanta matakan tsabtace da takarda ke bayarwa, masu bushe-bushe da iska mai zafi da kuma na zamani na jet-air hand dryers.
Bayan wanke hannu da bushewa da na'urar bushewa mai iska mai zafi, adadin kwayoyin sun karu da kashi 194 cikin dari a kan yatsunsu da kashi 254 cikin dari a kan dabino.
Drying tare da jet - air dryer ya kara yawan kwayoyin cuta a matsakaici 42% a kan yatsunsu da 15% a kan dabino.
Bayan wanke hannu da bushewa da tawul ɗin takarda, jimillar adadin ƙwayoyin cuta sun ragu da kashi 76% a kan yatsunsu da kashi 77% a kan dabino. Masana kimiyya sun kuma gwada su don tabbatar da ko kowane irin bushewa yana da damar ƙetare sauran masu amfani da gidan wanka da yanayin gidan wanka.
Jirgin jirgi mai bushewa, wanda ke fitar da iska daga na'urar a saurin 180 m/s (650 km/h; 400 mph), ya iya hura kwayoyin halitta daga hannaye da na'urar kuma mai yiwuwa ya gurɓata sauran masu amfani da bayan gida da kuma yanayin bayan gida har zuwa mita 2.
Yin amfani da na 'yan hannu mai bushewa mai iska mai zafi ya sa microorganisms su yada daga na 'yan bushewa har zuwa mita 0.25.
Takarda tawul bai nuna wani muhimmin watsawa na microorganisms. A shekara ta 2005, a cikin wani binciken da TÜV Produkt und Umwelt ya gudanar, an kimanta hanyoyi daban-daban na bushewa hannu.
An lura da canje -canje masu zuwa a cikin ƙididdigar ƙwayoyin cuta bayan bushe hannu:
Akwai masana'antun bushe hannu daban -daban, kuma an kwatanta bushe hannu da bushewa da tawul.
Wanke hannu ta amfani da wanke wanke wanke hannu a lokacin tafiya idan babu sabulu da ruwa.
Dole ne a yi amfani da kayan aikin tsabtace hannu na giya wanda ya ƙunshi aƙalla kashi 60 cikin dari.
Wanke hannu ya zama dole na dogon lokaci bayan binciken Inganaz Semmelweis, likitan Hungary, game da tasirinsa a rigakafin cuta a cikin asibiti (a 1846).
Akwai na'urorin lantarki da ke ba da ra'ayi don tunatar da ma'aikatan asibiti game da wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cutar.
Ana wanke hannaye na likita na akalla dakika 15, ana yin kumfa da amfani da sabulu da ruwa ko gel mai kyau kuma ana shafa kowane ɓangare na hannu.
Ya kamata yatsun hannu biyu su yi ta shafawa.
Idan akwai datti a ƙarƙashin ƙusa, ana iya amfani da goga mai gashi don cire shi.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwa a hannu, yana da muhimmanci a wanke sosai kuma a bushe da tsabtace tawul.
Bayan bushewa, ya kamata a yi amfani da tawul ɗin takarda don rufe ruwa (kuma idan ya cancanta, buɗe kowane ƙofar fita).
Wannan yana hana hannayen sake gurɓata su da waɗannan saman.
Manufar wanke hannu a cikin tsarin kiwon lafiya shine kawar da ƙwayoyin cuta masu cutarwa ("kwayoyin cuta") da hana su yaduwa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu ya kasance a matakin da ba za a iya yarda da shi ba a yawancin yanayin kiwon lafiya, tare da manyan likitoci da ma'aikatan jinya da suka manta da wanke hannayensu a kai a kai kafin su taɓa marasa lafiya, wanda ke haifar da yaduwar ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauki na iya rage kamuwa da cutar da ke tattare da jini da ke tattare da catheter da kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta wallafa wata takarda da ke nuna yadda ake wanke hannu da kuma shafa hannu a fannonin kiwon lafiya.
Ana iya samun takaddun jagorar tsabtace hannu da wannan ƙungiyar ta bayar a shafin yanar gizon don ra'ayin jama'a.
Wani bita mai dacewa da Witby da sauransu suka yi.
Idan ana buƙatar nuna bin ƙa'idodi, kayan aikin kasuwanci na iya auna da tabbatar da tsabtar hannu.
Hukumar Lafiya ta Duniya ta kafa "lokaci biyar" na wanke hannu:
Bayan an yi amfani da jini/ruwa na jiki
kafin aikin kashe ƙwayoyin cuta, da kuma
Bayan kulawar mai haƙuri. Ƙara sinadarai masu kashe ƙwayoyin cuta a cikin sabulu ("magani" ko "antibacterial" sabulu) yana ba da maganin kashewa ga wakilin wanke hannu.
Irin wannan maganin zai iya zama da muhimmanci kafin a yi aiki ko kuma a yanayin da kwayoyin da suka yi tsayayya da maganin rigakafi suka yi yawa. Don 'ƙwanƙwasa' hannayenka don ɓarna, yana da muhimmanci a sami bututun da za a iya kunnawa da kuma kashewa ba tare da taɓa hannayenka ba, wasu chlorhexidine ko iodine wash, tawul ɗin da ba a tsabtace su ba don bushe hannayenka bayan wanka, da kuma goga mai tsabta don tsabtace rubbing da kuma sauran kayan tsabta don tsabtace ƙusa.
Dole ne a cire duk kayan ado.
Wannan aikin yana buƙatar wanke wuyan hannu da wuyan hannu na minti 2-6.
Ba a buƙatar yin tausa na dogon lokaci (minti 10).
Ya kamata a hana ruwa daga komawa hannu yayin wanka.
Bayan an gama wanke hannu, ana bushe hannu da sutura mai tsabta kuma ana sanya rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe cuta kafin da kuma bayan kula da mai rashin lafiya.
Don sarrafa kamuwa da cutar staphylococcal a asibitoci, an gano cewa mafi girman fa'ida daga tsabtace hannu ya zo daga 20% kafin wanka, kuma an sami ƙarin fa'ida kaɗan lokacin da aka ƙara yawan tsabtace hannu sama da 35%.
Wanke hannu da sabulu mai sauƙi yana da sau uku fiye da yadda ake yada cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk da cututtukan cututtuk da cututtuk da cututtuk da cut
Amma sabulu da ruwa sun fi na hand rubs masu tushen giya tasiri wajen rage kwayar cutar H1N1 influenza A da kuma Clostridium difficile. Matakai don inganta tsabtar hannu a tsarin kiwon lafiya na iya haɗawa da ilmantar da ma'aikata game da wanke hannu, haɓaka wadatar hand rubs masu tushen giya, da rubutaccen da kuma tunatarwa na magana ga ma'aikata.
Ana bukatar ƙarin bincike a kan waɗanne daga cikin waɗannan hanyoyin ne suka fi tasiri a tsarin kiwon lafiya daban -daban.
A ƙasashe masu tasowa, wanke hannu da sabulu ana ɗaukansu hanya ce mai arha, da ake bukata don samun ƙoshin lafiya, har ma da abinci mai gina jiki.
Duk da haka, rashin isasshen ruwa, sabulu ko wuraren wanke hannu a gidajen mutane, makarantu, da wuraren aiki, yana kawo ƙalubale wajen cimma ɗabi'ar wanke hannu ta duniya.
Alal misali, a yawancin yankunan karkara na Afirka, babu wasu famfunan wanki a kowane gidan wanka na jama'a ko na masu zaman kansu, duk da cewa akwai wasu hanyoyin wanki masu arha.
Koyaya, ƙarancin wanke hannu na iya zama saboda halaye da aka saka maimakon rashin sabulu ko ruwa.
Ƙarfafawa da tallafawa wanke hannu da sabulu na iya rinjayar yanke shawara na manufofi, ƙara wayar da kan jama'a game da fa'idodin wanke hannu, da kuma kawo canji a cikin halayyar jama'a na dogon lokaci.
Don ya yi aiki da kyau, ana bukatar sa ido da kuma kimantawa.
Wani nazari na tsari na nazarin 70 ya gano cewa hanyoyin da aka kafa al'umma suna da tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen na tallafi na zamantakewa ba shi da tasiri. Misali na tallata wanke hannu a makarantu shine "Hanyar Taurari Uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, masu arha don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu tare da sauran bukatun tsabta.
Idan an cimma matsakaicin matsakaicin, makarantu za su iya zuwa taurari uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na tallata wanke hannu wanda aka yi don rage cututtuka da mutuwar yara.
Ranar Wanke Hannun Duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke da nufin ƙoƙarin kawo canji a cikin halayyar. A sakamakon annobar cutar coronavirus ta 2019-20, UNICEF ta inganta ɗaukar emojis na wanke hannu.
Wasu nazarin sun yi la'akari da yawan kuɗin da ake amfani da shi wajen wanke hannu a ƙasashe masu tasowa dangane da rigakafin DALYs.
Duk da haka, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran ruwa da tsaftace-tsaftace tsada.
Muhimmancin wanke hannu ga lafiyar ɗan adam - musamman ga waɗanda ke da yanayi mai wuya, kamar uwaye da suka haifi jarirai ko kuma sojoji da suka ji rauni a asibitoci - an fara gane su ne a tsakiyar ƙarni na 19 da masu gabatar da tsabtace hannu: Likita na Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, Ingilishi wanda shi ne "mai kafa aikin jinya na zamani".
A lokacin, mutane da yawa sun gaskata cewa ana kamuwa da cutar ta ƙanshi mai ƙanshi da ake kira miasma.
A cikin shekarun 1980, barkewar cuta da cuta da ke da alaƙa da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su ƙara haɓaka tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Barkewar cutar mura a shekarar 2009 da kuma annobar COVID-19 a shekarar 2020 sun kara wayar da kan mutane a kasashe da dama game da muhimmancin wanke hannu da sabulu don kare kansu daga irin wadannan cututtuka.
Alal misali, a Jamus, ana saka hotunan "daidaitaccen hanyoyin wanke hannu" a kusa da wurin wanke hannu a gidajen bayan gida da ofisoshin gwamnati da kuma a wuraren wanke hannu a filayen jirgin sama.
Furcin nan "wanke hannuwanka" daga wani abu yana nufin ka ƙi yarda da alhakin ko kuma ka yarda da wani abu.
Ya fito ne daga littafin Matta inda Bilatus Ba-Bunti ya ware kansa daga hukuncin da ya yanke na giciye Yesu Kristi, amma ya zama magana da ke da amfani sosai a wasu al'ummomin Ingilishi.
A Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari na wanke wani tabo na almara, wanda ke nuna lamirinta mai laifi game da laifuffukan da ta aikata da kuma yadda ta sa mijinta ya aikata laifi.
An kuma gano cewa mutane suna wanke hannayensu sau da yawa fiye da wasu, bayan sun tuna ko kuma tunani game da ayyukan lalata, kuma suna ba da fifiko ga kayan wanke hannu.
Bugu da ƙari, waɗanda aka ƙyale su wanke hannayensu bayan irin wannan tunani ba su da damar shiga cikin ayyukan "tsabta" kamar aikin sa kai.
Addinai suna ba da shawarar wanke hannu don tsabtace jiki da dalilai na alama. Wanke hannu da ruwa mai tsabta ba tare da sabulu don wanke hannu ba wani ɓangare ne na wanke hannu da aka ambata a addinai da yawa, ciki har da Baha'i, Hindu, Tevila da Netilat Yedayim a Yahudanci, Lavabo a Kristanci, da Wazu a Musulunci. Addinai kuma suna ba da shawarar wanke hannu musamman don samar da tsabta bayan wasu ayyuka.
Wanke hannu bayan amfani da bayan gida yana da mahimmanci a cikin addinin Hindu, Yahudanci da Islama.
Kuma, a addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci wanke hannu kafin da kuma bayan kowane abinci wajibi ne.
Gudanar da haɗarin yaduwar COVID-19 a wurin aiki
Aikin kiyaye lafiya da kiwon lafiya yana da aikace-aikace don sarrafa haɗarin yaduwar cutar COVID-19 a wurin aiki, don rigakafin cutar coronavirus 2019 (COVID-19).
Kulawa mai kyau na haɗarin yaduwar cuta a wurin aiki ya dogara da wurin aiki da aikin da ake yi, wanda ya dogara da kimanta haɗarin tushen haɗari, tsananin cutar a cikin al'umma, da abubuwan haɗarin ma'aikata na mutum waɗanda ke da haɗarin kamuwa da COVID-19.
Aikin da ke da ƙananan haɗari na haɗari yana da ƙarancin haɗari na aiki tare da mutane da sauran abokan aiki, wanda ya haɗa da shawarar da aka ba da shawarar matakan rigakafin kamuwa da cuta, kamar: wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, bin ƙa'idodin numfashi, da tsabtace da kuma tsabtace yanayin aiki a kai a kai, a cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA).
Ayyukan haɗarin haɗari na matsakaici sune waɗanda ke buƙatar yin hulɗa akai-akai ko kusa da waɗanda ba a san ko ana zargin cewa suna da COVID-19 ba, amma waɗanda na iya kamuwa da cutar saboda watsawar al'umma ko tafiya ta ƙasa.
Wannan ya haɗa da ma'aikata da ke da alaƙa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da kuma wasu manyan tallace -tallace.
Baya ga matakan rigakafin kamuwa da cuta na asali, matakan kula da haɗari ga wannan rukunin sun haɗa da: yin amfani da matattarar iska mai inganci, amfani da masu kariya, da kuma samar da kayan kariya na mutum idan mutum mai cutar COVID-19 ya gamu da shi.
OSHA ta ɗauki ma'aikatan kiwon lafiya da ma'aikatan gidan gawa suna da haɗarin haɗari waɗanda suka haɗu da mutumin da ke da cutar COVID-19 ko wanda ake zargi, kuma wannan haɗarin ya zama haɗarin haɗari idan ma'aikatan suka aiwatar da hanyoyin samar da aerosol, ko tattara ko sarrafa samfurori daga mutumin da ke da cutar COVID-19.
Kula da haɗari da suka dace da waɗannan ma'aikatan sun haɗa da kulawar injiniya kamar su ɗakunan watsawa na matsi da kayan kariya na sirri da suka dace da aiki.
Cutar COVID-19 na iya haifar da tasiri mai yawa a cikin wurin aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, bukatar kula da wasu, ko kuma tsoron yiwuwar haɗuwa.
Yanayin kasuwanci zai iya canzawa dangane da waɗanne kayayyaki ake buƙata, da kuma hanyoyin samun waɗannan kayayyaki (kamar lokacin da ake buƙata ko sayayya ta hanyar isarwa ko sabis na motsi).
A ƙarshe, zirga-zirgar kayayyaki daga yankuna masu tasowa waɗanda COVID-19 ya shafa na iya shafar su. Shirye-shirye da kuma shirin mayar da martani ga cutar mai yaduwa za a iya amfani da su don jagorantar ayyukan kariya.
Shirye -shiryen suna magance matakan haɗari da ke tattare da wurare daban -daban na aiki da ayyukan aiki, gami da tushen haɗarin, abubuwan haɗari da ke haifar da gida da tsarin al'umma, da abubuwan haɗarin ma'aikata na mutum kamar tsufa ko yanayin rashin lafiya na yau da kullun.
Sun kuma bayyana matakan da ake bukata don magance hadarin da kuma shirin gaggawa ga yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye -shiryen da kuma shirye -shiryen amsawa ga cututtukan cututtuka na iya zama batun shawarwari na ƙasa ko na ƙasa.
Manufofin amsawa ga ɓarkewar sun haɗa da: rage watsawa tsakanin ma'aikata, kare mutanen da ke da haɗarin haɗarin haɗarin cututtukan kiwon lafiya, kiyaye ayyukan kasuwanci da rage tasirin tasirin su ga sauran raka'a a cikin sarkar wadata.
Matsayin cutar a cikin al'umma inda ake aiki yana shafar yadda ake amsawa.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai don tsara kula da haɗari bisa ga tasiri a cikin lafiyar sana'a da lafiya.
Inda ba za a iya kawar da barazanar COVID-19 ba, mafi ingantattun sarrafawa sune sarrafa injiniya, sannan sarrafawar gudanarwa, kuma a ƙarshe, na'urorin kariya na mutum.
Gudanar da injiniya ya ƙunshi ware ma'aikata daga haɗarin da ke tattare da aiki ba tare da la'akari da halayen ma'aikaci ba, kuma yana iya zama mafi kyawun mafita mai amfani a aiwatar.
Kulawa ta gwamnati canje -canje ne a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko mai aiki.
An yi la'akari da cewa kayan kariya na mutum (PPE) ba su da tasiri fiye da na injiniya da na gudanarwa, amma zai iya taimakawa wajen hana wasu hulɗa.
Dole ne a zaɓi kowane irin PPE ga ma'aikata bisa ga haɗarin, a sanya shi yadda ya kamata (misali, masu numfashi), a saka shi akai -akai kuma yadda ya kamata, a bincika shi akai -akai, a kula da shi kuma a canza shi kamar yadda ya cancanta, kuma a cire shi, a tsabtace shi kuma a adana shi ko a watsar da shi don guje wa gurɓata.
Aikin da ke da ƙananan haɗari na haɗari yana da ƙarancin haɗari na kasuwanci tare da mutane da sauran abokan aiki, in ji Hukumar Kula da Lafiya da Lafiya ta Aikin Amurka (OSHA).
Matakan rigakafin kamuwa da cuta na yau da kullun da aka ba da shawarar ga duk wuraren aiki sun haɗa da: wanke hannu da kyau da kuma sau da yawa, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, samar da ladabi na numfashi wanda ke rufe tari da sneezing, samar da kayan aiki da kwandon shara, shirya nesa ko layi daya idan ya cancanta, hana ma'aikata amfani da kayan aikin wasu, da tsabtace da kuma tsabtace yanayin aiki akai -akai.
Ganowa da kuma warewar mutane masu cutarwa a wuri na aiki da wuri mataki ne mai mahimmanci don kare ma'aikata, abokan ciniki, baƙi da sauran mutane.
Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun cututtukan cututtukan numfashi na yau da kullun su zauna a gida har sai sun sami damar zama marasa zazzabi, alamun zazzabi, ko wasu alamun cutar a cikin akalla awanni 24 ba tare da shan maganin rage zazzabi ko wasu magungunan canza alamun ba, kuma cewa akwai manufofin hutu masu sassauci waɗanda ke ba ma'aikata damar zama a gida don kula da dangin da ke da rashin lafiya, kuma cewa ma'aikata sun san waɗannan manufofin.
Bisa ga OSHA, ayyukan haɗarin haɗari na matsakaici sun haɗa da ayyukan da ke buƙatar maimaitawa ko kusanci tare da mutane a cikin ƙafa shida (1.8 m) waɗanda ba a san ko ana zargin cewa suna da COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda watsawar al'umma da ke kewaye da wurin kasuwanci, ko kuma saboda mutumin ya yi balaguron ƙasa da ƙasa kwanan nan zuwa wurin da ke da yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke hulɗa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da wasu tsarin tallace-tallace masu yawa. Don wannan da kuma rukunin haɗarin haɗari, an tsara shirye-shiryen gaggawa a cikin sarrafawar injiniya, ƙara yawan hanyoyin sadarwa, kafa shinge na zahiri kamar masu tsaron filastik, da kuma kafa windows don sabis na abokin ciniki. Don wannan da kuma rukunin haɗarin mafi girma, gudanar da kulawar ma'aikata a cikin kulawar marasa lafiya a gida, canza tarurruka na fuska da fuska zuwa sadarwar kama-da-wane, kafa wuraren hulɗa na kama-da-wane, hana balaguron balaguro zuwa wuraren da ke fama da COVID-19, samar da shirye-shiryen gaggawa, gami da: samar da ma'aikata da ke da damuwa game da amfani da kayan aikin wanki na yau da kullun, samar da ma'aikata da ke buƙatar samun damar yin amfani da kayan aiki na yau da kullun, samar da horo ga ma'aikata da ke da ƙarancin haɗarin COVID-19, da kuma samar da kayan aiki na zamani, gami da takalma masu tsabta da kayan aiki masu kiyayewa, da kuma samar da horo ga ma'aikatan da ke buƙatar yin amfani da kayan aiki masu tsabta da kayan aiki masu kiyayewa, da kuma rage haɗarin COVID-19.
Ma'aikatan wannan rukunin haɗarin ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare lafiyar ma'aikata da sauran fasinjoji sun hada da: nisantar da mutum mai cutar da ƙafa 6 daga wasu, sanya wani memba na ma'aikatan da zai kula da mutumin da ke fama da rashin lafiya, da kuma ba wa mutumin da ke fama da rashin lafiya abin rufe fuska, ko kuma gaya wa mutumin da ke fama da rashin lafiya ya rufe bakinsa da hanci da nama idan ya yi tari ko sneezing.
Lokacin kula da matafiyi mara lafiya ko taɓa ruwan jiki ko ɓangarorin da ke da lahani, dole ne ma'aikatan jirgin su sa safofin hannu na likita, kuma idan matafiyi mara lafiya yana da zazzabi, yana ciwo, ko yana da wahalar numfashi, ya kamata a sa ƙarin kayan kariya na mutum.
Ya kamata a zubar da safofin hannu da sauran kayan more rayuwa a cikin jaka mai haɗari, kuma a tsabtace da kuma tsabtace wuraren da aka gurɓata daga baya. Don jiragen ruwa na kasuwanci, ciki har da jiragen ruwa da sauran jiragen ruwa, haɗarin yana cikin kula da dakatar da tafiya idan ya yi rashin lafiya da kuma keɓe kansa da kuma sanar da cibiyar kiwon lafiya a cikin jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamun bayyanar yayin da yake cikin jirgin.
Ainihin, ya kamata a bi likita a cikin ɗakin da aka ware. Don makarantu da wuraren kula da yara, CDC tana ba da shawarar rufewa na ɗan lokaci don tsabtace ko kuma kashe ƙwayoyin cuta idan mutumin da ke da cutar ya kasance a cikin ginin makaranta wanda ba shi da hanyar watsawa.
Lokacin da akwai ƙaramin watsawa na al'umma, ana iya aiwatar da dabarun nisantar zamantakewa, kamar soke cin abinci a rangadin yanki, tarurruka da sauran manyan tarurruka kamar ilimin motsa jiki ko azuzuwan kiɗa ko gidajen abinci, ƙara tazarar tsakanin tebur, daidaita lokutan isowa da hutu, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓiyar ofishin kiwon lafiya don yara masu alamun kamar mura.
Za a iya yin la'akari da tsawaita hutun makaranta, ban da dabarun nisantar zamantakewa, lokacin da akwai isasshen watsawa a cikin al'ummar cikin gida. Ga ma'aikatan tsaro da ke gudanar da ayyukan doka na yau da kullun, CDC ta ɗauki haɗarin lafiya na gaggawa a matsayin ƙasa.
Jami'an tsaro da ke da alaƙa da waɗanda aka tabbatar ko waɗanda ake zargi da COVID-19 ana ba da shawarar su bi ka'idodin da suka dace da masu fasahar likita na gaggawa, gami da kayan kariya na sirri.
Idan akwai kusanci yayin kamawa, dole ne ma'aikata su tsabtace da kuma kashe kayan aikin su da belin aikinsu, ta amfani da kayan aikin tsabtace gida ko gogewa, kafin a sake amfani da su, kuma su bi ƙa'idodin aiki don hanawa da kuma zubar da PPE da aka yi amfani da su da kuma hanawa da kuma wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da na gawawwaki a matsayin waɗanda ke cikin manyan ko kuma manyan rukunin haɗarin haɗari.
Ayyukan haɗarin haɗari sun haɗa da samar da kiwon lafiya, taimako, ma'aikatan dakin gwaje-gwaje da na jigilar likitoci waɗanda suka haɗu da waɗanda aka sani ko waɗanda ake zargi da COVID-19.
Waɗannan suna zama masu haɗarin haɗari sosai idan ma'aikata suka yi aiki, tattara ko sarrafa samfurori daga waɗanda ke haifar da aerosol akan waɗanda aka sani ko waɗanda ake zargi da COVID-19.
Hanyoyin da ke haifar da aerosol sun hada da tube penetration, cuff induction procedures, bronchoscopy, wasu hanyoyin da gwajin hakori, ko kuma tattara samfurin daga tsage.
Ayyukan gawawwakin da ke da haɗarin haɗari sun haɗa da mutanen da ke shirya jikin mutanen da ke da sanannun ko kuma waɗanda ake zargi da cutar COVID-19 a lokacin mutuwarsu; idan sun yi gwajin gawawwakin, za su zama masu haɗarin haɗari sosai. Ƙarin sarrafawar injiniya ga waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don sanannun ko marasa lafiya da ke da cutar COVID-19, ciki har da lokacin aiwatar da hanyoyin samar da aerosol.
A wasu wuraren kiwon lafiya da kuma gidajen gawa, ana iya yin amfani da takamaiman matsi mai guba.
Dole ne a kula da samfurori tare da matakan tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya masu zuwa a yankuna daban-daban na jiran aiki, dangane da ko suna da cutar COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar masu numfashi ga mutanen da ke aiki a cikin ƙafa 6 na marasa lafiya da aka sani ko ake zargin suna da cutar SARS-CoV-2, da waɗanda ke aiwatar da hanyoyin samar da aerosol.
A Amurka, NIOSH ta amince da N95 tace facepice respirators ko mafi kyau ya kamata a yi amfani da shi a cikin mahallin da m, rubutaccen tsarin kula da numfashi wanda ya hada da fit-testing, horo, da kuma likita.
Sauran nau'ikan masu numfashi na iya samar da ƙarin kariya da haɓaka kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar rufewa ba, saboda COVID-19 cuta ce ta numfashi maimakon yaduwa ta ruwa na jiki.
WHO ta ba da shawarar sanya abin rufe fuska guda ɗaya kawai ga ma'aikatan bincike a wuraren shiga.
Ga waɗanda ke tattara, kulawa ko jigilar samfuran numfashi daga marasa lafiya na COVID-19 ba tare da hanyoyin samar da aerosol ba, WHO ta ba da shawarar abin rufe fuska, tabarau, garkuwa da safofin hannu.
Idan an yi wani aikin samar da aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2 respirator.
Ganin cewa samar da PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, shinge na zahiri kamar su buɗe windows, ba da izinin shiga cikin daki tare da mai haƙuri na COVID-19, kawai waɗanda ke cikin kulawa ta kai tsaye, amfani da PPE da ake buƙata don takamaiman aiki, amfani da na'urar numfashi ɗaya ba tare da cirewa ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, dubawa da daidaita sarkar samar da PPE, da kuma hana amfani da abin rufe fuska ga mutanen da ke da rashin lafiya.
Daga: Catherine Meher, Shugaba na Gidauniyar Wikimedia
Sevaart: Dukan ma'aikatan Wikimedia Foundation
Jigo: [Covid-19] sauƙaƙa nauyi da kuma shirya don nan gaba
Ranar da aka aika: 14 ga Maris, 2020, 00:24 UTC
lasisi: CC0: Babu haƙƙoƙi
Muna fuskantar yanayi na musamman a wannan watan.
Cutar COVID-19 ta bayyana yadda dukkan mutane a duniya suke da alaƙa da juna da kuma nawayar da muke da ita ga juna.
Kalubalen da muke fuskanta ba su taɓa faruwa ba, amma mun san cewa amsarmu mafi kyau ta dogara ne da tausayawa, haɗin kai, da kuma inganta al'umma, waɗanda suke cikin zuciyar wannan ƙungiyar.
Irin haɗin kan da muka gani tsakanin dukan abokan aikinmu a kan imel, kira, da kuma taɗi, ya nuna mana cewa muna da gata mai girma na yin aiki da mutane masu ban mamaki.
Ina matuƙar godiya da kuma alfahari da samun ku a matsayin abokan aiki.
A makon da ya gabata, wani ya yaba mini game da aikinmu.
Ya tunatar da ni yadda yake da ma'ana a wannan lokacin da duniya ta juya zuwa Wikipedia, da kuma yadda yake da alama mai ƙarfi na ci gaba da kasancewa da wannan muhimmin albarkatun a kan layi da kuma samuwa ga kowa.
Aikinku ne ya sa hakan ya yiwu, ko kuna ci gaba da ci gaba da shafukan yanar gizo ko ku biya wa abokan aikinmu ko kuma ku kiyaye al'ummominmu.
Duniya na bukatar bayanai daga Wikipedia, kuma yanzu ne mafiya bukatarsu.
Wannan lokaci ne da abin da muke yi, da kuma yadda muke yi, za su yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan manufa, da kuma matsayinku a cikinta, za mu fara yin wasu muhimman canje-canje a yadda muke aiki da ku a wannan makon.
A wasu lokatai, muna iya yin wasu canje-canje a tsarinmu na aiki.
Kamar yadda Robin ya ambata a baya, ƙungiyar C ta taru a daren jiya don tattauna tsarinmu da kuma tsara jadawalin kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi tunani a kan yadda za mu bi da yanayin da muke fuskanta, da kuma yadda za mu ci gaba da kasancewa da haɗin kai a lokacin.
Mun yi farin ciki kuma muna son mu kawar da damuwa kuma mu ba da haɗin kai ga aikinmu na dogon lokaci.
Idan kana bukatar ka rage aikinka, babu wani laifi a yin hakan.
Ga dukan ma'aikata, 'yan kwangila, da ma'aikatan kwangila:
Za mu yi aiki na awa 4 a rana, ko kuma awa 20 a mako, har sai an ba da ƙarin bayani.
Ba ma sanar da hutu - idan za ka iya yin aiki fiye da sa'o'i na yau da kullum, to, aikin yana bukatar taimakonka.
Duk da haka, duniya ba ta da tabbas a yanzu, kuma ko kuna kula da ƙaunatattunku, ko kuna kawo kayan masarufi, ko kuna zuwa wurin likita, lafiyarku ita ce fifiko.
Ba ma lissafta lokacinku.
Idan kana rashin lafiya, kada ka yi aiki.
Ba ma bukatar mu faɗi haka, amma muna faɗin haka.
Babu bukatar hutu na rashin lafiya ko PTO - kawai ka gaya wa manajanka kuma ka taimaki ƙungiyarka ta gyara kalandar da kuma jadawalin don tabbatar da cewa babu wanda ya ga manyan wuraren aikin.
(Idan an tabbatar maka da COVID-19, don Allah ka gaya wa Brian na T&amp;C Ops don T&amp;C ta iya taimaka maka kuma ta tabbatar da cewa an kula da yanayinka yadda ya kamata daga hannun management.)
Za a biya ma'aikatan da ke aiki a kowane sa'a.
Mun riga mun faɗi haka, kuma mun sake bayyana alkawarinmu na cika alkawarin da muka yi wa 'yan kwangilarmu da abokan aikinmu na sa'a.
Kowa zai sami albashi bisa ga yawan lokutan aikinsa a lokacin al'ada.
Za a biya ku ko da ba za ku iya yin aiki ba idan kun yi rashin lafiya.
Idan kuna son yin aiki, muna tare da ku.
Mutane da yawa suna amfani da aikinsu a matsayin hanyar fita daga matsi da ke tattare da duniya.
Abin da za mu iya yi zai iya zama mai gamsarwa, musamman a irin wannan lokaci.
Kuma, kula da kanka yana da muhimmanci.
Abin da muke so mu yi shi ne ku tattauna da manajanku don mu san abin da za mu yi tsammani, kuma mu yi gyara da ya dace.
Wasu ayyuka ana ɗaukansu da muhimmanci.
Akwai wasu abubuwa da ba za mu iya ƙyale su su tsaya ba.
SRE, HR ops, Trust & Safety, da kuma ƙungiyoyin tara kuɗi (da sauransu) suna yin ayyuka masu muhimmanci da za su bukaci ƙarin taimako.
Za mu fara wani tsari tare da dukkan sassan don tantance abubuwan da muke da su yanzu kuma mu mai da hankali kan hada kai da abubuwan da suka dace da aikinmu.
Muna da abubuwa da yawa da za mu yi, za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka rage gudu yanzu, za mu guji yin rauni daga baya.
Babu wani shiri na ba da lokaci sau biyu don sake dawowa bayan annobar ta duniya ta wuce.
Ba za a sake bukatar ka yi awoyi da yawa ba don ka cika wasu takunkumi da suka wuce na gaskiya.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don kafa sababbin manufofi da kuma lokaci inda ya dace.
Menene zai faru da APP?
Don daidaitawa da sabon gaskiyarmu da tsammanin lokutan aiki na yau da kullun, muna son canza lokacin da za mu kammala shirinmu na shekara - shekara na 2020-2021.
Muna son mu ba da shawarar tsawaita shirinmu na 2019-2020 don mu sami ƙarin lokaci don tsara kasafin kuɗi, don ma'aikata su iya fifita mahimman ayyukansu, kula da kansu, da kula da ƙaunatattun su, kuma waɗanda suke buƙatar ko son yin aiki a kan jadawalin da aka rage a cikin makonni masu zuwa.
Wannan tsawaitawar lokaci zai kawo gagarumin rage aiki da matsin lamba na shirinmu na yanzu a dukan ƙungiyar.
Za mu gabatar da shawararmu ga hukumarmu ta daraktoci a mako mai zuwa kuma da zarar mun sami tabbaci, za mu sanar da wakilai da ƙungiyoyi game da matakai na gaba.
Na gode wa tawagar APP don jagorancinku.
Yanayin ofishi, sadarwa, da kuma tsabtace
A makon da ya gabata mun gano cewa wani abokin aikinmu na SF yana iya fuskantar cutar COVID-19.
Amma, da cikakken kulawa, mun tura ma'aikatan tsabtace rigakafin cutar don tsabtace dukkan wuraren da ke ofishinmu na San Francisco.
Ta kashe kowace farfajiya da lobby da kuma lif din da ke zuwa bene da maganin rigakafin cutar da ke cikin asibiti.
Ana aiwatar da tsarin kula da kansa a cikin ginin ta amfani da samfuran da ke taimakawa amincin mazaunan.
Muna da tabbacin cewa za mu dawo da ofishin a shirye.
Ofishinmu na DC yana cikin WeWork wanda ya raba mana da dukkan ma'aikatan da ke DC ka'idojin COVID-19.
A makon da ya gabata, ofishinmu na DC ya yi amfani da tsarin nesa gaba ɗaya daidai da jagorar da aka raba daga San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, ana magana ne game da yin hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki daga gida / nesa a karon farko.
Abokanmu da suka daɗe suna aiki daga gida/a waje sun san cewa hakan zai bukaci gyara, kuma suna son su ba ka wasu shawarwari:
Ka ƙayyade lokacin taro zuwa fiye da sa'a ɗaya ko biyu.
Idan ana bukatar ƙarin lokatai, ka yi la'akari da raba su zuwa kwanaki da yawa.
Ka bayyana tarurruka a fili, ka shirya ajanda, kuma ka aika da kayan karatun tun da wuri.
Ka sa bidiyo ya zama na asali ta yin amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Ka ɗauki mataki don sauƙaƙa kowane taro, mutum ɗaya ya kula da hira don tambayoyi da lissafin masu magana, kuma mutum ɗaya ya taimaka wajen yin rubutu (ko kuma yin rubutu tare)
Idan kana son na'urar mai saukin kai, ka aika imel zuwa ga masu goyon bayan fasaha.
Ka yi amfani da kuɗin kiwon lafiya don cin abincin rana.
Shiga tashar #remoties a Slack don tattaunawa da abokan aikinka game da aikin da aka rarraba.
Ƙungiyar HR Operations tana nazarin jagorar ƙwarewar aiki na yanar gizo don tallafawa haɓaka aikin da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma da su soke ayyukan jama'a da Wikimedia ke tallafawa, kamar su Editathon, da sauransu, har sai WHO ta sanar da ƙarshen annobar duniya.
Mun gaya musu cewa mun fahimci cewa buƙatarmu ta sokewa da sauran takunkumi na iya sa ba zai yiwu a cika ayyukan ba da tallafi da suka amince da su ba, kuma ba za a hukunta kowa ba don jinkirta ko tilasta musu su gyara waɗannan burin.
A wannan makon da ke zuwa, za mu ci gaba da ba da ƙarin bayani game da taron Wikimedia da sauran taron yanki da na al'umma.
Wannan matsalar ta haifar da baƙin ciki a cikin al'ummar duniya baki ɗaya amma kuma ta haifar da jin daɗin kasancewa a bayyane da kuma iyawar mayar da hankali ga al'ummomin su, Wikimedia, da sauransu.
A gaba, CRT yana aiki don tsara shafi a kan Met-Wiki tare da manufar samar da wuri ga al'umma don saka idanu kan masu tasiri da kuma bin hanyoyin sadarwa tare da su.
Ci gaba da tuntuɓar batun COVID-19
Za mu aika muku da gayyatar ranar Alhamis mai zuwa, 14: 00 UTC / 7: 00 PT, don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokaci don samar da ƙarin sabuntawa, amsa tambayoyinku, da kuma ciyar da ɗan lokaci don haɗi da juna.
Muna tare a wannan yanayin kuma muna nan don taimakawa duk yadda za mu iya.
A halin yanzu, zaku iya ci gaba da nemo bayanai daga wannan imel ɗin, da duk sauran mahimman bayanai game da COVID-19 akan Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma ta ajiye dukan bayanai a wuri guda.
Muna kuma aiki don ci gaba da sadarwa na yau da kullun tare da ma'aikatan da ke zaune a cikin ƙasashe masu wahala a halin yanzu.
Idan kana da tambayoyi game da tafiye -tafiye, shirye -shirye, wani babban aiki, ko ƙalubalen ɗaukar hoto, ko kuma idan kana bukatar taimako game da wani abu, don Allah ka ji daɗin sanar da CRT kuma ka yi aiki tare da ita.
Muna nan don ba da taimako da kuma taimaka wajen kafa dangantaka idan ya cancanta.
Idan batunku na sirri ne ko kuma mai saukin ganewa, ku aika imel zuwa Brian Juddine, Daraktan Ayyuka na HR na Duniya.
Babu wani canji da ya kamata a ɗauka a matsayin watsi da aikinmu da kuma hakkinmu.
Maimakon haka, sun fahimci cewa a wannan lokacin, za mu bukaci mu daidaita ayyukanmu da kuma hakkokinmu a hanyar da ba mu taɓa yi ba a dā.
Mun yi imanin cewa waɗannan matakai suna da mahimmanci don taimakawa juna, don mu ci gaba da aiki, samar da ayyukanmu tare da haɗin kai da suke buƙata, da kuma samar da sabis ɗin da duniya ta dogara da shi.
Aikinmu zai jira mu idan lokaci ya yi.
A yanzu, lokaci ya yi da za mu taimaki juna, kuma mu yi wuri don muhimman ayyuka da za su zo cikin makonni masu zuwa, da wata masu zuwa.
Don mu yi wannan, muna bukatar ku duka, kuma muna so ku kula da kanku da iyalanku domin ku kasance a kan gaba a lokacin da ake bukata.
Yanzu, ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Catherine, CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jame V, Joel L, Lynette L, Ryan M, da Tony S), da kuma sauran 'yan ƙungiyar shugabanci (Grant I, Heather W, Jame V, Jenine U, Lisa S, Robin A, Ryan M, da Toby N).
Angiotensin - modifying enzyme 2 (ACE2) wani enzyme ne da ke da alaƙa da farfajiyar ƙwayoyin cuta (cell membranes) a cikin huhu, jijiyoyi, zuciya, koda, da kuma hanji.
ACE2 yana daidaita aikin enzyme mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da haɓaka angiotensin (1-7), yana mai da shi mai fa'ida mai magani don maganin cututtukan zuciya. ACE2 kuma yana aiki azaman ƙofar shiga cikin ƙwayoyin cuta don wasu coronaviruses.
An kira nau'in ɗan adam na enzyme hACE2.
Angiotensin - modifying enzyme 2 shine zinc - dauke da metaloenzyme wanda ke cikin ciki da kuma sauran kwayoyin halitta.
Kwayar ACE2 tana da N - terminal peptidase M2 domain da kuma C - terminal collectrin renal amino acid mai ɗaukar hoto.
ACE2 shine mai sauya nau'in membrane na I tare da yanki mai aiki na enzymatically wanda ba a bayyana shi a saman ƙwayoyin cuta a cikin huhu da sauran kyallen takarda.
An cire yankin waje na ACE2 daga yankin paraselate ta wani enzyme da ake kira Shades, kuma furotin da ke narkewa yana samun 'yanci a cikin jini kuma a ƙarshe a fitar da shi cikin fitsari.
ACE2 yana cikin yawancin gabobin jiki: ACE2 yana haɗuwa da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Ana kuma samun bayyanar ACE2 mRNA a cikin kwakwalwar kwakwalwa, streat, hypothalamus, da kuma kwakwalwar kwakwalwa.
Aikin farko na ACE2 shine ya zama mai ɗaukar nauyin ACE.
ACE yana lalata hormone angiotensin I zuwa angiotensin II mai narkewa.
ACE2 sannan ya rushe carboxyl - terminal amino acid phenylalanine daga angiotensin II (Asp - Arg - Val - Tyr - Ile - His - Pro - Phe) kuma ya watse shi zuwa mai fadada jijiyoyin jini angiotensin (1 - 7), (H - Asp - Arg - Tyr - Ile - His - Pro - OH).
ACE2 [des-Arg9] na iya lalata wasu peptides da yawa, ciki har da bradycainin, epelin, neurotensin, dinorphine A, da ghrelin.
ACE2 kuma yana sarrafa jigilar membrane na SLC6A19 mai ɗaukar amino acid kuma an nuna rawar da yake takawa a cikin cututtukan zuciya.
A matsayin furotin na parasite, yana aiki a matsayin babban wurin shiga cikin ƙwayoyin cuta don wasu ƙwayoyin cuta na corona, ciki har da ACE2, HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da enzymatic domain na ACE2 a saman ƙwayoyin SARS-CoV da SARS-CoV2 na S1 sunadarai na SARS-CoV2 yana haifar da endositosis da kuma canja wurin duka kwayar cutar da enzyme zuwa endosomes da ke cikin ƙwayoyin.
Wannan tsarin shigarwa yana buƙatar ƙwayoyin S sun kunna ta hanyar mai gina jiki Serine protease TMPRSS2, wanda hanawa yana ƙarƙashin binciken yanzu a matsayin magani mai yiwuwa. Saboda haka, wasu sun yi tunanin cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, yawancin ƙungiyoyi masu sana'a da hukumomi masu tsarawa sun ba da shawarar ci gaba da daidaitaccen mai hana ACE da maganin ARB.
Wani nazari da aka yi a kan yadda ake yin maganin da aka yi amfani da shi da kuma wani bincike da aka yi a kan yadda ake yin maganin da aka yi amfani da shi da aka yi amfani da shi a yau, da aka buga a ranar 11 ga Yuli, 2012, ya gano cewa "yin amfani da maganin da ake kira ACE inhibitors yana da alaƙa da raguwar cutar ciwon huhu da kashi 34% idan aka kwatanta da na masu kula.
Bugu da ƙari, "an kuma rage haɗarin kamuwa da cutar huhu a cikin marasa lafiya da aka yi wa maganin ACE inhibitors, waɗanda ke da haɗarin kamuwa da cutar huhu, musamman a cikin waɗanda ke da ciwo da kuma rashin ƙarfi na zuciya.
Amfani da masu hana ACE ya kuma haɗa da rage yawan mutuwar da ke da nasaba da ciwon huhu, ko da yake sakamakon ya fi ƙarfin haɗarin ciwon huhu gaba ɗaya".
Ana ganin sake tsara ɗan adam ACE2 (rhACE2) a matsayin sabon magani don mummunan lalacewar huhu, kuma ya bayyana don inganta hawan jini da ƙoshin oxygen a cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
Rabin rai na rhACE2 a cikin mutum kusan awa 10 ne kuma farkon aiki minti 30 ne, tare da tsawon lokaci na sakamako na awa 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai kyau ga mutanen da ke da rashin haƙuri ga masu hana tsarin rhinin-angiotensin (RAS inhibitors) ko kuma cututtuka da ke haifar da karuwar angiotensin II. An kimanta rhACE2 a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
COVID-19 Apps aikace-aikacen software ne na wayar hannu waɗanda aka kirkira don taimakawa wajen ganowa, wato, aiwatar da gano mutanen da ("saduwa") waɗanda wataƙila sun kasance tare da wanda ke da cutar, a cikin martani ga annobar cutar coronavirus ta 2019-20.
An haɓaka ko kuma an ba da aikace-aikace da yawa tare da taimakon gwamnati a wasu yankuna da yankuna.
An tsara tsarin da yawa don gina aikace -aikacen ganowa.
An yi ta da damuwa game da sirrin, musamman game da tsarin da ke bisa bin diddigin yanayin yanayin masu amfani da manhajar.
Zaɓin da ba shi da hankali ya ƙunshi amfani da siginar Bluetooth don yin rajistar kusanci da sauran wayoyin salula na mai amfani.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa aikin kai tsaye zuwa tsarin aikin su na Android da iOS don tallafawa irin waɗannan aikace-aikacen da ke amfani da Bluetooth.
A China, gwamnatin kasar Sin ta tura wani manhaja tare da Alipay, wanda zai ba wa 'yan kasa damar duba ko sun yi hulɗa da mutanen da ke da COVID-19.
Ana amfani da shi a birane fiye da 200 na kasar Sin. A Singapore, ana amfani da wani app mai suna TraceTogether.
Aikace-aikacen da al'ummar IT na gida suka haɓaka, an saki shi a matsayin mai buɗewa kuma za a ba da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da "StopKorona!" aikace-aikacen da ke kan Bluetooth don gano alaƙa da mutanen da ke da cutar kuma samar da saurin amsawa ga hukumomin kiwon lafiya.
An haɓaka app ɗin ne ta Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya.
Har zuwa 14 ga Afrilu, 2020, wannan app yana jiran amincewa ta Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce manhajar ganowa tana cikin wani ci gaba na ci gaba, kuma za ta kasance a cikin makonni don tsarawa. An tsara irin wannan app ("StopCovid") a Ireland da Faransa.
Dukansu Ostiraliya da New Zealand suna la'akari da aikace-aikacen da suka dogara da TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha tana son gabatar da aikace-aikacen geofencing ga marasa lafiya da aka gano COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa fita daga gida.
Ross Anderson, Farfesa a fannin aikin tsaro a Jami'ar Cambridge ya lissafa wasu matsaloli masu yuwuwa na aiki tare da tsarin tushen app, gami da maganganun kuskure da yiwuwar rashin tasiri idan amfani da app ya iyakance ga ƙananan ɓangaren jama'a.
Da yake magance damuwa game da yaduwar aikace-aikacen "coronavirus" masu yaudara ko cutarwa, Apple ya ƙayyade irin nau'ikan ƙungiyoyi da za su iya haɗa aikace-aikacen da suka shafi cutar coronavirus a cikin App Store, yana iyakance ga ƙungiyoyi "suna" ko kuma waɗanda aka yaba da su.
Google da Amazon sun kafa irin wannan takunkumi.
Masu fafutukar tsare sirri sun nuna damuwarsu game da tasirin sa ido mai yawa ta amfani da aikace-aikacen coronavirus, musamman ma game da ko za a lalata tsarin sa ido da aka gina don magance cutar ta coronavirus bayan wannan barazanar ta wuce.
Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke neman a takaita irin wannan sa ido.
Kungiyoyi sun bayyana sharudda takwas kan ayyukan gwamnati:
Dole ne sa ido ya zama "daidai, dole, da kuma daidaitacce";
Dole ne a sami sashe na ƙarshe don ƙarin kulawa da kulawa;
Amfani da bayanai ya zama iyakance ga dalilai na COVID-19.
Dole ne a kiyaye tsaro da kuma rashin sani na bayanai kuma a nuna cewa an kiyaye su bisa ga shaidar;
Ya kamata a guji sanya saɓani da kuma hana mutane samun 'yanci ta hanyar sa ido ta hanyar dijital;
Dole ne a ayyana kowane rabawa na bayanai tare da ɓangare na uku a cikin doka;
Dole ne a sami matakan kare haƙƙin 'yan ƙasa don magance cin zarafi da kuma amsawa ga cin zarafi;
Za a buƙaci "matsayi mai ma'ana" ta duk "masu ruwa da tsaki" ciki har da masana kiwon lafiyar jama'a da ƙungiyoyi marasa ƙarfi. The German Chaos Computer Club (CCC) da Reporters Without Borders (Reporters Without Borders) (RSF) suma sun fitar da jerin abubuwan bincike.
Manufar shirin Google / Apple da aka gabatar shine magance matsalar sa ido na yau da kullun ta hanyar cire tsarin ganowa daga tsarin aiki na na'urorin su lokacin da ba a buƙatarsa.
Wasu ƙasashe sun yi amfani da hanyar sadarwa maimakon aikace -aikacen, suna kawar da buƙatar saukar da aikace -aikace da ikon guje wa bin sawu.
A Isra'ila, an amince da bin hanyar sadarwa.
Hanyoyin sadarwa da suke da damar samun bayanai na wuri suna da matsala mai muhimmanci na tsare sirri.
Duk da haka, ba duk tsarin da ke da uwar garken tsakiya ba ne ke buƙatar samun damar bayanan wuri na mutum; an halicci tsarin tsare sirri da yawa waɗanda ke amfani da uwar garken tsakiya don sadarwa kawai (duba sashe na ƙasa).
An yi amfani da tsarin da ba na app ba wajen gano abokan hulɗa a Koriya ta Kudu.
Maimakon amfani da ƙa'idar da aka keɓe, tsarin ya tattara bayanan bin diddigin daga tushe daban-daban, gami da bayanan bin diddigin na'urar hannu da bayanan ma'amalar katin, kuma ya haɗa su don samar da sanarwar ta hanyar saƙonnin rubutu ga mutanen da ke da yiwuwar kamuwa.
Baya ga amfani da wannan bayanin don faɗakar da masu alaƙa, gwamnati ta ba da bayanin wurin jama'a saboda canje-canje masu nisa a cikin dokokin sirrin bayanai bayan barkewar cutar MERS a wannan ƙasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar aikace-aikace da yanar gizo da yawa. Kasashe da dama, ciki har da Jamus, sun yi la'akari da amfani da tsarin tsakiya da tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a ba da waɗannan bayanan ba.
Bayanin tuntuɓar sirri shine ingantaccen ra'ayi tare da babban jikin adabin bincike tun aƙalla 2013. Har zuwa 7 ga Afrilu 2020, sama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Duk da haka, PEPP-PT ƙoƙari ne na daidaitawa wanda ya ƙunshi duka hanyoyin da aka rarraba da kuma rarraba, kuma ba yarjejeniya ɗaya ba. Tsarin da aka rarraba ya haɗa da tsarin da aka rarraba na tsare sirri-tsare na kusanci (DP-PPT/DP-3T), lambar tuntuɓar wucin gadi (TCN, a baya lambar taron tuntuɓar, CEN), yarjejeniyar sirri mai mahimmanci da kuma tsarin don gano hanyoyin sadarwa na wayar hannu (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan mutum da za a iya ganewa ba sa fita daga na'urar, kuma duk na'urar da ta dace tana nan.
The Privacy Group a MIT Media Lab yana haɓaka SafePaths, dandamali don amfani da fasahohin kare sirri yayin tattarawa da amfani da wurin ko hanyar haɗuwa da bayanai don bin diddigin yaduwar COVID-19.
Wannan yana dogara ne akan bincike a cikin takarda mai suna "Apps Gone Rogue: Kula da Sirrin Sirri a cikin Cutar", wanda aka fitar a watan Maris na 2020. Irin wannan yunƙurin shine SafeTrace ta Enigma MPC, kamfanin haɓaka fasahar tsare sirri, wanda aka fara kafa shi a MIT Media Lab.
SafeTrace yana amfani da fasahohin kayan aiki masu aminci, wanda ke ba masu amfani damar raba wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi ba tare da yin sulhu da sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Alliance na Duniya ta ƙungiyoyi waɗanda suka shirya a cikin mahimman ra'ayi da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTrace da ake amfani da ita ta hanyar aikace-aikacen hukuma na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun ba da sanarwar wani shiri don gano tuntuɓar, wanda suka yi iƙirarin zai kare sirrin bisa haɗin fasahar Bluetooth mai ƙarancin makamashi da kuma ɓoye-ɓoye na sirri.
Ya kuma wallafa takamaiman fasahohi na asali da ake amfani da su a cikin tsarin.
A cewar Apple da Google, ana nufin samar da wannan tsarin a matakai uku:
Bayar da kayan aiki don bawa gwamnatoci damar ƙirƙirar aikace-aikacen gano cutar coronavirus na sirri na sirri.
Shigar da wannan aiki kai tsaye zuwa iOS da Android
Maimaita magani (wanda kuma ake kira sake amfani da magani, sake fasalin, sake sanyawa ko sauyawar magani), shine sake amfani da magani da aka amince dashi don magance wata cuta ko yanayin likita daban da wanda aka fara kirkirarsa.
Wannan tsari ne na bincike na kimiyya wanda a halin yanzu ake amfani da shi don haɓaka ingantaccen magani na COVID-19.
Sauran umarnin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma allurar plasma da ke da alaƙa da fa'idodin kiwon lafiya. SARS-CoV-2 yana da kusan sunadarai 66 masu niyya, kowannensu yana da wuraren ɗaure ligand da yawa.
Binciken waɗannan wuraren da ke ɗaure yana ba da kyakkyawan shiri don haɓaka ingantaccen maganin antiviral don kariya daga sunadarai na COVID-19.
Mafi mahimmancin sunadarai na SARS-CoV-2 sune papane-like protease, RNA mai dogara da RNA polymerase, helicase, S protein, da ADP ribosphate.
Hussain da sauransu sun yi nazarin wasu magungunan da suka yi takara, sannan suka daidaita da kuma bincika su don kamanceceniya da tsarin su tare da magungunan da aka amince da su mafi yawa, don hanzarta ci gaban ingantaccen maganin SARS-CoV-2 a cikin nazarin farko da aka ba da shawarar a cikin tsarin binciken asibiti.
Chloroquine magani ne na rigakafin zazzabin cizon sauro wanda kuma ake amfani dashi don kariya daga wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da kuma hydroxychloroquine mai alaƙa za su kasance cikin magunguna huɗu da za a yi nazari a kansu a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin New York State na chloroquine da hydroxychloroquine zai fara daga ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquyl phosphate a ƙarƙashin izinin amfani da gaggawa (EUA).
Ba a amince da maganin ta hanyar FDA ba ta hanyar gwajin gwaji kuma an ba da izini ne kawai a ƙarƙashin EUA a matsayin magani na gwaji don amfani na gaggawa a cikin marasa lafiya waɗanda ke asibiti amma ba su iya samun magani a gwajin gwaji ba.
CDC ta ce "Amfani, sashi ko tsawon lokacin hydroxychloroquine don rigakafi ko magani na cutar SARS-CoV-2" ba a kafa ba tukuna.
Likitoci sun ce suna amfani da maganin ne lokacin da "babu wani zaɓi".
Wata ƙungiyar bincike ta Turkiyya a Istanbul tana yin karamin nazari a kan amfani da Chloroquine a hade da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan bincike a jami'ar Duke da kuma jami'ar Oxford.
NYU Langoon Medical School tana gudanar da gwaji kan aminci da ingancin amfani da maganin hana cutar hydroxychloroquine.
Gwaje -gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin nuna favipiravir a matsayin "mai tasiri sosai".
A Shenzhen, marasa lafiya 35 sun gwada rashin lafiya a matsakaicin kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kai kwanaki 11 a cikin marasa lafiya 45 da ba su samu ba.
A wani bincike da aka yi a Wuhan a kan marasa lafiya 240 da ke fama da ciwon huhu, rabi sun sha maganin favipirovir, rabi kuma sun sha maganin omifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa hujjojin da ke goyon bayan maganin ba su da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiyarta, kuma za ta yi amfani da sojojin don isar da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya tura wa gwamnatin Trump takardar neman sayan maganin da zai iya zama mai tasiri a cikin mawuyacin yanayin cutar, inda cutar ta riga ta ninka.
Ba zai zama lafiya ba ga mata masu juna biyu ko mata da ke ƙoƙarin yin ciki.
Wani bincike na maganin rigakafi na lopinovir da ritonavir, mai hadewa, lopinovir/ritonavir (Caletra), ya kammala da cewa "babu wani amfani da aka gani".
An tsara su ne don hana kwayar cutar HIV yin kwafi ta hanyar ɗaure su da protease.
Wata ƙungiyar masu bincike daga Jami'ar Colorado suna ƙoƙarin gyara magunguna don nemo mahaɗin da zai ɗaure zuwa protease na SARS-CoV-2. Ana fuskantar zargi a cikin ƙungiyar kimiyya game da tura albarkatu don sake amfani da magungunan da aka haɓaka musamman don HIV / AIDS.
WHO ta haɗa lopinavir/ritonavir cikin gwajin haɗin kai na duniya.
Gilead Sciences ne ya kirkiro Remdecivir kuma ya bunkasa shi a matsayin magani na cutar Ebola da kuma kamuwa da cutar Marburg. Gilead Sciences daga baya ta gano cewa Remdecivir yana da aikin yin amfani da maganin rigakafi na wucin gadi don kare kariya daga wasu kwayoyin cutar phyllo-, pneumo-, paramexo - da coronaviruses.
Wata matsala da maganin rigakafi ita ce ci gaban juriya ta hanyar maye gurbi wanda zai iya haifar da mummunar cuta da watsawa.
Wasu nazarin farko na gwaji sun nuna cewa Remdesivir na iya samun babban takunkumi na kwayoyin halitta ga juriya. Akwai gwaje - gwaje na asibiti da yawa da ke gudana, ciki har da gwaje - gwaje biyu da asibitin Jami'ar Cleveland ke gudanarwa; daya ga mutanen da ke da matsakaiciyar cuta da kuma na biyu ga mutanen da ke da cuta mai tsanani.
Akwai gwaje - gwaje na asibiti guda uku na intravenous Vitamin C don waɗanda ke asibiti da waɗanda ke da cutar COVID-19; biyu da aka sarrafa da placebo (a China, Kanada) da ɗaya ba tare da sarrafawa ba (a Italiya).
Jihar New York ta fara gwaji don maganin rigakafi azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya (NCGM) ta Japan tana shirin yin gwajin asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Ana gudanar da gwajin kashi na II na enzyme mai canza angiotensin 2 tare da marasa lafiya 200 da ke da ciwo mai tsanani a Denmark, Jamus da Austria don tantance tasirin maganin.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar da colchicine ke takawa wajen rage kumburi da cututtukan huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Binciken COLCORONA yana ɗaukar manya 6000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna fuskantar ƙananan alamun da ba sa buƙatar asibiti.
Mata da suke da juna biyu ko masu shayarwa ko kuma waɗanda ba sa amfani da hanyar hana haihuwa mai inganci ba su cancanci.
Ana gwada wasu maganin hana yaduwar jini a Italiya.
Ana amfani da ƙananan ƙwayar heparin don magance marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta wallafa jagororin amfani da shi.
An sanar da wani bincike mai yawa a Italiya a ranar 14 ga Afrilu, wanda ya shafi marasa lafiya 300 da ke gudanar da bincike kan amfani da Enoxaparin sodium a allurai na rigakafi da na magani.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan sake amfani da magungunan rigakafin kwayar cuta da aka amince da su, waɗanda aka haɓaka don ɓarkewar da ta gabata kamar MERS, SARS da West Nile Virus.
Ribavirin: An ba da shawarar ribavirin don maganin COVID-19 bisa ga jagororin na 7 na kasar Sin.
Umyfenovir: An ba da shawarar Umyfenovir don maganin COVID-19 bisa ga jagororin na 7 na kasar Sin.
Wasu maganin rigakafi da aka gano cewa za a iya sake amfani da su a matsayin maganin COVID-19:
Tosilizumab (mai hana IL-6): an amince da shi a kasar Sin.
An kuma yi gwaji a Italiya da China.
Allurar COVID-19 allurar rigakafi ce da ake tsammani don kariya daga cutar Coronavirus 2019 (COVID-19).
Ko da yake babu wani allurar rigakafi da ta kammala gwajin asibiti, ana ta yin ƙoƙari sosai don samar da irin wannan rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin samun allurar rigakafi a ƙasa da watanni 18 don kariya daga SARS-CoV-2, kwayar cutar da ke haifar da cutar.
'Yan takarar allurar rigakafi guda biyar suna cikin gwajin lafiya na farko a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020, wata babbar annoba ta bazu a duniya, wanda ya haifar da zuba jari da kuma ayyukan bincike don samar da allurar rigakafi.
Kungiyoyi da yawa suna amfani da kwayoyin halittar da aka buga don haɓaka yiwuwar allurar rigakafi don kariya daga SARS-CoV-2.
A watan Afrilu, an bayyana cewa, abubuwan da CEPI ke bukata don samar da allurar rigakafi su ne saurin, iyawar samarwa, tsarawa a kan sikelin da kuma samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun sanar da cewa a farkon 2020 ana gudanar da bincike da ci gaban dandamali daban-daban guda 10 na fasaha don samar da ingantaccen rigakafi don kariya daga COVID-19.
Ƙarfafa manyan manufofin dandamali a cikin nazarin tsaro na Phase I sun haɗa da:
Kwayar nucleic acid (DNA da RNA) (mai haɓaka mataki na 1 da kuma ɗan takarar allurar rigakafi: Moderna, mRNA-1273)
Mai ɗaukar hoto (mataki na I mai haɓaka da kuma ɗan takarar rigakafi: CanSino Biologics, Adenovirus Type 5 vector)
Kamar yadda masana kimiyyar CEPI suka sanar a watan Afrilu, akwai masu neman allurar rigakafi 115 a farkon matakin ci gaba, 78 daga cikinsu an tabbatar da su a matsayin ayyukan aiki (milken institute ya ce 79) da kuma wasu 37 da aka sanar, amma akwai karancin bayanan jama'a (wanda ake tsarawa ko kuma ake tunaninsa a cikin shiri).
A Phase I - II gwaji yana da farko aminci da immunocompetence gwaje - gwaje, wannan yawanci ana yi a bazuwar, placebo - sarrafawa da kuma a wurare da yawa, saita mafi daidai, tasiri sashi.
Gwaje - gwaje na Phase III yawanci suna da ƙarin mahalarta, tare da rukunin kulawa don lura da tasirin cutar a mafi kyawun sashi, da kuma gwajin tasirin rigakafin cutar.
Daga cikin 'yan takarar allurar rigakafi 79 da ke cikin ci gaba (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su cikin kimantawar ɗan adam (har yanzu suna cikin binciken "preclinical").
A kusa da 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayar halitta, wanda zai canza kwayar cutar ta kwayar halitta don haifar da amsawar rigakafi.
A Kanada, a ranar 24 ga Janairu, 2020, Cibiyar Alurar riga kafi ta Duniya a Jami'ar Saskatchewan (VIDO-InterVac) ta sanar da fara aiki kan allurar rigakafi, tare da burin fara gwajin ɗan adam a 2021.
An sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020 da kuma a Jami'ar Hong Kong a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairu, 2020, kamfanin Yansen Pharmaceutical, wanda Hanneke Schutemaker ke jagoranta, ya sanar da cewa ya fara aiki kan samar da rigakafi.
Yansen yana haɓaka allurar rigakafin baki tare da abokin aikinsa na fasahar zamani, Vaxart.
A ranar 18 ga Maris, 2020, Emergent Biosolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, Laboratory Oncogene a Romania ta buga wata takarda kan ƙirar allurar rigakafi mai kama da fasahar da ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala aikin samar da rigakafin kuma suna fara gwaji.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani reshen Generex, ya sanar da cewa suna ƙaddamar da aikin rigakafi don ƙirƙirar maganin peptides mai mahimmanci don kariya daga COVID-19.
Suna son samar da wani takarar rigakafi da za a iya gwadawa a cikin mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye -shiryenta na samar da rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Binciken Likita da Kayan Aikin Sojoji ta Amurka a Fort Detrick da Walter Reed Army Institute of Research a Silver Spring, Western Maryland, sun sanar da cewa suna aiki kan rigakafi.
A kusan 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa za ta ci gaba da yin amfani da wannan fasaha wajen samar da allurar rigakafi.
Za su yi aiki tare da Novavax Inc.
Abokan hulɗa sun sanar da tsare-tsare don gwajin farko da gwajin gwaji na Phase I zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da masu rarrabuwa 11, kuma hakan zai ɗauki akalla shekara ɗaya da rabi zuwa biyu don haɓaka rigakafi, koda a kan hanya mai sauri.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere a Quebec City, Quebec, ya ba da rahoton ci gaban kwayar cutar coronavirus a karkashin wani bangare na kudi daga Cibiyar Nazarin Lafiya ta Kanada.
Maganin rigakafin yana cikin binciken dakin gwaje-gwaje, tare da shirin gwajin ɗan adam a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa Shugaba Donald Trump na Amurka ya ba Kurwak "babban kuɗi don sayen takardar rigakafin COVID-19 na musamman", wanda gwamnatin Jamus ta ƙi.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin Biotech na Jamus don haɓaka allurar rigakafin mRNA.
BNT162, ɗan takarar rigakafin mRNA, a halin yanzu yana cikin gwajin farko, wanda ake tsammanin zai fara gwajin asibiti a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, kamfanin fasahar kere-kere na Italiya Taxis Biotech ya sanar da cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020 kuma za a iya fara gwajin a kan takardar rigakafin su na ƙarshe a cikin kaka.
A ranar 19 ga Maris, 2020, a Faransa, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar rigakafin COVID-19, wanda ya haɗa da Institut Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh, wanda ke sanya CEPI saka hannun jari na dala miliyan 29 a cikin ci gaban allurar rigakafin COVID-19.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na 'yan takarar allurar rigakafi guda shida.
Masu bincike a Imperial College London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka rigakafin RNA mai haɓaka kansa don COVID-19.
An haɓaka wannan ɗan takarar rigakafin a cikin kwanaki 14 na samun jerin daga China.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da dala miliyan 275 a cikin kuɗi don ayyukan bincike 96 kan hanyoyin kiwon lafiya don kariya daga COVID-19, gami da yawancin masu neman allurar rigakafi daga kamfanoni da jami'o'in Kanada, kamar su Medicago da Jami'ar Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta sanar da dala miliyan 192 don haɓaka takardar rigakafin COVID-19 musamman, tare da shirin kafa "Bankin rigakafin" na ƙasa na sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su yayin da wasu cututtukan coronavirus suka ɓarke.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, wata allurar rigakafin COVID-19 a cikin beraye, suna cewa "SARS-CoV-2 S1 subunit vaccines da aka bayar ta MNA sun haifar da martani na rigakafin antigen-takamaiman [a cikin beraye] wanda ya bayyana ya fara makonni 2 bayan allurar rigakafi".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da ƙirar ɗan takarar rigakafin DNA a matsayin mai yuwuwar fesa hanci.
Yin amfani da bacteriophage, za a tsara DNA don yin kwafi a cikin kwayoyin halittar mutum don samar da kwayoyin cutar da ba su da lahani, wanda zai iya motsa tsarin garkuwar jiki don samar da kwayoyin cuta don kariya daga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun tara albarkatu don samun damar yin amfani da su daga IBM zuwa manyan kwamfutoci, tare da haɗin gwiwar girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako mai ban mamaki, wanda ake kira sakamako mara mahimmanci.
Wannan yana nufin cewa suna iya samun fa'ida ban da cutar da suke hanawa.
Wani gwaji na bazuwar a Ostiraliya yana kiran ma'aikatan kiwon lafiya 4,170 su shiga.
Yana yiwuwa cewa allurar rigakafi ba za ta kasance mai lafiya ko tasiri ba a cikin ci gaba.
Bincike na farko da ke tantance tasirin allurar rigakafi ta amfani da ƙirar dabbobi na COVID-19, kamar ACE2-transgenic mice, sauran dabbobin gwaji, da kuma primates waɗanda ba na ɗan adam ba, yana nuna buƙatar matakan kiyaye lafiyar 3 don magance kwayar cutar mai rai da kuma haɗin kai na duniya don tabbatar da daidaitaccen hanyoyin kariya.
An gwada allurar rigakafi don kariya daga SARS da MERS a cikin samfuran dabbobi marasa ɗan adam.
Har zuwa 2020, babu magani ko rigakafin rigakafin SARS da aka nuna duka biyu masu lafiya da tasiri a cikin mutane.
Bisa ga takardun bincike da aka buga a shekara ta 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don maganin SARS ya kasance babban fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya.
Lokacin da MERS ya zama gama gari, an yi imanin cewa binciken SARS na yanzu na iya samar da tsari mai amfani don haɓaka allurar rigakafi da magani don kariya daga kamuwa da cutar MERS-CoV.
Har zuwa Maris 2020, akwai allurar rigakafin MERS (mai dogara da DNA) da ta kammala gwajin gwaji na farko a cikin mutane, kuma akwai wasu uku a cikin ci gaba, dukkansu allurar rigakafin ƙwayar cuta ce, biyu adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), da kuma MVA-vectored (MVA-MERS-S).
Shafukan sada zumunta sun inganta makirci da ke da'awar cewa an san cutar da ke haifar da COVID-19 kuma cewa riga an sami rigakafi.
Takaddun shaida da aka ambata ta hanyar rubutun kafofin watsa labarun daban-daban suna nuni ne ga takaddun shaida na yanzu don jerin kwayoyin halitta da kuma alluran rigakafi don wasu nau'ikan coronavirus kamar SARS coronavirus.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da cutar coronavirus 2 (SARS-CoV-2).
Alamun na kowa sun haɗa da zazzabi, tari, da kumburi.
Sauran alamun na iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙanshi, da kuma ciwon ciki.
Lokaci daga lokacin da aka kamu da kwayar cutar zuwa lokacin bayyanar cututtuka yawanci kusan kwanaki biyar ne amma yana iya zuwa kwanaki biyu zuwa goma sha huɗu.
Ko da yake a mafi yawan lokuta alamun suna da sauƙi, a wasu lokuta cutar sankarar cutar da kuma rashin ƙarfi na jiki.
Ya zuwa 17 ga Afrilu 2020, an sami rahotanni sama da miliyan 2.24 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yaduwa tsakanin mutane a lokacin hulɗa ta kusa, galibi ta hanyar tari, sneezing, ko kuma ta hanyar magana.
Ko da yake ana samun waɗannan ɗigon sa'ad da mutum ya yi numfashi, amma yawanci sukan fāɗi a ƙasa ko kuma a kan saman ƙasa maimakon su yaɗu a nesa.
Mutane ma za su iya kamuwa da cutar ta wurin taɓa datti kuma daga baya su taɓa idanunsu, hanci, ko kuma bakinsu.
Kwayar cutar na iya rayuwa har tsawon sa'o'i 72.
Yana da mafi yawan kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya yiwuwa a watsa a cikin matakan cututtuka da kuma bayan bayyanar cututtuka. Hanyar ganewar asali shine ainihin lokacin jujjuyawar jujjuyawar polymerase chain reaction (rRT-PCR) daga fashewar nasogastrin.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ke zargin cewa suna da kwayar cutar da kuma masu kula da su.
Shawarwarin amfani da abin rufe fuska ta hanyar jama'a sun bambanta, wasu hukumomi suna ba da shawarar kada a yi amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna ba da shawarar yin amfani da su.
A halin yanzu, babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An sami yaduwar cutar a cikin yawancin ƙasashe na duk yankuna shida na WHO.
Mutanen da suka kamu da kwayar cutar na iya zama masu rashin lafiya ko kuma su sami alamun cutar kamar zazzabi, tari, gajiya da kumburi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsi na yau da kullun, rikicewa, wahalar farkawa da launin shuɗi na fuska ko lebe; ana ba da shawarar neman kulawa ta gaggawa idan waɗannan alamun sun bayyana.
A wasu lokatai, ana iya ganin alamun sama na numfashi kamar su sneezing, nasal flush, ko kuma ciwon makogwaro.
An lura da alamun gastrointestinal kamar naushi, amai da kuma zawo a cikin kashi daban -daban.
A wasu lokutan da aka yi a ƙasar Sin, an fara ganin ƙwanƙwasawa da kuma bugun zuciya.
A wasu lokatai, cutar na iya ƙaruwa zuwa ciwon huhu, rashin aiki da yawa, da mutuwa.
Ana kiran wannan lokacin lokacin farkawa.
Lokacin fitowar COVID-19 yawanci kwanaki biyar zuwa shida ne, amma yana iya zuwa kwanaki biyu zuwa 14.
97.5% na mutanen da suka samu alamun cutar sun samu a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duka mutanen da suka kamu da cutar ba ne suka samu alamun cutar.
Ba a san cikakken matsayin waɗannan masu ɗaukar hoto a cikin watsawa ba; duk da haka, shaidar farko ta nuna cewa suna iya ba da gudummawa ga yaduwar cutar.
Rashin bayyanar cututtukan da ba su da alamun cutar ba a halin yanzu ba a sani ba kuma ana nazarin su, wanda Cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da su sun kasance marasa lafiya yayin da suke asibiti.
Hukumar Lafiya ta kasa ta kasar Sin ta fara hada da cututtukan da ba su da cutar a cikin al'amuranta na yau da kullun a ranar 1 ga Afrilu; 130 (78%) daga cikin kamuwa da cutar 166 a wannan ranar sun kasance marasa cutar a lokacin gwaji.
Dukansu mucous da saliva na iya samun babban adadin kwayar cutar.
Magana da ƙarfi yana sa saurin magana ya yi yawa fiye da magana da murya.
Wani bincike da aka yi a Singapore ya nuna cewa tari marar rufi zai iya haifar da ɗigon ruwa mai tsawon mita 4.5 (15 feet).
Ko da yake ba a yawan samun cutar ta iska, National Academy of Sciences ta ce ana iya samun cutar ta hanyar amfani da iska, kuma samfurori da aka samu daga masu tara iska a cikin ɗakunan mutane sun nuna cewa akwai kwayar cutar RNA.
Wasu hanyoyin kiwon lafiya kamar su tube penetration da cardiopulmonary therapy (CPR) na iya haifar da aerosol daga numfashi kuma ta haka ne ya zama iska.
Ko da yake akwai damuwa cewa za a iya yada shi ta hanyar fitsari, an yi la'akari da cewa wannan hadarin yana da ƙananan. Wannan kwayar cutar tana da saurin yaduwa lokacin da mutane ke da alamun; kodayake yana yiwuwa a yadu kafin bayyanar cututtuka, amma haɗarin yana da ƙananan.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a bayyana yadda sauƙin cutar take yaɗuwa ba, mutum ɗaya yakan kamu da mutane biyu ko uku.
Musamman, an gano kwayar cutar a cikin kwana ɗaya a kan kwali, har zuwa kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), da awanni huɗu a kan 99% na jan ƙarfe.
Duk da haka, yana da bambanci dangane da zafi da kuma zafin jiki.
Idan aka yi amfani da shi daidai, sabulu da masu cirewa suna da tasiri; kayayyakin sabulu suna kashe ƙwayoyin cuta ta hanyar lalata fat da ke kare su, tare da kawar da su daga fata da sauran wurare.
Wasu magunguna, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe ƙwayoyin cuta), ba su da tasiri sosai. A wani binciken da aka yi a Hong Kong, an ɗauki samfurori na hanta bayan kwana biyu bayan an fara asibiti.
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna yawan kwayar cutar, kuma mai haƙuri na shida ya nuna yawan kwayar cutar a rana ta biyu na gwajin.
Cutar cutar sankarar numfashi mai tsanani coronavirus 2 (SARS-CoV-2) wani sabon kwayar cutar sankarar numfashi mai tsanani ne, wanda aka fara ganowa daga mutane uku da ke fama da cutar sankarar numfashi a Wuhan.
Dukkanin halayen kwayar cutar SARS-CoV-2 ana samunsu a cikin kwayar cutar coronaviruses da ke da alaƙa da juna.
A wajen jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke karya garkuwar kariya. SARS-CoV-2 yana da alaƙa da ainihin SARS-CoV.
Fuka-fukan su ne gabobin da COVID-19 ya fi shafawa saboda kwayar cutar tana kaiwa ga ƙwayoyin abinci ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin cuta na nau'in II na huhu.
Kwayar cutar tana amfani da wani takamaiman glycoprotein mai farfajiya da ake kira "contact" (peplomer) don haɗuwa da ACE2 da shiga cikin kwayar halitta.
An gano lalacewar zuciya mai tsanani a kashi 12% na waɗanda suka kamu da cutar a asibiti a Wuhan, China, kuma ya fi kowa a cikin mummunar cuta.
Akwai ƙimar cututtukan zuciya saboda rashin lafiyar amsawar jiki da kuma rashin lafiyar tsarin rigakafi yayin ci gaban cutar, amma lalacewar myocardial mai tsanani na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da yawa a cikin zuciya kuma suna cikin aikin zuciya.
An sami ƙaruwar yawan cutar thrombosis (31%) da kuma ƙwayar cuta ta jini (25%) a cikin marasa lafiya na ICU da ke da kamuwa da COVID-19, wanda zai iya danganta da rashin ganewar asali. An gano lalacewar iska mai iska (DAD) da kuma lymphocyte-containing extraneous substance a cikin huhu a cikin autopsies na mutanen da suka mutu daga COVID-19.
Kodayake SARS-COV-2 yana da bin diddigin ƙwayoyin cuta na ACE2-expressing epithelial cells na hanyar numfashi, marasa lafiya da ke da COVID-19 mai tsanani suna da alamun hawan jiki.
Musamman, kwayoyin cutar GM-CSF-secretory T-cell an nuna su suna da alaƙa da zaɓin mai ba da IL-6-secretory monocytes da kuma mummunar cutar huhu a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton wani abu na waje na lymphocytic a cikin autopsy.
WHO ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwaji ta yau da kullum ita ce ainihin lokaci na juyawa na polymerase chain reaction (rRT - PCR).
Ana yin wannan gwajin ne a kan samfurin numfashi da aka samu ta hanyar hanci na hanci; duk da haka, ana iya amfani da hanci na hanci ko samfurin mucous.
Sakamakon yana samuwa a cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki misalai biyu na jini a tsakanin makonni biyu kuma sakamakon ba shi da muhimmanci nan take.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in kwayar cutar coronavirus da kuma buga jerin kwayoyin domin dakunan gwaje -gwaje a duniya su samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da kwayar cutar.
Har zuwa 4 ga Afrilu 2020, gwajin antibody (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya riga ya kamu) suna cikin ci gaba amma har yanzu ba a yi amfani da su sosai ba.
Gwajin da aka yi a kasar Sin ya nuna cewa tsarkinsa ya kai kashi 60 zuwa 70 cikin dari.
A Amurka, FDA ta amince da gwajin farko-a-wuri a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagororin asibiti da asibitin Zhongnan na Wuhan University ya bayar sun ba da hanyoyin gano kamuwa da cuta bisa ga abubuwan asibiti da haɗarin cutar.
A farkon kamuwa da cuta, ana samun bambancin gilashin ƙasa mai yawa tare da rarrabawar gefe, asymmetric da baya.
Yayin da cutar ke ci gaba, za a iya ganin rinjaye na subplural, Crazy Paving (ƙwaƙwalwar ganuwar da ke da canzawar ƙwayar iska), da kuma ƙarancin.
Akwai ƙananan bayanai game da ƙananan raunuka da kuma aikin jiki na COVID-19.
Babban binciken da aka samu daga binciken gawa shine:
Yin amfani da allon gani: Cutar kumburi, ciwon zuciya, ƙuƙwalwar huhu, da kuma kumburi a cikin ƙuƙwalwar huhu
Za a iya ganin nau'i huɗu na cutar sankarar bargo:
Ƙananan ciwon huhu: ƙwayoyin huhu, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa tare da ƙwayoyin cuta na lymphocytic, ƙwayoyin cuta masu yawa da kuma ƙwayoyin cuta masu yawa.
Cutar ciwon huhu mai tsanani: lalacewar iska mai iska (DAD) tare da zubar da iska mai iska.
DAD yana haifar da ciwon numfashi mai tsanani (ARDS) da kuma rashin isashshen iskar oxygen.
Kula da ciwon huhu: kula da ɓarna da kuma ƙwayoyin cuta na cikin huhu a cikin ƙwayoyin cuta
Jinin: Rashin ƙwayar cuta mai yaduwa (DIC); halayen leukoarrhythroblasts
Matakan rigakafi don rage yiwuwar kamuwa da cuta sun hada da zama a gida, guje wa wuraren taruwa, wanke hannu da sabulu da ruwa akai -akai kuma aƙalla na dakika 20, kiyaye tsaftace numfashi mai kyau, da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa wanke.
CDC ta ba da shawarar rufe baki da hanci da wani abu idan ka yi tari ko sneezing kuma idan babu wani abu da za ka yi amfani da shi, sai ka yi amfani da ciki na gwiwar hannu.
Ana ƙarfafa tsaftace hannu bayan tari ko sneezing.
CDC ta ba da shawarar yin amfani da sutura a cikin wuraren jama'a don iyakance watsawa ta hanyar mutanen da ba su da rigakafi. Dabarun nisantar da jama'a suna nufin rage hulɗa da manyan rukuni na mutane masu kamuwa da cutar, ta hanyar rufe makarantu da wuraren aiki, hana tafiya, da soke manyan tarurrukan jama'a.
Shawarwarin nisantar mutane sun hada da nisantar mutane da nisan akalla ƙafa 6 (1.8 m).
Babu wani magani da aka sani da zai iya magance COVID-19. Tunda ba a tsammanin samun allurar rigakafi aƙalla har zuwa 2021, wani muhimmin ɓangare na gudanar da COVID-19 shine ƙoƙarin rage girman cutar, wanda ake kira "rage ƙwanƙolin".
CDC ta kuma ba da shawarar cewa mutum ya wanke hannayensa da sabulu da ruwa akai -akai na akalla sakan 20, musamman bayan ya je bayan gida ko idan hannayensa sun kasance masu datti, kafin cin abinci, da kuma bayan ya fesa hanci, tari, ko kuma yayyafa.
Bugu da ƙari, yana ba da shawarar yin amfani da mai tsabtace hannu mai tushen giya wanda ke da aƙalla kashi 60% na giya, amma kawai idan sabulu da ruwa ba su da sauƙi. A yankunan da ba a samun sauƙin samun kayan aikin tsabtace hannu na kasuwanci, WHO tana ba da tsari biyu don samarwa na gida.
A cikin waɗannan maganganun, maganin antimicrobial yana fitowa daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide a cikin giya don taimakawa wajen kashe ƙwayoyin cuta; "ba abu ne mai aiki don hana hannu ba".
Ana haɗa glycerol a matsayin mai laushi.
Ana kula da mutane tare da kulawa mai taimako, wanda zai iya haɗawa da maganin ruwa, taimakon oxygen, da kuma taimakon sauran gabobin da suka shafi.
CDC ta ba da shawarar cewa mutanen da ake zargin suna da kwayar cutar su sanya abin rufe fuska na yau da kullun.
An yi amfani da maganin ƙwayar cuta na ƙwayar cuta (ECMO) don magance matsalar rashin numfashi, amma amfaninsa har yanzu yana cikin tambaya.
An ba da shawarar tsabtace mutum da salon rayuwa mai kyau da abinci don inganta rigakafi.
Magungunan taimako na iya zama da amfani a cikin mutanen da ke da alamun cututtuka a farkon matakin kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun wallafa shawarwari don kula da mutanen da ke asibiti tare da COVID-19.
Masana ilimin motsa jiki da masu ilimin cututtukan huhu a Amurka sun tattara shawarwarin magani daga hukumomi daban -daban a cikin wani tushen kyauta, IBCC.
Har zuwa Afrilu 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu ma'aikatan kiwon lafiya suna ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Dole ne a ɗauki matakan kiyayewa don rage haɗarin watsa kwayar cutar, musamman a cikin tsarin kiwon lafiya, lokacin da ake aiwatar da hanyoyin samar da aerosol kamar su shigar da bututun mai ko kuma yin amfani da hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutanen da ke dauke da cutar COVID-19, CDC ta ba da shawarar sanya mutumin a cikin dakin keɓewar kamuwa da cutar (AIIR) ban da yin amfani da daidaitattun matakan tsaro, matakan tuntuɓar mutane da kuma hanyoyin iska. CDC ta tsara jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan da aka ba da shawarar su ne: rigar PPE, na'urar numfashi ko abin rufe fuska, kayan kariya na ido, da safofin hannu na likita. Idan akwai, ana ba da fifiko ga na'urar numfashi (maimakon abin rufe fuska).
An amince da masu numfashi na N95 don tsarin masana'antu, amma FDA ta ba da izinin abin rufe fuska don amfani a ƙarƙashin Ikon Amfani da Gaggawa (EUA).
An tsara su don kariya daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da inganci ga takamaiman mai amfani da kwayoyin ba don gwaje - gwaje marasa yarda.
CDC ta ba da shawarar yin amfani da garkuwar fuska ko, a matsayin na ƙarshe, abin rufe fuska da aka yi a gida idan ba a samun abin rufe fuska.
Yawancin lokuta na COVID-19 ba su da tsanani har su buƙaci aikin gyaran inji ko wasu zaɓuɓɓuka, amma a cikin kashi kaɗan, hakan ya zama dole.
Ana yin nazarin nau'ikan taimakon numfashi don mutanen da ke fama da cutar COVID-19 tare da masu shiga asibiti, tare da wasu shaidu cewa ana iya guje wa shigar hanci tare da babban kwararar nasal ko matsin lamba biyu na iska.
Ba a san ko ɗaya daga cikin waɗannan yana ba da fa'ida iri ɗaya ga waɗanda ke da ciwo mai tsanani ba.
Wasu likitoci sun fi son yin amfani da inhalation na inji idan akwai saboda wannan fasaha tana iyakance yaduwar aerosol fiye da na nasal mai yawa. Abubuwa masu tsanani sun fi kowa a cikin tsofaffi (sama da shekaru 60 da musamman ma sama da shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti a kowane mutum, wanda ke iyakance ikon tsarin kiwon lafiya don ɗaukar ƙaruwar kwatsam na adadin mummunan COVID-19 da ke buƙatar asibiti.
Wani bincike a China ya gano cewa kashi 5% na waɗanda aka kwantar a rukunin kulawa mai tsanani, kashi 2.3% suna bukatar taimakon inji don yin aiki, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na waɗanda aka kwantar a asibiti tare da COVID-19 sun ƙare a cikin ICU.
Haɗin inji yana da rikitarwa yayin da COVID-19 ke haɓaka ciwon ƙwayar cuta mai tsanani (ARDS) kuma yana da wahala a samar da iskar oxygen.
Ana buƙatar tsarin sarrafa matsin lamba da masu ƙarfin PEEP masu ƙarfi don haɓaka isar da iskar oxygen yayin rage haɗarin lalacewar huhu da pneumothorax.
Ƙananan PEEP bazai kasance a kan tsofaffin masu sanyaya iska ba.
Bincike kan yiwuwar magani ya fara a watan Janairun 2020, kuma magungunan rigakafin cutar da yawa suna cikin gwajin asibiti.
Remdesivir ya fi nuna cewa yana da kyau.
Kodayake ana iya haɓaka sabbin magunguna har zuwa 2021, yawancin magungunan da ake gwadawa an riga an yarda da su don sauran amfani ko kuma suna cikin gwaji na ci gaba.
Ana iya gwada maganin rigakafi a cikin mutane da ke da mummunar cuta.
WHO ta ba da shawarar masu sa kai su shiga gwajin inganci da amincin magunguna. FDA ta ba da izinin ɗan lokaci don samar da plasma mai fa'ida ga lafiyar mutum a matsayin magani na gwaji a cikin yanayin da akwai haɗarin gaske ko na gaggawa ga rayuwar mutum.
Ba a gudanar da nazarin asibiti da ya dace don nuna cewa yana da lafiya da tasiri ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar salula domin magance annobar.
Ana tambayar masu amfani su shigar da sunansu da lambar ID.
Wannan app yana iya gano yiwuwar haɗarin kamuwa da cuta ta hanyar gano 'kusa da lamba' ta amfani da bayanan sa ido.
Kowane mai amfani zai iya ganin matsayin wasu masu amfani uku.
Idan aka gano yiwuwar haɗarin, app ɗin ba kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da manyan bayanai don nazarin bayanan wayar salula, fasahar ganewar fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin mutanen da ke da cutar da waɗanda suka sadu da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zargin suna da cutar coronavirus.
An dauki wannan matakin ne don aiwatar da keɓewa da kuma kare mutanen da suka sami hulɗa da mutanen da suka kamu da cutar.
Bugu da ƙari, a cikin Maris 2020, Deutsche Telekom ta raba bayanan wurin waya tare da Robert Koch Institute, hukumar gwamnatin tarayya ta Jamus don hana yaduwar cutar da bincike.
Rasha ta yi amfani da fasahar gane fuska don gano masu keta dokar keɓewa.
Kwamishinan kiwon lafiya na yankin Italiya Julio Galera ya ce masu wayar salula sun sanar da shi cewa "kashi 40% na mutane suna yin wasu motsi".
Gwamnatin Jamus ta shirya taron karshen mako na sa'o'i 48 tare da mahalarta sama da 42,000
Bugu da ƙari, Shugaban Estonia, Kirsti Kaljulaid, ya yi kira na duniya don samar da hanyoyin magance cutar coronavirus.
Mutane na iya fuskantar wahala daga keɓewa, hana tafiya, tasirin magani, ko tsoron kamuwa da cutar da kansu.
BBC ta nakalto Rory O'Connor, "ƙaruwar warewar jama'a, kaɗaici, damuwar lafiya, matsi, da kuma koma bayan tattalin arziki, su ne yanayi na yanayi da ke lalata lafiyar mutane da kuma lafiyarsu".
Wannan cuta na iya zama mai sauƙi ko kuma ba tare da wasu alamun da suka dace da sauran cututtukan na sama ba, kamar sanyi.
Sauƙaƙan yanayin yakan warke cikin makonni biyu, yayin da mawuyacin yanayi ko kuma matsanancin yanayi zai iya ɗaukar makonni uku zuwa shida.
Dangane da bayanai daga wasu irin waɗannan ƙwayoyin cuta kamar SARS da MERS, mata masu juna biyu na iya samun babban haɗarin kamuwa da cutar COVID-19, amma akwai ƙarancin bayanai game da COVID-19. A cikin wasu mutane, COVID-19 na iya haifar da cutar huhu ta hanyar shafar huhu.
A cikin mutanen da suka fi fama da cutar, COVID-19 na iya saurin zama cutar rashin ƙarfi na numfashi (ARDS), wanda ke haifar da rashin ƙarfi na numfashi, ciwon baya ko rashin ƙarfi da yawa.
Matsalar da ke tattare da COVID-19 sun haɗa da kumburi, rashin daidaituwa, da lalacewar zuciya, koda, da hanta.
Rashin daidaituwa na scandial, musamman ma a cikin prothrombin lokaci, an ba da rahoton a cikin 6% na mutanen da aka kwantar da su a asibiti tare da COVID-19, yayin da 4% na wannan rukunin ke da aikin koda mara kyau.
Kimanin kashi 20-30% na waɗanda ke kamuwa da COVID-19 suna nuna ƙaruwar enzymes na hanta (transaminases).
A wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da kwanaki biyar da aka yi a asibiti.
Koyaya, marasa lafiya da aka tura ICU suna da matsakaicin kwanaki bakwai tsakanin shiga asibiti da mutuwa.
A cikin wani binciken farko, matsakaicin lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance kwanaki 14, tare da cikakken kewayon kwanaki shida zuwa 41.
A wani binciken da Hukumar Lafiya ta kasa (NHC) ta kasar Sin ta yi, mace-mace sun mutu a kashi 2.8 cikin dari, yayin da maza suka mutu a kashi 1.7 cikin dari.
Binciken ƙwayoyin cuta na jikin jikin mutum na samfurori na huhu na autopsy ya nuna lalacewar iska mai iska tare da salwantar fibromycoside a cikin huhu biyu.
An lura da canje -canje na kwayar cutar da ke haifar da kwayar cutar a cikin ƙwayoyin cuta.
Fure ya bayyana kamar cutar numfashi mai tsanani (ARDS).
A cikin kashi 11.8 na mutuwar da Hukumar Lafiya ta Kasa ta China ta ruwaito, an lura da lalacewar zuciya ta hanyar yawan troponin ko kuma bugun zuciya.
A watan Maris na shekara ta 2016, kashi 89 cikin ɗari na waɗanda aka kwantar a asibiti suna da cututtukan da suka riga sun wanzu. Samun wadatar magani da kuma yanayin zamantakewar al'umma na iya shafar yawan mutuwa.
Ƙididdigar yawan mutuwa daga wuri zuwa wuri ya bambanta saboda bambancin yanki da kuma matsalolin da suka shafi tsarin.
Ƙananan ƙididdigar ƙananan lokuta na iya haifar da ƙimar mutuwa.
Koyaya, gaskiyar cewa mutuwar ta kasance sakamakon abubuwan da suka faru a baya na iya nufin cewa an rage yawan mutuwar yanzu.
Masu shan sigari sun fi masu shan sigari sau 1.4 na fuskantar bayyanar cututtukan COVID-19 da ke da haɗari fiye da waɗanda ba sa shan sigari, kuma kusan sau 2.4 na buƙatar kulawa mai tsanani ko mutuwa.
Hukumar Asibitocin Hong Kong ta gano cewa a cikin wasu mutane da suka warke daga cutar, damar huhu ta ragu da kashi 20 zuwa 30 cikin dari, kuma hotunan huhu sun nuna lalacewar gabobin jiki.
Zai iya haifar da ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon.
Har zuwa Maris 2020, ba a san ko kamuwa da cuta ta baya tana ba da rigakafi mai tasiri da na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
An ga rigakafi a matsayin mai yuwuwa dangane da halayyar sauran coronaviruses, amma an sami rahoton gwajin tabbatacce ga coronavirus a kwanan wata bayan an warke daga COVID-19.
Ana ganin waɗannan shari 'yan sun fi cutar da ba ta warke ba.
An yi la'akari da cewa kwayar cutar ta zama ta halitta kuma ta yadu daga dabba zuwa mutum ta hanyar kamuwa da cuta.
Ba a san ainihin asalin ba, amma ya zuwa Disamba 2019, yaduwar kamuwa da cuta kusan gaba ɗaya ta hanyar yaduwar mutum zuwa mutum ne.
A cikin nazarin shari'o'in farko 41 na COVID-19 da aka tabbatar, wanda aka buga a cikin Lancet a cikin Janairu 2020, an ba da farkon farkon bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Ofishin WHO ya sanar da farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni da yawa don ƙayyade yawan mutuwa.
Waɗannan lambobin suna canzawa ta yanki da lokaci kuma suna da tasiri ta hanyar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da aka fara barkewar cutar, da halaye na yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta ƙaddara lambar cutar ta gaggawa ta ICD-10 U07.1 don mutuwar da ke faruwa daga kwayar cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da kuma lambar cutar U07.2 don mutuwar COVID-19 da aka yi ba tare da tabbatar da SARS-CoV-2 ba.
Bisa ga bayanan Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Lambar ta bambanta ta yanki. Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano cewa sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (wanda aka gano da wanda ba a gano ba).
Waɗannan bayanan ba na lokaci ba ne kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warkewa.
Ko da yake ba dukan mutane da suka kamu da cutar ba ne suke samun rigakafi, bayyanar rigakafin zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, a cikin wani karamin ƙauye na mutane 4,600, Castiglione d'Aeda, 80 (1.7%) sun riga sun mutu.
A Gangelt, cutar ta bazu ta hanyar bukukuwan Carnival da kuma tsakanin matasa, wanda ya haifar da raguwar mutuwar, kuma ba za a iya rarraba duk mutuwar COVID-19 bisa hukuma ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba shi da iyaka.
A Netherlands, kimanin kashi 3 cikin ɗari na masu ba da jini suna da rigakafi.
An tabbatar da mutuwar 69 daga COVID-19 (0.004% na yawan jama'a).
Cutar da kuma yawan mutuwar ta ya bambanta ga maza da mata.
Nazarin da aka yi a ƙasar Sin da kuma Italiya ya nuna cewa maza suna mutuwa sosai.
Maza suna da haɗari sosai a shekarunsu na 50, kuma bambancin tsakanin maza da mata ya ragu ne kawai a shekarunsu na 90.
A China, mace - mace ta kai kashi 2.8 ga maza da kuma kashi 1.7 ga mata.
Ba a san ainihin dalilin da ya sa ake wannan bambancin tsakanin mata da maza ba, amma za a iya cewa wasu abubuwa da suka shafi hali da kuma hali ne suke haddasa hakan.
Bambancin rigakafi na jinsi, ƙarancin shan sigari a cikin mata, da kuma ci gaba da yanayin co -motherhood a cikin maza kamar hawan jini a cikin matasa fiye da mata na iya ba da gudummawa ga yawan mutuwar maza.
A Turai, 57% na waɗanda suka kamu da cutar maza ne kuma 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa Afrilu 2020, gwamnatin Amurka ba ta bin diddigin ƙididdigar jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura, da SARS suna shafan maza da mata a hanyoyi dabam dabam.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna iya kamuwa da cutar.
Hukumar Lafiya ta Duniya (WHO) ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar zai zama "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin Corona, VI na nufin Virus, D na nufin cutar, kuma 19 na nufin shekarar da aka fara gano cutar, wato 31 ga Disamba, 2019.
An zaɓi sunan ne don kauce wa ambaton takamaiman wuri na ƙasa (kamar China), nau'in dabbobi, ko ƙungiyar mutane, wanda ya dace da shawarwarin ƙasa da ƙasa don suna don hana ɓarna.
WHO ta ƙara amfani da "COVID-19 Virus" da "Virus responsible for COVID-19" a cikin sadarwa ta jama'a.
Dukkanin cutar da kwayar cutar ana kiranta "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da kuma "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV a matsayin sunayen wucin gadi na cutar da cutar na cututtukan numfashi, wanda ke bin ƙa'idodin 2015 na rashin amfani da wurare a cikin sunayen cututtukan da ƙwayoyin cuta.
An ba da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakokin iya aiki a cikin sarkar samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su nasal faeces da sassan masu sanyaya iska.
A wani misali, sa'ad da asibiti na Italiya yake bukatar bawul na iska da gaggawa, kuma mai ba da kayayyaki bai iya ba da su a cikin lokacin da ake bukata ba, wani sabon kamfanin da ke wajen ya buga bawul 100 da ake bukata cikin dare.
Bayan barkewar COVID-19, makirci, kuskuren bayani da kuma ɓatar da hankali game da asalin cutar, matakin, rigakafi, magani da sauran fannoni sun bayyana kuma sun yadu cikin sauri ta yanar gizo.
Mutane sun iya yada cutar a wasu dabbobi.
Binciken ya kasa samun tabbacin kwayar cutar a aladu, ducks, da kaji.
Babu magani ko allurar rigakafi da aka amince da shi don maganin cutar.
Ana gudanar da bincike na duniya kan alluran rigakafi da magunguna a cikin COVID-19 ta hanyar ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu binciken masana'antu.
A watan Maris, WHO ta ƙaddamar da "Gwaji na Solidarity" don kimanta tasirin maganin maganin ƙwayoyin cuta huɗu da ke akwai waɗanda ke da mafi yawan bege na tasiri.
Babu allurar rigakafi a halin yanzu, amma hukumomi daban -daban suna haɓaka masu neman allurar rigakafi.
Aikin da ya gabata akan SARS-CoV yana amfani dashi saboda duka SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Ana bincika dabarun allurar rigakafi guda uku.
Na farko, masu bincike suna son samar da cikakkiyar allurar rigakafin cutar.
Amfani da irin wannan kwayar cutar, ko ta mutu ko ta mutu, yana da nufin haifar da saurin amsawar rigakafin jikin mutum ga sabon kamuwa da cutar tare da COVID-19.
Wata dabarar ta biyu, allurar rigakafi, tana da nufin samar da rigakafi wanda zai sa tsarin garkuwar jikin mutum ya zama mai saukin kamuwa da wasu ɓangarorin cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya mai da hankali ne akan furotin S-contact wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce allurar nucleic acid (DNA ko RNA, sabuwar fasaha ta yin allurar).
Dole ne a gwada allurar rigakafin gwaji don aminci da tasiri a kowane ɗayan waɗannan dabarun. A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko na allurar rigakafi tare da masu ba da agaji huɗu a Seattle.
Allurar rigakafin tana ɗauke da kwafin kwayar cutar da ba ta da lahani. An nuna ƙaruwa mai dogara da ƙwayoyin cuta a matsayin wata ƙalubale ga ci gaban allurar rigakafin SARS-COV-2, amma wannan yana da rikici.
Fiye da gwaji na asibiti 300 suna gudana har zuwa Afrilu 2020.
Gwaje -gwaje bakwai suna kimanta maganin da aka riga aka amince da shi don zazzabin cizon sauro, ciki har da gwaje -gwaje huɗu a kan hydroxychloroquine ko chloroquine.
Tare da gwajin Phase III tara a kan Remdesivir a ƙasashe da yawa, wanda aka shirya sanar da su a ƙarshen Afrilu, yawancin binciken na Sin suna kan magungunan antiviral masu sake amfani.
Har zuwa watan Afrilu 2020, ana ci gaba da nazarin ci gaban asibiti don allurar rigakafin COVID-19 da kuma 'yan takarar magani. Ana kimanta yawancin magungunan rigakafin cutar COVID-19, gami da Remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir tare da interferon beta.
Har zuwa Maris 2020, akwai tabbacin gwaji don tasirin Remdesivir.
An ga ci gaba a asibiti a cikin marasa lafiya da aka bi da su tare da amfani da Remdesivir wanda ba a amince da shi ba.
Ana gudanar da gwajin gwaji na Phase III a Amurka, China da Italiya. Chloroquine, wanda aka riga aka yi amfani da shi don maganin zazzabin cizon sauro, an yi nazari a cikin China a watan Fabrairun 2020 tare da sakamakon farko.
Duk da haka, ana bukatar a sake nazarin binciken.
Hukumar kiwon lafiya ta Koriya da ta Sin sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayoyin cuta ta Wuhan ta ba da shawarar a sha kashi ɗaya a rana, tana lura cewa ninki biyu na cutar yana da haɗari sosai kuma yana iya zama mai mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga hydroxychloroquine da chloroquine a kan ƙwarewar likitocin da ke kula da mutanen da ke da COVID-19. Jagororin na 7 na kasar Sin sun haɗa da interferon, ribavirin, ko umyfenovir don amfani da kariya daga COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar manyan allurai na ribavirin don hana SARS-CoV-2 na wucin gadi.
An ba da shawarar nitazoxanide don ƙarin nazarin cikin kwayoyin bayan nuna ƙarancin ƙwayar SARS-CoV-2. Nazarin ya nuna cewa farkon haɗin haɗin protein na farko ta hanyar sirrin protease 2 (TMPRSS2), hulɗa tare da mai karɓar ACE2, yana da mahimmanci don shigar da SARS-CoV-2.
Akwai manyan iyakoki ga nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba, wanda ya hana ƙungiyar likitanci ɗaukar waɗannan jiyya ba tare da ƙarin nazari ba. Osaltamivir ba ya hana SARS-CoV-2 na wucin gadi kuma ba shi da wani sanannen matsayi a cikin maganin COVID-19.
Hawan cytokines na iya zama matsala a cikin matakan ƙarshe na COVID-19.
Akwai tabbaci cewa hydroxychloroquine na iya samun halayen hana ƙaruwar cytokines. Tukilizumab an haɗa shi cikin jagororin magani ta Hukumar Lafiya ta China bayan kammala ƙaramin bincike.
Ana gudanar da gwajin ba tare da izini ba na Phase 2 a Italiya bayan an sami sakamako mai kyau a cikin mutane masu cutar mai tsanani.
A hade tare da gwajin jini na serum ferritin don gano ƙaruwar cytokines, an yi niyya ne don magance irin wannan ƙaruwar, wanda ake ganin ya haifar da mutuwa a wasu mutanen da ke fama da cutar.
An amince da maganin mai karɓar mai karɓar Interleukin-6 a cikin 2017, bisa ga nazarin yanayin da aka yi a baya, don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Har zuwa yau, babu wani gwaji na yau da kullum, wanda aka sarrafawa cewa tosilezumab yana da tasiri ga maganin CRS.
Ana bincika sauya tsarkakakkun da kuma ƙwararrun rigakafin da tsarin rigakafin mutane ke samarwa daga waɗanda suka warke daga COVID-19 zuwa waɗanda suke buƙatar su a matsayin hanyar da ba ta rigakafi ba ta yin allurar rigakafi.
An yi amfani da wannan dabarar don SARS tare da sakamako mara kyau.
Rashin ƙwayar cuta na ƙwayar cuta shine tsarin da ake tsammani wanda maganin rigakafin da ba shi da aiki zai iya daidaita kariya daga SARS-CoV-2.
Duk da haka, wasu hanyoyin aiki, kamar su ƙwayoyin cuta masu ƙwayoyin cuta da kuma/ ko phagocytosis, suna iya faruwa.
Wasu nau'o'in maganin rigakafin da ba su da aiki, misali yin amfani da rigakafin monoclonal da aka yi, suna ci gaba.
Za a iya ƙara samar da magani mai amfani da ke dauke da ruwan jini daga jinin waɗanda suka warke da kuma ƙwayoyin cuta da ke da takamaiman rigakafi ga wannan cuta don saurin tsarawa.
Cutar Coronavirus, rukuni ne na cututtukan da suka shafi kusanci
Li Wenliang, likita a asibitin Wuhan, wanda ya kamu da COVID-19 kuma ya mutu bayan ya kara wayar da kan jama'a game da yaduwar cutar.
